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Abstract 
The reporting of blood cell morphology, by biomedical scientists using microscopy, is a 
subjective and relatively uncontrolled process; morphology reports impact directly 
upon the clinical care of patients, however, no large studies of the processes 
morphologists employ to reach their conclusions have been undertaken. 
This thesis chronicles the collaborative process with a national provider of quality 
assessment services (UK NEQAS(H)); detailing the pioneering developments that 
culminated in the creation of a national scheme, incorporating digital images of 
peripheral blood cells and accredited for continuous professional development. Annual 
exercises, using digital images distributed via the internet, were used to develop, test 
and create the scheme. Two workshops provided early assessment and feedback from 
participants.  The aim of this research was to then evaluate the responses of the large 
number of professionals who completed cases, to give insights into how they interpret 
the blood cell morphology to produce their succinct report.  
The responses of between 732 and 1,018 participants (median 878) were examined for 
five digital morphology cases specifically selected to cover a range of morphological 
features. The subsequent data examination shows that patterns of error and bias were 
found in the responses that have not been described in blood film reporting before. 
Where a single morphological abnormality existed (glandular fever or Pelger-Huët 
anomaly), the ability to identify the feature of interest was high (97% and 84% 
respectively), however, errors in knowledge-based classification were seen. For 
complex cases, with multiple abnormal features, additional errors of inattention and 
premature completion were found; in the case of lymphoma with oxidative haemolysis 
68% correctly reported the acute haemolysis, however, only 17% correctly reported 
both abnormal pathologies. Heuristic methods of decision-making, not considered in 
morphology reporting before, help the understanding of these patterns of error and 
bias.  
Following this research the national scheme will be adapted to support participants by 
indicating the potential common forms of error found in morphology reporting.  
Words: 315 
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York, 2014 (Joint with John Burthem). 
 
Oral presentations at international meetings 
 
Digital morphology for training and competency in laboratory haematology: do you see 
what I see? At the Indian Ocean Rim Laboratory Haematology Congress. 15th October 
2015. Freemantle, Western Australia. 
 
Digital Blood Cell Morphology for Education of Laboratory Professional: Do you see 
what I see? At the New Zealand Institute of Medical Laboratory Scientists Annual 
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We Make Errors in Morphological Diagnosis? An Analysis of Approach and Decision-
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Consideration of Ethics and Governance        
 
08/06/2011  Project Proposal Professional Doctorate Candidate 381533. 
 
Project Working Title: Digital Morphology: A National Scheme Supporting Continuous 
Professional Development. 
 
The UK NEQAS scheme for General Haematology has overall governance for the Digital 
Morphology Scheme. This project was initiated in 2000 and is reviewed by the national 
Scientific Advisory Panel at the annual meeting of the Morphology Scientific Advisory 
Group. The overall development of the Digital Morphology scheme is governed by UK 
NEQAS (H) of which this project forms part. Ethical issues have been considered by 
both the Morphology SAG and UK NEQAS (H) under two main categories:   
 
a/ The preparation of morphology cases is covered by the policies applied to the 
collection of all material for EQA purposes in that samples may only be used if they are 
discard material from routine testing which has been fully anonymised and is not 
traceable back to a patient. For the use of images in the digital morphology scheme 
clinical details and patient demographic data are also altered from the original, ie 
patient ages and test results are altered from the original source data. 
 
 b/ The extraction of participant input from the CPD scheme is totally anonymised and 
not traceable. It is not possible to associate extracted data to any individual. No 
participant demographic data will be extracted nor made available. This project will 
use only the morphology features selected and the diagnosis input. Once data is 
extracted, it will not be possible to associate data with any individual. The participants 
are not being tested, this data extraction is to interrogate the scheme design and 




Professor  Keith Hyde PhD, FIBMS, FRCPath 
Director United Kingdom External Quality Assessment Scheme for  
General Haematology [UK NEQAS(H)] & 
Director World Health Organisation (WHO) 
Collaborating Centre for Quality in Haematology 
  
Clinical Director (Joint) Greater Manchester Laboratory Medicine 
(Pathology) Network 
  
Consultant Clinical Scientist 
Manchester Royal Infirmary Medical Centre 
 
Governance of ethical considerations of research controlled by UK NEQAS(H) no 
further applications for ethics required.  
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Chapter One: Introduction 
The Department of Health’s (DH) requirement for a publicly accountable National 
Health Service (NHS) has produced a number of important reports that directly 
influence the way pathology services are implemented and operated (HBN 15, 2005). 
Government led initiatives, including the review by Lord Carter of Coles on 
unwarranted variation in the operational productivity and performance of NHS acute 
hospitals in England, (Carter, 2016, page 36) demand that laboratories constantly 
strive to improve efficiency. They must maintain and improve quality standards in a 
patient focused environment. As laboratories evolve to meet these objectives they 
must embrace a culture of accountability and responsibility by effectively 
demonstrating to patients and other service users that they are continually achieving 
targets and tackling areas of weakness. 
1.1 Professional practice and clinical governance in pathology laboratories 
The Health and Care Professions Council (HCPC) were created by legislation; Health 
and Social Work Professions Order 2001, updated 2016 (Bircham Dyson Bell, 2016). 
The HCPC are the independent regulator of health professionals working within the 
NHS in the United Kingdom (UK) with the aim of protecting the public by setting 
standards and maintaining a public register of properly qualified professionals; 
including laboratory-based biomedical scientists (BMS) who meet those standards. The 
HCPC take action to prevent any individual on their Register continuing to practice 
should they be proven to be in breach of those standards (HCPC, 2014).  
In January 2006 the HCPC introduced legislation requiring all professional registrants to 
take responsibility for proving their commitment to continuing professional 
development (CPD). This legislation, updated in 2011, aims to ensure that any 
individual who wishes to remain on the register demonstrates they are continuing to 
develop their knowledge and skills (HCPC, 2011). Importantly both the individual 
professional, and the laboratory that employs them, are subject to formal inspection 
by a number of national regulatory bodies including the UK Accreditation Service 
(UKAS). Both the individual and the organisation must provide evidence of compliance 
with professional standards and a commitment to raising skill levels by CPD, all within 
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a climate of increasing productivity and improving efficiency. Medical laboratories 
work to the international quality management standard developed by the 
International Organization for Standardization's Technical Committee 2012: ISO 15189. 
(ISO, 2012). Inspection of evidence against the standard is carried out by UKAS for all 
aspects of sample processing and result reporting (UKAS, 2017).    
The Institute of Biomedical Science (IBMS) is the national professional body for 
biomedical scientists (BMS) who provide most of the technical services within routine 
service pathology laboratories. The IBMS publishes polices for professional practice 
(IBMS, 2017), sets examinations, offers professional educational facilities and provides 
a forum for laboratory staff to interact, however, membership of the IBMS is not 
mandatory but those who choose not to join must also comply with HCPC regulations 
and provide evidence of CPD but do so independently.       
1.2 The modern haematology laboratory  
The individuals’ requirement to demonstrate CPD and improving skills have to occur in 
laboratories evolving their services to meet the public demand to access pathology 
whenever they require. The implementation of Agenda for Change in 2004 began the 
standardisation in the terms and conditions of service within the NHS (NHS Employers, 
2016). This included rates of pay, so laboratories were encouraged to move away from 
minimal, but expensive, emergency style cover outside of core hours to a more robust 
continuous service. This new 24/7 laboratory also needed to provide a wider test 
repertoire than had generally been made available outside core hours at nights and 
weekends, requiring managers to replace minimal out of hours staffing with new shift 
patterns.  
Laboratories are required to demonstrate that they provide high quality services, no 
matter when they are accessed, whilst remaining efficient and providing value for 
money. Managers are challenged to increase productivity, absorb increasing 
workloads, achieve faster turn-a-round times and ensure consistency so have invested 
in automated processes. This has led to an increased reliance upon the latest 
technology, including computer-based information strategies (IT) and also by 
workforce restructuring to reduce staff costs.  
Page | 24  
 
1.2.1 Quality assurance within the haematology laboratory  
To achieve targets laboratories use sophisticated analysers to produce precise 
measurements of multiple biological parameters at a rapid speed for immediate 
clinical use. To achieve speed the analysers are designed to detect and measure 
analytes within predefined limits into which the majority of patient results are 
expected to fall. Such analysers are subject to intensive validation and verification 
processes, and employ rule-based, continuous IT monitoring systems to ensure the 
results produced are rigorously controlled to the highest possible quality standard. For 
the haematology laboratory, the main routine test profile is the full blood count (FBC) 
which provides a measure of the quantity and quality of all the cells expected to be 
present in peripheral blood (Brereton, McCafferty, Marsden, Kawai, Etzell & Ermens, 
2016). The FBC is processed using highly automated analysers, with flow cytometry 
technology to produce a profile of at least 20 different test parameters from a single 
sample in a matter of minutes. Individual laboratories may analyse over a thousand 
individual patient FBC samples every day so must run their analysers to the highest 
level of precision and accuracy and be able to prove to external inspectors that they 
are doing so.  
Where available, biological material of a known data value is used as a calibrator to 
ensure those tests are as accurate as possible when referenced against this value. 
Analyser manufacturers also produce material of set values termed internal quality 
control (IQC) to check analyser function; laboratories then define a regular protocol for 
IQC use. Furthermore, for high volume testing of patient samples, the laboratory can 
set limits in the analyser software against all component tests of the FBC and then 
monitor the mean values obtained from batches of patient results giving a real time 
measure of the precision of analyser function. Should the quality of the results 
deteriorate, or values drift beyond those preset limits the analyser will stop. A BMS 
must then investigate the cause before any more patient samples can be processed.   
Despite such advances in the testing and control of the FBC, the any subsequent 
examination of that sample generated results which lie outside the set limits, is usually 
carried out manually via the labour intensive examination of a blood film. These blood 
films are prepared by spreading a drop of blood of variable size (< 5 µl) on a glass slide 
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and staining the smear using a combination of biochemical stains with acidic and basic 
dyes reliant on the pH of cellular components (Horobin & Walter, 1987). The stained 
slide is then examined by an experienced laboratory-based BMS using microscopy. 
Even in the modern haematology laboratory the examination and reporting of the 
blood film remains primarily a manual and, therefore, highly subjective process 
(Constantino, 2015). Demonstrating effective IQC for morphology reporting is difficult, 
laboratories should introduce some form of competence testing for their staff but 
there are no guidelines upon which to base the criteria for this (Sinclair, 2005). The 
blood film report issued by the BMS may drive further test selection and provides key 
diagnostic information to the clinician, upon which action will be taken and medical 
treatments influenced or determined.  
1.2.2 Automating morphology examination 
Semi-automated cell recognition systems are available and successfully used in some 
laboratories; the most widespread in the UK being produced by the Swedish based 
company CellaVisionTM (Ceelie, Dinklelaar & Gelder, 2007). Originally designed to use a 
standard microscope these systems scan the blood film to locate possible white cells 
then produce a series of separate images of individual white cells taken with x50 or 
x100 oil immersion objective. The images are then presented in a probable differential 
classification for a BMS to verify as correct or re-classify the cells (Brereton et al., 
2008c; Rezatofighi & Soltanian-Zadeh, 2011). The advantages to such systems include 
the speed in which they can produce a white cell differential, that images can be 
viewed by a number of people locally and remotely and the fact that results can be 
stored and are auditable. The systems are less advanced for red cell imaging, possibly 
because the lack of an internal structure e.g. granules or nucleus, means the system 
has no textural point to focus on, making red cells less easy to capture effectively. The 
technology requires complex IT interfacing to be used within the automated workflow, 
these reasons may explain why uptake nationally has been slow. Additionally, in the 
UK, the laboratory cannot alter the recognition capability, so if the system is poor at 
classifying any particular cell type it cannot be improved and user irritation can occur 
knowing the system will continually fail to correctly classify certain cells. The blood film 
limits the number of cells these systems can be set to classify, usually 100 to 200 white 
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cells, however, the automated FBC analysers process a larger volume of sample and 
classify more than 5,000 cells to produce a white cell differential (Meintker, Ringwald, 
Rauh & Krause, 2013). So, providing abnormal cells are not detected the BMS will 
usually select the results from the FBC analyser in preference. There are many reasons 
for examining a blood film, of which producing a white cell differential is a small part of 
the process. These considerations, along with the cost, cause laboratories to consider 
carefully whether they are appropriate.   
Microscopic viewing of a blood film in order to examine blood cell morphology is still 
regarded the `gold standard’ for interpreting abnormal FBC results for the requesting 
clinician (Bain, 2005). To perform the microscopic examination effectively requires that 
the BMS has a high level of expertise and an extensive knowledge of haematology, yet 
there are no professional guidelines or proficiency tests set at a national level for this 
service. Laboratory protocols should dictate that abnormal blood films are referred to 
a Consultant Haematologist for interpretative clinical comment, although to do this the 
BMS must recognise that an abnormality is present and understand when an 
abnormality requires referral. 
1.3 Challenges faced by laboratories providing blood cell morphology reporting 
Providing evidence and assurance verifying blood cell morphology reporting, which 
relies upon subjective recognition and interpretative skills by individuals, sets 
laboratories a great challenge, and little has been published on the reporting process 
to support them.  
The modern laboratory struggles to justify the labour intensive training and support 
previously used to raise skill levels for morphology reporting, where high levels of 
technical expertise are still required. Those BMS performing microscopy need to 
provide evidence for inspectors that they are maintaining and continuously developing 
their skills. This conundrum proves difficult to resolve, especially as morphology 
reporting expertise may be concentrated in a few key individuals, and presents a 
particular problem for smaller laboratories where the opportunity to gain experience 
of complex morphological cases may be limited. Supporting continuous 24/7 access to 
quality morphology reporting means that laboratory managers must provide training 
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and CPD opportunities; a problem when shift patterns dilute expertise from the day 
and so disrupt conventional training initiatives. With experienced staff working varied 
shifts across different sites it becomes difficult to arrange group based tutorials, allow 
staff time out of the laboratory to attend lectures, off-site training courses or to 
provide one to one training. One way to meet these demands is for employers and 
employees to embrace computer-based technologies and adopt new ways of 
supporting education and training (Kumar et al., 2004).  
1.4 Examination and reporting of blood cell morphology  
Many haematology laboratories have an automated process for blood film 
preparation, where the smear is made by a mechanical device and then stained either 
by the same device, or by a separate “staining” machine. There is published guidance 
on staining methods both from the International Committee for Standardization in 
Haematology (ICSH) (ICSH, 1984) and in the nationally popular reference book Dacie 
and Lewis Practical Haematology (Lewis, Bain & Bates, 2008). Manufacturers of stains 
and staining machines also offer guidance (Sysmex, 2017). Each laboratory will, 
however, then design its own specific protocol, choose to prepare or buy pre-prepared 
stains and select their own preferred timings to be used by the staining procedure to 
create a final blood film for examination by microscopy. BMS will become familiar with 
the appearance of films from their own laboratory but this will differ across sites. 
Essentially this lack of a core standard introduces a challenge for those learning and 
then practicing morphology reporting (Rajamaki, 1980). Such a subjective process 
demands that the quality of the blood film being examined is optimum; however this 
may not be the case. BMS who work for large NHS Trusts may find themselves working 
their shifts at different laboratory locations and may even find variation in staining 
quality across sites.  
BMS will have varied opportunities to acquire morphology reporting skills, their first 
experience being the training they receive at universities whilst obtaining their degree, 
but this is likely to cover only the basic techniques of using a microscope with a limited 
number of cases. Once employed, however, they will receive their initial exposure of 
microscopy in working practice and the opportunity to see a wide variety of different 
pathological disorders. Successful training requires that an expert or an experienced 
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BMS has time with the trainee morphologist, that they have an extensive selection of 
blood films showing all aspects of morphology they might encounter and access to 
reputable published training material (Bain, 2015). 
Laboratories set their own criteria for defining at what point their BMS staff are 
competent to report patient blood films and define a process for referring clinically 
urgent and abnormal findings. Under ISO 15189 laboratories must also document their 
expectations of what a person might safely report outside routine service hours and 
what expert support is available. The Royal College of Pathologists (RCPath) published 
a guideline for the communication of critical results but this is limited and not 
mandatory (RCPath, 2015).  The lack of national support for BMS reporting blood films 
remains largely unrecognised, it is only recently that the ICSH has published guidance 
for morphology nomenclature but these are unenforceable recommendations and do 
not provide offer guidance on the format of the final report (Palmer et al., 2015). 
When providing a morphology report the BMS must report the abnormal features they 
see, know how to react to those features and then decide what action to take. This 
might be to phone the clinical team, add further tests or to refer the film to a clinical 
colleague. It is also important that their report has meaning to the clinicians caring for 
the patient, who need to understand the significance of the features reported or their 
actions might not be appropriate. An experienced morphologist will summarise his or 
her morphology comments so as to convey an appropriate summary of their findings 
and may also suggest further tests or advise clinical referral to another team. 
1.5 External quality assessment and the role of the UK national external quality 
assessment service for general haematology 
Managing quality is an essential component of the daily processes for haematology 
services, although the real-time result monitoring using IQC and patient batch mean 
data (Chapter 1.2) is not easily applied to morphology reporting. Laboratories also 
subscribe to externally run quality assessment schemes (EQA) to compare the standard 
of their test results against that of other laboratories performing the same tests and 
using the same reagents or equipment. The UK National External Quality Assessment 
Service (UK NEQAS) is a company limited by guarantee (number 3012351) and a 
registered charity (number 1044013), the company vision is to use education as a tool 
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to improve standards in pathology laboratories, in doing so, to optimise patient care 
(UK NEQAS, 2017a). Any quality assessment scheme conforming to professional quality 
standards and complying with the UK NEQAS code of practice can be awarded a UK 
NEQAS designation. The main provider of EQA services for haematology laboratories in 
the UK is the UK NEQAS service for general haematology (H) located at Watford 
General Hospital. 
EQA schemes distribute material, by post, to registered laboratories which perform the 
tests within a set time frame and send their results back to the scheme headquarters, 
usually electronically, for subsequent comparison analysis. The reports returned will 
compare the performance of the registered laboratory to the consensus of all 
participating laboratories and/or to an expert opinion and often provide a 
mathematical score of performance. Should the performance of a laboratory in a 
NEQAS scheme be substandard, it is the duty of the scheme`s manager to report poor 
performance to the relevant laboratory manager and clinical lead. In the first instance 
UK NEQAS(H) seek to offer advice and to support laboratories with understanding why 
the poor performance has occurred and to resolve any technical issues which may be 
the root cause.  If a laboratory has a persistent poor performance then UK NEQAS(H) 
must also alert the national quality assurance advisory panel (NQAAP) for 
haematology. This panel has the responsibility of ensuring standards for analytical and 
interpretative work in UK laboratories; the IBMS nominate a professional 
representative to sit on the panel alongside a representative from the RCPath. The UK 
NEQAS(H) Steering Committee has an integrated relationship with the NQAAP, liaising 
over poor performance and reporting advice offered to participants with performance 
issues. Laboratories must disclose any poor performance letters they have received 
from UK NEQAS(H) to UKAS inspectors.  
In the UK, participation in EQA schemes is voluntary; however laboratories are 
required to produce evidence of participation in EQA programmes to various 
inspection bodies. Many laboratories also provide services to clinical trials and 
commercial enterprises which require that the laboratory is not only certified by 
independent inspection (e.g. UKAS) but has proven good performance in registered 
EQA schemes.    
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1.5.1 The UK NEQAS(H) scheme for blood cell and bone marrow morphology using 
glass slides 
EQA is available for morphology reporting in the UK, the most widely recognised 
scheme being the blood cell and bone marrow reporting scheme run by the UK 
NEQAS(H). This scheme began in 1968 and is popular, not only in the UK where more 
than 500 laboratories are registered including some from the private sector, but also 
from 80 non-UK countries where local national EQA schemes either do not provide an 
option for morphology reporting (e.g. Ireland) or have limited distributions of material 
(e.g. Portugal) (UK NEQAS, 2017b). 
The operation and developments of the scheme are overseen by a scientific advisory 
group (SAG) comprising of professionals, both clinical and scientific, who have 
significant experience and expertise in morphology reporting. The morphology SAG 
meet annually to select and approve the glass slide peripheral blood films that will be 
used by the scheme for distribution to participating laboratories. In recent years they 
have also overseen developments such as the increase in number of surveys 
distributed annually to eight in 2015 and the introduction of electronic data return in 
2016. The morphology SAG also reviews the schemes findings and the chair will report 
on developments and problems to the UK NEQAS(H) Steering Committee, comprised of 
the chairs of various haematology SAGs along with the manager and scheme director 
of UK NEQAS(H). In 2016 the morphology SAG looking to comply with ISO 15189 and 
reported some level of performance scoring would be developed for the glass slide 
scheme, to be introduced in 2018 (UK NEQAS(H), 2016). 
As a member of the morphology SAG since 2006, understanding the operational 
aspects of this scheme, its aims, achievements and limitations was essential when 
considering the possibilities for employing digital imaging technology for blood cell 
morphology.  
1.5.1.1 The glass slide scheme: operational issues 
Each survey contains two morphology cases, in the form of Romanowsky stained blood 
films posted out to participating laboratories, making a total of 16 cases per annum. 
With hundreds of laboratories participating both in the UK and abroad UK NEQASH) 
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require at least 700 blood films prepared for each case. Laboratories have 
approximately 10 days to examine the blood films, they are asked to: 
o Report up to 5 morphological features selected from a standard list of 
72 options, there is no priority rank to those features. 
o Suggest a morphological diagnosis 
Providing glass slide prepared blood films is comparable with the way most 
laboratories examine and report blood films so is suitable for EQA purposes but by 
default there are limitations.  
 To prepare a case there must be suitable blood available to make the sufficient 
blood films. Obtaining good material from unusual clinical cases or from 
children and babies is difficult to arrange.  
 There are logistical challenges in preparing and sending slides to so many 
laboratories, both in the UK and beyond, also in both the time it takes for 
laboratories to receive the cases and the time allowed for queries or repeat 
slides to be sent has to be factored in to the process.  
 There is the cost of preparing the material and the postage. 
 The appearance of the stain will be different to the laboratories own stain. 
 Registration and participation are by the laboratory as an entity and not by the 
individual professionals who are reporting the blood films, so the scheme 
cannot test an individual’s proficiency.  
 UK NEQAS(H) do not know whether slides are examined by one member of the 
laboratory staff, or reviewed by a team, neither is the level of experience 
known for the person reporting the slides. Without this information the 
scheme is limited about what scoring assessment can be offered and remains 
primarily educational into 2017.  
The glass slide surveys can provide laboratories with a good educational resource once 
the survey is completed and the final reports received, however, this process takes 
several weeks making engagement with staff on shift patterns a challenge. The 
laboratory must also provide storage space for the glass slides and access to copies of 
the relevant reports. Glass slides require cleaning and ideally covering with a thin glass 
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piece to protect them from being scratched whilst in storage. Glass slides are easily 
damaged or may simply not be returned correctly to storage by multiple users thus 
reducing the value of the resource.    
Whilst BMS reporting blood films do not provide a clinical diagnostic report for 
patients, as per regulation of practice by the HCPC, the morphological comments they 
do report are an interpretative summary of their findings and can directly impact on 
the clinical treatment or further testing that patients may then undergo. This infers 
that the BMS reporting films carry a high degree of responsibility for providing 
clinicians with the correct morphological information, yet there is no data on how 
influential that film report might be. In recognition of this situation UK NEQAS(H) 
actively encourage laboratories to suggest a morphological diagnosis for the glass slide 
survey cases. UK NEQAS(H) collate the returns and issue a report including histograms 
of consensus data of the morphological features selected and an expert opinion, which 
provides guidance for improved reporting and comment on the actual morphological 
diagnosis. The process takes time with reports available a number of weeks after the 
scheme has closed. Prior to 2014, reports were sent to the laboratory by post, they are 
now available electronically to laboratory leads, however, the mechanism by which 
reports are disseminated to the staff is undocumented. The length of the entire 
process creates difficulties with feedback to BMS whose shift patterns may mean that 
those receiving and reviewing the reports may not be those who originally participated 
in the survey.  
Overall, with so many laboratories participating, the glass slide scheme remains 
extremely successful. A key limitation being that it does not provide a measure of 
competency in morphology reporting for participating laboratories nor does it provide 
an indication of the standards of reporting between individuals within laboratories.    
1.6 The emergence of internet-based digital images of blood cell morphology for 
laboratory professionals 
The emergence of digital imaging within service pathology laboratories was most 
noticeable in histopathology where the scanning of tissue sections, at acceptably low 
magnification (x40 objective or less), could be easily achieved relatively successfully for 
archive. The storage of images has, in some histopathology laboratories, replaced the 
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need to store tissue sections on glass slides whilst the production of images deemed of 
satisfactory quality for education and teaching has been achieved without major 
expense (Krippendorf & Lough 2005). The use of histopathology images for the actual 
reporting of patient specimens has developed, understandably with caution (Furness, 
2007), but the drivers for employing images in a teaching environment for 
histopathology were clear as a limited amount of pathological material could be used 
and reused safely to teach numerous individuals. 
The acceptance of images for blood cell morphology education at a professional level 
in haematology was originally met with more resistance; the reluctance to embrace 
imaging was because the resolution of images taken with a x40 objective provided 
insufficient cellular detail (Szu-Hee 2005). However there are many advantages for 
incorporating digital images into a professional educational process (Solberg, 2012): 
 A single image can be evaluated by many users so multiple samples are not 
required. 
 Every user evaluates the same material so there is no variation in content. 
 Images are preselected for items of interest. 
 Reduced exposure to pathological material improves health and safety. 
 Image data is easily anonymised improving governance of patient information 
 Access to rare cases and low volume material as only one original image is 
required. 
 Potential to increase educational impact across geographic distance. 
 User access can be away from the laboratory. 
 Stability of image and retention of quality over time. 
 Organisation of archive material with storage of information with the image. 
 Ease and speed of retrieval from storage. 
 Transportable. 
 Annotation or narration against the image for education. 
 Cheap to acquire, store and replace. 
Convincing pathologists that images could be effective as a training tool for 
professionals who would then go on to report actual patient samples using microscopy 
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presented challenges. Digital technology provides an environment which is simply not 
the same as reporting using microscopy. 
Unless the image is equivalent size as the original tissue the preparation of the image 
will inevitably focus on features that are meant to be found. This bias may impact on 
the user’s ability to translate the learning experience to a clinical reporting 
environment where the significant features may be less easily found (Kumar et al., 
2004). 
In other areas of pathology digital images had begun finding a role alongside actual 
glass slides as both a solution to the problems of physical storage and archive, and also 
as a tool for education and teaching of professional skills such as recognition and 
classification of cellular tissues (Leong, Graham, Schwarzmann & McGee, 2001; 
Steinberg & Ali, 2001; Dee, Lehman, Consoer, Leaven & Cohen, 2003). In laboratory 
haematology, however, the quality of the first widely published images failed to 
convince the professions that images could, in some areas, be a suitable alternative to 
the original blood or bone marrow smear kept on a glass slide (Szu-Hee, 2005). 
1.6.1 Digital images: quality and governance 
The global success of the internet as a tool for delivering information for teaching and 
education has enabled the publication of material from a myriad of sources, available 
for access by all, but often lacking formal peer review or validation by expert 
reference. The resultant explosion of material available enables individual 
professionals to access new resources in real time beyond the perceived restrictions 
associated with conventional sources via libraries or academic institutions. The use of 
digital cameras fitted on to microscopes saw a plethora of images appearing on the 
internet with little validation, examples of poor quality images, some with incorrect or 
misleading content are easily found.  
Laboratories across the UK have witnessed the explosion of internet-based information 
over the past ten years, encouraging free or paid access to a wide spectrum of 
educational materials. Such materials are frequently produced without reference to 
source material, lack structured content and fail to respond to the requirements or 
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feedback of users. Importantly internet-based education material often lacks 
verification by expert professionals.   
An internet-based resource that pertains to offer educational information to 
laboratory professionals must gain the trust of those individual professionals in order 
to maintain engagement and become successful. It is essential that the quality of the 
information provided is understood to be validated by appropriate experts and that 
the standard of the product is considered sufficiently high to meet the needs of the 
user (Luethi, Risch, Korte, Bader & Huber, 2004).       
1.7 The digital morphology project in collaboration with UK NEQAS(H) 
Close professional links between staff in laboratory haematology at Central 
Manchester University Hospitals NHS Foundation Trust (CMFT) and Manchester 
Universities had been in place for many years in order to deliver training and degree 
courses at the universities. With senior laboratory staff at CMFT also involved with the 
UK NEQAS(H) steering committee and SAGs the opportunity arose, in 2000, to form a 
collaborative partnership of interested professionals, with the aim of exploring 
possible uses for the emerging digital technologies as part of EQA for blood cell 
morphology. Project development was to be undertaken in Manchester with guidance, 
advice and support from UK NEQAS(H) headquarters at Watford. The digital 
morphology (DM) project would be subject to the ethical codes of practice of UK 
NEQAS(H) for sample collection and data handling. All decisions and developments 
would need authorisation from the UK NEQAS(H) morphology SAG and ultimately the 
steering committee.  
It was not known whether laboratories would accept a role for digital morphology at a 
national level and, if so, what form that role would take. Importantly the principal 
driver for the direction of the project would be the needs of participants of the well-
established glass slide scheme. This would be achieved by running a series of internet-
based exercises and workshops for participants, the results of which were then fed 
back at the annual UK NEQAS(H) symposium. If the DM project was to lead to the 
development of a successful product it was imperative that the requirements and 
opinions of prospective users were fully incorporated into the project at all stages.      
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Another unknown would be how laboratories were going to respond to the influx of 
technologies at the start of the digital age, indeed many laboratories had limited 
internet access with personal computers (PCs) being a small but growing part of 
laboratory hardware.  
The advantages that high quality digital images, the content of which has been verified 
by experts and delivered to users in a consistent and secure manner, have over 
conventional glass slide blood films for professional education purposes were 
acknowledged (Brueggeman, Swineheart, Yue, Conway-Klaassen & Wiesner, 2012). 
The key attraction for using images in education is that all participants accessing 
material are presented with exactly the same cells.    
1.7.1 Developing professional consensus and educational elements 
From 2000 the increasing use of computer-based technology within routine hospital 
laboratories enabled the DM project team at CMFT to develop a preliminary test 
exercise in collaboration with UK NEQAS(H). Using a Nikon E400 microscope with high 
quality x50 magnification plan apochromatic oil-immersion objective attached to a 
Nikon Coolpix 995™ camera and Coolpix relay lens (0.82-0.29) and Lexar™ card 
reader/writer (model GS-UFD-20SA-TP) a selection of five single frame images were 
taken of blood cells from two different blood films that UK NEQAS(H) had previously 
distributed as glass slide surveys (film one: chronic myelomonocytic leukaemia; film 
two: leucoerythroblastic film with disseminated intravascular coagulation). These 10 
images were released to participating laboratories via the UK NEQAS(H) website. 
Laboratories were asked to print an accompanying question form, view the on-line 
images, answer the questions and to fax their completed form to UK NEQAS(H). The 
anonymised data returned was then referred to the DM project team in Manchester 
for analysis.  
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Figure 1.1 Example image from the first DM exercise for UK NEQAS(H) participants 
undertaken in 2000, as reported back at the symposium in October, 2001 
Some 480 laboratories were sent details of this first DM exercise by UK NEQAS(H), of 
which 38 successfully completed the process (Brereton et al., 2002). Considering the 
lack of sophistication of the computer technology available in some laboratories at 
that time (35% of responders completing reports said they did not have access to a PC 
at work, so had completed the exercise from home) the level of response was 
regarded as a success. Presenting the findings and feedback at the UK NEQAS(H) 
participants annual symposium “perspective in performance” in 2001, there was a 
sense of optimism and anticipation, from those who had participated, that the 
introduction of computer-based technology would bring innovation to the way in 
which laboratories could access verified professional material for education. Reviewing 
these initial exercises against the quality of modern images and current speed of 
computer downloads that early positive feedback now appears generous but it 
reflected the excitement and eagerness of an enthusiastic minority to embrace the 
digital revolution, just gaining momentum in laboratories.  However, there was also 
strong criticism from some quarters at the symposium, who vehemently opposed the 
use of digital images and believed there would be no call to develop digital or internet-
based techniques for laboratory morphology training. Concerns that the quality of 
images viewed over the internet would never be comparable with the actual view 
obtained via a microscope and that the entire DM process had no relevance to 
performing morphology evaluation by microscopy were eloquently expressed. Such 
concerns had genuine foundation, as poor quality images from unnamed sources 
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proliferated across the internet with little evidence of professional validation. It was 
clear to the DM project team from that first exercise that we would need to engage 
with the fears and expectations of concerned potential users if we were to succeed in 
developing a service which would be effective for all professionals. 
1.7.2 Responding to participant requirements and changing technology 
Each year a DM exercise was prepared in order for UK NEQAS(H) participants to drive 
the direction of the project, with feedback at the annual symposia. The question the 
DM team asked of itself was in two parts: 
1. Could digital images of blood films be prepared and presented at a sufficient 
quality for them to be acceptable as a professional resource? 
2. If digital images of high quality were made available how would UK NEQAS(H) 
participants want to use them?  
In 2003, feedback from the exercises led the project team to concentrate on DM 
images for educational purposes as this was the route favoured by participants. There 
were still too many vehement objections to the use of digital images in performance 
assessment to support consideration of that line of development.   
The team released 12 images with a series of individually numbered cells, an answer 
form could be printed, participants had to identify the numbered cells and return the 
completed form to UK NEQAS(H). The case selected was complex so that there were 
numerous features that could be found in any one single field of view. One hundred 
and twenty eight laboratories participated (30% of invited laboratories), a marked 
increase on the first exercise and indicative of the increase in internet availability in 
laboratories and an increased interest in using the internet as a medium. For the first 
time laboratories across the UK could debate a consensus approach to morphology. An 
example image is shown in Figure 1.2 below.    
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Figure 1.2 Example of feedback to UK NEQAS(H) participants following a DM exercise 
in 2003. The responses are shown for morphology feature number 6; the expected 
response from the options given was an acanthocyte. 
 
The feedback reports showed there were clearly issues for users over the quality of the 
technology; of those participating 26% could not access the viewing program 
QuickTimeTM from their place of work due to institution security policies and 
`firewalls’. Even though the images had been prepared using professional quality 
objectives and checked by the DM team, the quality of the viewing facilities available 
to users varied (Wells et al., 2004). So there could be morphological debate by 
professionals e.g. for cell number six as shown in Figure 1.2 there are elongated spikes 
jutting out from the surface of the cell membrane, so laboratories could debate 
whether the erythrocyte shown was an acanthocyte or an echinocyte. Interestingly, 
however, eleven laboratories termed it a spherocyte, the project team did not know 
whether those 11 participants genuinely believed it was a spherocyte or whether their 
computer screen did not have the quality to allow them to see the contour variation of 
the cells membrane.   
Along with debate over individual cells the team sought participants’ feedback on the 
educational element, in the form of annotation to certain images as shown in Figure 
1.3 
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Figure 1.3 Morphological features identified for participants. Image originally 
presented without annotation or arrows, participants used a click of a computer 
mouse to display the arrows after first viewing the image. 
1.7.3 Assembling images to provide a larger field of view 
One problem previously identified with using single frame images, was that in order to 
obtain the required magnification to allow the user to “zoom” in on key features, such 
as the granularity of neutrophils, the original image must be taken using a microscope 
objective which is a minimum of x50 magnification. This meant that the overall 
numbers of cells that could be captured in each single frame was relatively few, whilst 
this was ideal for imaging single white cells, such as a blast cell, it was inadequate for 
creating a wide enough field of view associated with actual microscopy. If a lower 
power objective was used, i.e. x40 magnification, the size of the field of view was 
greater with more cells per field, but the definition of the final image not sufficient for 
examining fine details such as granules.  
Image-processing software was being used in other areas to create larger blended 
images of good quality (Weinstein et al., 2002). The next development had to be to 
increase the field of view whilst retaining the higher resolution. PanaVueTM Image 
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Assembler software was used to blend images that had been taken sequentially; this 
process was termed “stitching”. Initially 4 individual but sequential images were taken 
of a blood film, then blended together using the software. These mini-stitched images 
were then re-presented to the software as single images and the rows blended or 
stitched together as shown in Figure 1.4 panels A to C below. Participants were then 
asked to use QuickTimeTM software, available freely on the internet, which 
incorporated a “zoom” facility to view the final stitched image (Figure 1.4 panel D). 
Whilst innovative at the time (Bromilow et al., 2003) compared to current technology 
those final images now appear of poor quality particularly for red cell morphology. 
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Panel B: Stitching 3 rows together using the PanaVueTM software 
Figure 1.4 Creating a stitched image. Panel A: three rows of 4 sequential images 
loaded into PanaVueTM software for stitching. Panel B: three rows to be stitched 
together. 





Panel C: The three rows of images stitched into one single image. 
 
 
                               
Panel D: Using QuickTime Movie ™ to present the final image 
 
Figure 1.4 Creating a stitched image. Panel C: final stitched image made from three 
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1.8 Generating high quality images for digital morphology: technical challenges 
The most commonly used format for image capture was the Joint Photographic Experts 
Group (JPEG). Images captured in other formats were often not found to be 
compatible with freely available viewing or storage systems, so images of high quality, 
but which require special software for viewing, or excessive memory for storage, are 
unlikely to succeed with potential participants. 
The requirement, by haematology morphologists, to detect and interpret details seen 
within single blood cells is not generally required in histopathology where a dry x40 
objective is employed for imaging (Furness, 2007). The level of resolution required 
must allow the haematology morphologist to define and separate the cellular 
elements, enabling them to see, for example, the granules of a neutrophil as definite 
and distinct entities and not a vague blur of purple colour. Individual granules less than 
one micrometer (µm) in size must be distinguishable from each other. This higher 
resolution demanded to view the features of individual cells and their inclusions (i.e. 
granularity or nucleoli), proved more difficult to achieve by automated systems. The 
use of oil-immersion with the higher magnification objectives (x50 and above) 
presented a particular problem for automated systems, as the process of physical 
movement of the slide beneath the objective, needed to create a large image, affects 
the refractive index of the oil, ideally manual refocusing of the cells is required every 
time the slide moves. This combination of an automated stage but with additional care 
taken to manually focus when required was not an attractive option to the developers 
of automated systems as it slowed the process, however the DM team believed this 
required more exploration.   
The demand for high resolution of cytological detail creates a requirement for images 
to be of a higher quality than might first be expected. When viewing a blood film via a 
microscope the level of resolution is controlled by a set level of objectives, such that 
the highest resolution is achieved by a x100 objective, whereas the zoom facility on 
viewing software enable the users to “zoom in” to a much higher magnification. With 
no enforced zoom limits the viewer of an image on a computer screen expects the 
image to be clear at high zoom. 
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In the laboratory, blood films are routinely examined using an oil-immersion objective 
of x50 magnification or greater in order to examine the appearance of cellular 
inclusions which are only 0.2-0.5 µm in diameter. Such inclusions are resolved at the 
limit of the microscopes optical system, requiring the brain to interpret them as 
separate entities (Figure 1.5). For images to provide the resolution quality that 
professionals would deem suitable to train morphologists the images must be 
prepared with care to allow the examination of cellular structures such as granules 
(Hutchinson, Brereton & Burthem, 2005).  
When using a microscope, the morphologist can alter the focus to gain a three 
dimensional view which the brain then translates, along with the visual information 
gained on the colour, contrast and texture of the cells to create a mental vision of a 
complete cell. The digital camera uses a “charge-coupled device” (CCD chip) which 
detects and focuses light via a series of units termed photosites, arranged together in 
sequence; these photosites each provide one electronic element, termed a “pixel”, of 
the final image. The CCD reads the accumulated charge at each photosite and an 
analog-to-digital converter changes the pixels charge into a digital reading in binary 
form.  
A small secondary granule in the cytoplasm of a neutrophil might only be 0.2 µm in 
diameter but when magnified by the x50 objective lens it will be detected by the CCD 
chip as an area of 10 µm. This requires the chip to use between two and four adjoining 
light sensing units to capture the granule in its entirety. The chip then presents a final 
image made up of between two to 20 pixels. This enables the user to see the granules 
clearly in the final image; however, the viewing technology provides only a two-
dimensional final view whereas the microscopist uses fine focus control to allow a 
three-dimensional effect.  
The ability of the brain to create a textural view of the cellular inclusions is lessened 
when looking at images because the colour produced in every pixel is averaged across 
the pixel; this has the effect of further reducing textural contrast between features, 
most notably at the edges of features e.g. membranes of cells or their inclusions 
bodies. Furthermore each photosite only registers the total light it is exposed to, so 
red, green and blue filters are used (the Bayer filter pattern) with an alternating 
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pattern across the pixels to create mosaic of colour. Algorithms are then employed to 
average the colours across a pixel, taking into account the colours of the surrounding 
pixels, to blend the mosaic so that the greater the number of pixels, the more detail 
can be captured and the finer the resolution of the final image (Hutchinson, Brereton 
& Burthem, 2005).      
 
Figure 1.5 Digital image of a neutrophil showing typical granulation taken using a 
x100 objective lens. The detail of the image is shown in the inset panels. Panel (a) 
shows a magnified image of an intermediate sized granule, magnified again in panel (b) 
to show how it is constructed from individual picture-forming elements (pixels). In this 
case the granule is constructed from 12 to 16 separate pixels. The figure illustrates 
how the colour and contrast is ‘averaged’ in each individual pixel resulting in an 
indistinct outline for the illustrated granule (Hutchinson, Brereton & Burthem, 2005). 
Initially cameras fitted to microscopes, including the Nikon CoolpixTM used in the early 
exercises for the DM project, were based on the technology found in the standard 
cameras used for general photography. This meant that the photosites were not 
evenly distributed across the camera but were found in greater density at the centre of 
the lens as suited to people taking recreational pictures, where the person or subject 
matter at the centre was likely to be of more interest than the subject matter at the 
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edge of view. The problem when using the CoolpixTM attached to a microscope being 
that the cells situated at the edges of the image were captured at a lower resolution 
than those in the centre. This proved particularly problematic when blending 
sequential single images together to create a larger image. 
1.8.1 Developing large images taken at high resolution  
The response to the initial DM exercises had been positive with an increasing number 
of laboratories responding each year despite a lack of external publicity for the 
exercises. UK NEQAS(H) gave their participants the opportunity to engage with the 
annual exercises and the DM team gave feedback at the following annual symposium. 
Participation in EQA schemes is a well-established mechanism for improving quality 
standards and more than 500 laboratories were already registered with UK NEQAS(H) 
for their blood and bone marrow morphology scheme using glass slides. There was, 
however, no comparable morphology scheme available for those same professionals 
to participate in as individuals, so the DM project team selected this as its area for 
development.   
In 2004 the DM team updated to a Nikon DN100 digital camera, designed specifically 
for use in the haematology morphology setting, attached to a Nikon Eclipse 600 
microscope with a plan Apo x60/1.40 oil-immersion objective lens. The camera 
produced a colour image of a resolution of 1.3 mega pixels at a speed of 15 frames per 
second. With the photosite units distributed evenly across the camera the quality of 
resolution for cells at the edge of the image was equal to that of those cells in the 
centre. By manually adjusting the shutter speed and the aperture gain (Speed 1/500, A 
Gain) for each image the light could be better controlled to ensure the finer detail of 
cells was adequately captured (Brereton et al., 2005). The network facility allowed the 
creation of images using file transfer protocol (FTP format) which could be easily 
communicated to users across standard network access. Importantly the system had 
software to allow the user to adjust exposure and sensitivity with adjustment of light 
and colour intensity across red, green and blue settings (interpolation). The quality of 
the actual Romanowsky stain used for the blood films varied in intensity even when 
performed with a controlled and standardised method. By their very nature different 
clinical conditions also impact on the final stain i.e. hypochromic red cells appear paler 
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than well haemoglobinised red cells and paraprotinaemia can increase the level of 
purple background stain on the slide. To a microscopist these are an acceptable and 
accepted part of blood film examination, but when taking images they add a layer of 
complexity in capturing the image. It becomes essential to perform a “white balance” 
for each blood film before taking any images, this simple procedure requires finding a 
cell free area on the slide, taking the image out of focus, the software will then take 
the colour of the area as the background and adjust the light and colour to remove 
unnecessary background shading.    
Improvements in technology allowed the upgrade from the PanaVueTM Image 
Assembler software to Adobe photoshop CS™ with photomerge software, a more 
sophisticated system for blending single images taken in a sequence with an 
overlapping area. The final image was composed of 40 separate but overlapping 
sequential images and made available for participants to view using the freely 
available software package QuickTime™ example Figure 1.6 (Brereton et al., 2005).   
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Figure 1.6 Sequential images taken at high resolution (x60 oil objective) to create a 
large image or “virtual” slide and the resulting ability to “zoom” to high 
magnification using QuickTimeTM.  
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This work showed that creating a large image that allows the viewer the facility to 
“zoom” in to view individual cells of interest at a high resolution, sufficient to 
distinguish the inclusion bodies of both red and white cells, requires that the original 
image be taken with an objective above that of the x40 available on automated 
scanning systems. To achieve the larger image a series of sequential images must be 
taken and then blended seamlessly together. This process is best achieved using a 
semi-manual technique as each frame may require fine adjustment to focus as the oil 
readjusts with each movement of field.  
 
1.8.2 The role of images compared to glass slide blood films for morphology 
Using these techniques the DM team asked participants of the UK NEQAS(H) 
conventional glass slide morphology scheme whether DM images stitched from 40 
separate high resolution images were adequate for educational or reporting purposes. 
Four cases were selected for imaging that had been distributed in previous years to 
participants of the conventional glass slide scheme. The cases were re-coded and 
participants were not informed that these DM cases had been seen previously. Cases 
comprised: 0001BF2 sickle cell anaemia (HbSS), 0403BF1 chronic myeloid leukaemia 
(CGL), 0002BF1 B cell prolymphocytic leukaemia (B cell PLL) and 0403PA1 malaria 
(Plasmodium ovale (P. ovale)).  
Once prepared the images were placed on the CMFT website and linked to UK 
NEQAS(H) so that participants could enter via the UK NEQAS(H) website. The cases 
were selected to cover a range of red cell and white cell morphological features, 
snapshots are shown in Figure 1.7 below (Brereton et al., 2005). 
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Figure 1.7 Example images from the 2004 UK NEQAS(H) DM exercise as reported 
back at the annual symposium. The images shown each depict approximately four high 
power fields stitched into a single image and showing key morphology features. The actual 
images used had a total of 40 fields each. The case number shown as given to the original glass 
slide survey (two were distributed in 2000 and two distributed 2004).  
Encouragingly 166 laboratories participated (approximately one third of UK NEQAS(H) 
registered laboratories), viewing the images via the internet using QuickTimeTM. 
Participants were asked to select the top five most significant features exactly as they 
would for a conventional survey, and to answer a series of questions in order to rate 
their viewing experience (1 being poor to 5 being excellent). The responses for the 
morphological features were compared with the original returns from the 
conventional glass slide survey in which 400 laboratories had participated. Despite the 
images being comprised of only 40 stitched single fields participant morphology 
comments agreed remarkably well with the findings from the conventional surveys 
(Figure 1.8). 
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Figure 1.8. Comparison of morphological features selected from cases as reported 
from the conventional glass slide scheme and from the DM exercise.  Features are 
shown as percentage selected by total number of those laboratories who participated 
(400 for glass slide and 166 for DM). The malaria chart from case 0403PA1 shows the 
species of malaria selected by participants of the glass slide and the DM exercise. 
Significant differences p = <0.05 are shown ** above the respective feature column. 
(Burthem et al., 2005). 
Of the top 22 morphology features selected across the four cases only three were 
significantly different, using Chi-square tests, from those found in the original survey 
(Figure 1.8). In the case of B cell PLL, spherocytes and polychromasia were reported by 
64% and 36% respectively of centres evaluating the images, but these features had 
registered at lower levels (6% and 17%, p < 0.05 Chi-square test)) when the glass 
smears had been distributed. Most likely these differences were due to the selection 
of the fields of view presented in the images, in review the collaborative DM team felt 
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that the area of smear depicted for the B cell PLL may have been from an area of the 
film where the red cells were spread too thinly affecting their appearance and 
accentuating the spherocytic elements of the red cells. This bias of the photographer 
was a concern and supported the need for image selection to be monitored with 
images validated by other skilled individuals. To add rigour to the process formal 
agreement that images be viewed by at least two members of the morphology SAG in 
addition to the two members of the DM team who had prepared them, was agreed by 
UK NEQAS(H) at the annual morphology SAG 2005. 
In the image showing malarial parasites of species P. ovale the overall pattern of 
species selection was the same however fewer participants incorrectly identified the 
species as P. falciparum compared with the results from the original glass slide survey 
(4% compared to 14%, p < 0.05 Chi-square test). Again the problem of presenting only 
40 fields of view was considered by the DM team as creating a bias i.e. with such a 
relatively small total area to view we were presenting the key features rather than 
letting the participant search to find them.  When asked if participants thought the 
area of view offered for each case was adequate for morphological comment on 
average 76% responded positively however this dropped to 52% for the malaria case (p 
< 1.01 Chi square test), total numbers are shown in Figure 1.9. Despite this lack of 
confidence in image size, the results for the malaria case reflected the findings from 
the conventional glass slide survey, with the majority selecting the incorrect species of 
P. vivax (Figure 1.8). These findings suggested that the image correctly reflected the 
parasite morphology from the glass slide, despite the concern over the bias of field 
selection and of size of image (Burthem et al., 2005). 
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Figure 1.9 Participant opinion as to whether the 40 field mages were of adequate 
size for reporting purposes. Opinions of participants (n = 162) are shown at total for 4 
morphology cases where YES = participant agreed image size adequate for 
morphological and NO = participant disagreed that image size was adequate for 
morphological reporting. (Burthem et al., 2005). 
When asked about the potential use of such images and the role UK NEQAS(H) could 
play in delivering them participant responses (n = 162) about their experience were 
mainly positive, with the use of images for teaching, and providing rare cases (bone 
marrow or paediatric cases) seen by > 90% participants as possible uses for the system. 
Furthermore 71% of participants stated that following the exercise digital images 
would be considered a useful addition to morphology quality assurance (details shown 
in Figure 1.10).    
                                            
Figure 1.10 Participant responses to subjective questions following completion of the 
DM exercise. Results of 162 laboratories, shown as a mean of all participant responses, 
answers were rated 1 to 5 where 1 = poor or not acceptable, 3 = acceptable or agree, 5 
= excellent or desirable. Participants were asked to rate their experience of examining 
the digital slides comparing them to conventional microscopy and considering the 
computer based experience and the opportunities and pitfalls (Burthem et al., 2005). 
Page | 55  
 
1.9 Creation of the UK NEQAS(H) digital morphology library 
Whilst continuing to test and improve the quality of “stitched” images the DM project 
team also considered how images should be presented to potential uses.  
A digital image library of morphology cases was created for UK NEQAS(H) by imaging 
all glass slide blood film surveys distributed from mid-2002 (cases 0205BF) up to 2010 
(Nambale et al., 2010). The library was designed to be an internet-based reference 
package for participants. A formal process was agreed with the UK NEQAS(H) 
morphology SAG to ensure the library was of high quality and validated fit for purpose: 
 Between 30 and 50 high quality single field images were taken from each glass 
slide case (a selection of both x60 and x100 oil immersion objectives were 
used).  
 Images were reviewed for quality and morphological content by two 
morphologists at CMFT (members of the DM project team, usually myself and 
one other), reducing the number of images per case to between 15 and 25.  
 These images were then copied to a compact disc and distributed, by post, to 
members of the morphology SAG for further review. A copy of the glass slide 
survey results was included to aid the review of morphology content. 
 A final selection of between 8 and 16 images was then authorised for use by Dr 
John Parker-Williams (Consultant Haematologist providing expert comment for 
the UK NEQAS(H) glass slide scheme and member of the morphology SAG). 
 The images were then presented alongside the FBC results and a minimal 
patient data set (age, sex) as used for the original glass slide surveys. 
 Each case was presented on a different “web page” linked from CMFT to UK 
NEQAS(H) by a specified internet address. Users could enlarge each image to 
full screen by clicking on it (examples Figure 1.11). 
 Some cases had extra links to other relevant data e.g. immunological markers, 
biochemistry results or cytogenetic information. 
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Figure 1.11 Screen shot from the digital image morphology library prepared for UK 
NEQAS(H). From a list of available cases one could be selected, leading to an overview 
of single shot images depicting the main morphological features alongside summary 
information. Each single image could be enlarged for view. 
The DM library created a valuable resource for UK NEQAS(H) containing over 80 
different morphology cases comprising more than 800 separate images.   
  
1.10 The UK NEQAS(H) digital morphology pilot scheme: a two year trial 
In order to test the theory that digital images would be accepted by laboratory-based 
professionals as an educational tool for developing their morphology skills it was 
proposed that the DM library be employed to create a UK NEQAS(H) pilot scheme. A 
series of cases was identified, with questions that participants could access via the 
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internet. The morphology SAG agreed a 2 year pilot scheme to be formally registered 
by UK NEQAS(H) with the IBMS in order for participants to use as evidence for CPD.  
The pilot scheme ran from April 2005 (Harcourt et al., 2006) closing September 2007, a 
presentation was fed back to participants at the annual symposium (Brereton et al., 
2008a) and a full report published (Brereton et al., 2008b). In total 16 morphology 
cases, selected from the DM library, were issued in the format of 2 cases per release to 
individuals who registered for the pilot scheme with UK NEQAS(H). Registrants had to 
be professionals who worked in a laboratory which already participated in the 
conventional glass slide morphology scheme and the pilot DM scheme was limited by 
UK NEQAS(H) to a maximum of 500 participants. This limit was set in order to test the 
operational processes that needed to be put in place at UK NEQAS(H) headquarters 
and also to avoid overwhelming the project development team as no similar process 
had ever been attempted. UK NEQAS(H) had invited participating laboratories of the 
glass slide scheme to nominate one individual per laboratory to register and the first 
case went live to 221 individuals increasing to 416 individual registrants by April 2006. 
The majority of registrants were based in the UK (86%), however individuals also 
registered from 14 countries (Table 1.1). This was the first time UK NEQAS(H) had been 
able to distribute morphology cases to such geographically disparate laboratories and 
their participation confirmed that there was potential for an internet-based 
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Table 1.1 Location of registrants completing cases in the DM pilot scheme 






Saudi Arabia 2 
Sierra Leone 2 








United Arab Emirates   1 
 
Registrants received email notification of each case release. The cases were selected 
from the DM image library, so all had been released previously as glass slide surveys 
but the cases were renamed. Case information was made available on separate “web 
pages” giving expert opinion, additional clinical comment and technical test results 
along with consensus data from the original glass slide surveys (Figure 1.12). Cases 
were scheduled for quarterly release and registrants were given four weeks to 
complete a questionnaire, selecting what they believed to be the most significant 
features morphologically and to complete a reflective feedback form. Within two 
weeks of the completion date forms had to be posted or faxed back to UK NEQAS(H) 
who then issued the IBMS CPD participation certificates to registrants by post. There 
was no process for electronic return of participant data or UK NEQAS(H) reports.  
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Figure 1.12 Screen shot of a library case from the pilot scheme. This case has 17 
separate images alongside basic FBC data and a case history. Registrants could enlarge 
each image by clicking the PC mouse. A link at the base of the page took the registrant 
to the relevant documents they needed to print and complete. (Brereton et al., 
2008b). 
 
1.10.1 Lessons learnt from the UK NEQAS(H) DM pilot scheme 
Overall more than 50% of registrants fully completed the cases (lowest completion 
rate 19%, highest completion rate 69%) but there were substantial issues reported 
with internet access at some institutions. Feedback showed registrants had spent an 
average of 30 minutes completing a case but had also spent additional time on 
background reading around the clinical condition confirming that the total time spent 
on a case was about 1 hour which was considered acceptable for CPD purposes 
(Brereton et al., 2008b). The free format reflective feedback, however, varied from just 
a few comments to several pages which proved difficult and time consuming for the 
experts at UK NEQAS(H) headquarters to assess. If a national DM scheme was to be 
developed with UK NEQAS(H) then serious consideration of how to get data reports to 
and from potential participants was needed. 
 Registrants’ feedback stated that the benefits of completing cases were their 
increased awareness of both clinical and technical issues. More than 70% of those who 
completed feedback stated that involvement in the pilot scheme had improved their 
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knowledge of the clinical aspects of the morphology, with less than 20% saying their 
knowledge had not changed (improved knowledge varied with complexity of the 
clinical condition depicted). Comments were particularly positive from those in smaller 
laboratories where access to certain clinical conditions was unusual and feedback 
showed that registrants clearly felt the system had value for teaching and education in 
laboratories where time or expertise were limited. Whilst the quality of the images 
was rated highly by registrants, the criticism of the system mainly related to the 
problem that sets of single frame images do not provide a comparable experience to 
microscopy. (Brereton et al., 2008b). When using a microscope the user can move 
across a blood film and assimilate information on the morphological appearance of the 
cells as they appear on a slide. 
Despite all the problems with IT security, variable internet access, the operational 
problems of faxing and collating paper-based returns and the deliberations over the 
number of single images required, the UK NEQAS(H) pilot scheme had successfully 
maintained a completion rate of more than 45% over the 2 year period.  
Acknowledging the significant level of maintained interest by registrants the pilot 
scheme had also demonstrated that it was possible to produce high quality images 
that would be found acceptable to professionals as a validated form of education. The 
lessons learnt could be taken forward with the goal of incorporating high resolution 
stitched images (Brereton et al., 2009). 
1.11 Perceptions of image quality: workshop 
As image quality was a key element of the DM project, the collaboration proposed a 
morphology workshop for interested professionals; UK NEQAS(H) scheme director, 
Professor Keith Hyde, invited participants and prominent professionals working in 
morphology. Both medical and scientific staff came to discuss emerging digital imaging 
technologies and their possible roles in EQA. The DM team were aware that digital 
images of blood cells, accessed from a variety of web sites, were criticised for poor 
rendition of stain colour, professionals deemed them not of the same staining quality 
that could be found in their own laboratories. However, as each laboratory sets its own 
internal standards and although the variation in staining times or stain concentrations 
may be small, the overall difference in the final appearance may be substantial. For the 
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UK NEQAS(H) glass slide scheme all slides distributed are stained at UK NEQAS(H) 
headquarters to their own standardised method, yet the returns show that up to 5% of 
laboratories report the staining to be unsatisfactory.  
As discussed in section 1.4 it is likely that some of this dissatisfaction is merely that the 
stain used is different from the laboratories own, so morphologists become 
accustomed to the finer detail and nuances of the morphology using a stain they are 
familiar with and may find fault with a different stain. For this reason it is unlikely that 
regardless of how carefully the DM team try to recreate the colours, shades and 
contrast of a blood film under the microscope they simply will never be able to achieve 
each laboratories perception of how the film should look. 
Prior to the workshop those agreeing to attend were sent two fixed, unstained 
peripheral blood smears, one with aberrant red cell morphology (sickle cell anaemia), 
and one with abnormal white cell morphology (chronic myeloid leukaemia). They were 
asked to stain the slides in their own laboratory and return the slides to the DM team 
for imaging prior to the workshop (sets of slides from 22 institutions were returned for 
imaging). The resultant images were randomised and presented at the workshop, 
attendees were asked to compare the images and vote for the stain which they felt 
depicted the best morphology due to stain quality. As two images for both cases 
received >80% of the votes and 10 images received no votes at all, attendees found 
themselves voting for another laboratory’s stain. (Brereton et al., 2007b). Less than 10 
people voted images from their own slide and many acknowledged that their staining 
protocols had been set for many years, rarely revalidated or critically reviewed. 
Examples of 9 images presented at the workshop are shown as a montage in Figure 
1.13, panels A and B.   
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Figure 1.13 Examples of images taken from two cases stained by different 
laboratories. Images were taken sequentially in one session on identical microscope 
and camera settings so that no alterations in the imaging process occurred. Panel A 
highlights differences in the staining of red cells and panel B highlights differences in 
staining of white cells. (Brereton et al., 2007b). 
Although the number of participating laboratories was small (22), six different staining 
machines had been used and no two laboratories were found to use an identical 
staining protocol.  
Once the quality of staining is assured, the capture of the true colour of the image 
must be considered if imaging is to best represent what the viewer can see down the 
microscope. The process of creating a digital image from a blood film adds further 
variation in colour and shading which needs to be considered and controlled at the 
time of image capture. The ability to change the colour saturation within an image 
could be used to improve a poorly stained blood film by manipulating the blue, red or 
green elements to intensify colour or change the hue. A lack of care at this stage of 
preparation, however, can detract from the quality of the final image by making the 
image unrealistic and reduce the satisfaction of the user. Figure 1.14 shows options 
that were available to alter the red, green and blue elements of two slides stained by 
two different laboratories.   
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Figure 1.14 Images taken from the same case (sickle cell anaemia) but stained in 
different laboratories using different staining protocols. The bar charts show the 
different red cell colour saturation (normal red cells, reticulocytes or polychromatic 
cells and dense red cells without central pallor) due to the different laboratory staining 
protocols. The colour differences are shown as detected by the software (for red, 
green and blue) for images 1 and 2. (Brereton et al., 2007b). 
Once the image is captured the quality of the display must be capable of presenting 
the high resolution used to capture the image, with no further effect on colour, thus 
standards of display are also needed. Software enhancements at both the point of 
image capture and that of image manipulation could reduce, rather than enhance, user 
satisfaction if not considered and controlled. In 2006 UK NEQAS(H) were able to give 
instructions to participants for setting up their monitors for optimal viewing. 
Beginning with the first exercise in 2000 the collaboration had worked with participant 
feedback to progress the digital imaging of blood cell morphology for professionals. 
The work summarized in this chapter culminated in the decision to develop a full 
national scheme using digital images of morphology cases for educational purposes to 
be part of the UK NEQAS(H) portfolio. The governance, successful launch and early 
analysis of the scheme are presented in chapter two.   
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Chapter Two: The UK NEQAS(H) digital 
morphology scheme for continuing 
professional development 
The DM project team was conscious that there had to be sufficient capacity within the 
collaboration for a scheme to deal appropriately with participant expectations. The 
reputation of UK NEQAS(H) as a leading provider of EQA and with a proven record for 
delivery of quality services could not be put at risk. The collaboration needed to prove 
that the scheme could be robust, from a technical standpoint, and manageable by UK 
NEQAS(H) headquarters for prospective participants. Monthly telephone meetings 
were put alongside six monthly face to face meetings, with the image development 
and presentation format driven primarily from Manchester with the administration, 
security and data integrity being controlled at UK NEQAS(H) headquarters. As an 
entirely new development for UK NEQAS(H) a DM scheme for CPD could not be 
launched or operated without rigorous testing so additional help was sought from 
members of the morphology SAG who were asked to participate in testing. 
2.1 Selecting equipment for the UK NEQAS(H) Digital Morphology project 
Whilst the DM pilot scheme had been operating advances in DM technology for 
pathology microscopy had been significant, with all the major suppliers of 
haematology microscopes offering some form of imaging system. Feedback from UK 
NEQAS(H) participants completing the annual exercises had highlighted their 
increasing expectations for both quality of image and ease of access for delivery. Early 
enthusiasm by some registrants had lessened the trauma of slow download times and 
varied image quality, although if a national scheme using this technology was to be 
successful all of these problems needed to be overcome. 
2.1.1 Selection of microscope and camera system  
Advice was sought from support specialists and also from histopathology colleagues 
already using digital systems for teaching to ensure money would not be wasted on 
overly complicated systems which might outperform requirements. Microscope 
manufacturers have related software packages aimed at simplifying and optimising the 
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image capture process and include the ability to set white balance, colour correction 
facilities and image alteration capabilities (sharpness, fine focus, brightness). Standard 
image manipulation packages can also be used for viewing, selecting and refining 
image content including the movement of cells within the image. 
Taking sequential, overlapping images at high power is time consuming and requires 
patience but by moving across a smear a strip of images can be collected which can 
then be blended or “stitched” together to produce a larger image. Using appropriate 
software to stitch several overlapping strips together a large section (comprising 40 to 
100 fields) can be imaged providing a “virtual smear”, or at least taking the part of the 
smear which is representative of the whole.   
Available imaging technology for haematology was reviewed and equipment trialled 
with the support of the companies involved, microscopes were with their associated 
cameras and recommended imaging software. Notably the number of pixels in a 
camera lens had increased from 1.3 megapixels per frame (DN100 used at that point) 
to between 5 and 12 megapixels. Companies were also asked to include their best 
quality objective lenses. The main microscope suppliers had automated stages in 
development, or already in their portfolio, so were asked to provide systems with and 
without this facility as the team remained unsure that a fully automated system could 
provide a consistent level of focus across the whole image and wanted to test this 
option.  
The emergence of full slide scanning technology had proved of interest in 
Histopathology laboratories where the problems around long term storage of glass 
slides was well documented (Weinstein et al., 2002). The market leader for slide 
scanning was AperioTM whose Scanscope OS technology used a fully automated system 
to create images of whole tissue sections at x40 dry objective (leicabiosystems.com, 
2017). At three to five times the cost of a semi-automated microscope system the 
Scanscope OS was seen as expensive but it was at the forefront of slide scanning 
technology and so included in the equipment assessment by the DM project team. 
Initial testing included: 
1. The Leica DFC490 and PAXcam3 digital camera and motorised stage 
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2. Nikon Eclipse microscope, with and without automated stage, and DXM1200F 
camera and DS-Fi2 camera (with IR-cut filter and enhanced frame rate). Nikon 
offered two different camera system so both were trialled. 
3. The Aperio Scanscope OS automated slide scanner with x 40 dry objective. 
4. The Zeiss M1 Axio microscope and imager with automated stage and Axio Cam 
HR Camera. 
5. Olympus microscope with DSCF0025 “slide” camera system. 
At that time the Leica and Olympus systems were not fully validated by the 
manufacturers so more extensive testing was continued with the Aperio, Nikon and 
Zeiss systems. Four cases from previous UK NEQAS(H) glass slide blood cell morphology 
scheme were selected for imaging by all systems. Cases had been selected to provide a 
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     Panel A                                        Panel B                                         Panel C 
  
 
 Case one: Acute promyelocytic leukaemia (APML): atypical promyelocytes 
 
 Case two: From a patient with severe burns: microspherocytes. 
 
 Case three: Haemoglobinopathy HbAE beta thalassaemia; multiple red cell 
abnormalities including hypochromia and target cells. 
 
 Case four: T cell prolymphocytic leukaemia: atypical lymphoid cells with nucleoli. 
 Figure 2.1 Snapshot comparative images from three different imaging systems used 
on four different cases. Panels A = Aperio Scanscope with x40 dry objective. Panels B = 
Nikon DS Fi L2 DC and eclipse microscope. Panels C = Zeiss Mi axio imaging system and 
microscope. All snapshots are prior to manipulation with colour correction software, variation 
in resolution was dependant on the magnification offered by the manufacturers on their 
systems. Both microscope systems offered plan apochromatic oil objective lenses at x60 or x63 
and x100. 
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The systems were tested against a list of criteria namely; ease of use (settings, fine 
tuning of resolution, colour control), speed of process, size of final image and image 
file size, flexibility of software (ability to annotate images, ease of interaction), viewing 
software (ease of navigation of final image and download process) and quality of 
image (resolution and fine detail at zoom). The final images produced were viewed by 
four morphologists from the DM development team, each reporting independently on 
quality of the image. Consideration was given to availability of technical support and to 
overall costs. The findings were presented back to participants and at the British 
Society of Haematology congress (Sibanda et al., 2009). The equipment that most met 
the criteria of the DM project was found to be the semi-automated Zeiss Axio Imager 
and this system was selected as the standard tool for UK NEQAS(H) DM projects and 
for the development of a national DM CPD scheme Figure 2.2     
             
Figure 2.2: Photographs of the Zeiss Axio M1 imager system used for the creation of 
images for the UK NEQAS(H) DM project (Sibanda et al., 2009).  
 
2.2 Optimising the image 
When examining a blood film the haematology microscopist rarely needs to look at the 
entire smear, usually the area being examined covers less than a third of the smear. An 
experienced morphologist will move quickly over a number of fields to gain an 
impression of the normality of the overall film whilst looking for the presence or 
absence of abnormal cells. In doing so they confirm that all cells seen are normal, both 
in number and ratio to each other, and that the overall morphology of features seen is 
consistent with the numeric full blood count data and any clinical details given (Bain, 
2015). This is an intuitive and subjective process during which the morphologist aims 
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to provide information to the clinical team that will be additional to the numeric result 
data and can be interpreted in a clinical setting to impact directly on patient care.   
Whilst single frame images provide excellent educational material on individual cells 
such as blast cells, they give a disjointed view of the relationship between different 
cells which is part of the microscopy experience. This is particularly important for 
assessing the level of abnormality of a blood film such as the frequency of damaged 
erythrocytes or the impact of platelet clumping on the numeric platelet count. The 
most widely accepted semi-automated blood film scanning system in the UK is 
CellaVisionTM which concentrates on imaging separate white cells but provides a larger 
stitched image for red cell review (CellaVision, 2017b).  Participants of the DM 
exercises and the DM pilot scheme constantly gave positive feedback about the quality 
of the single frame images for education purposes, however they wanted the facility to 
move across an image in a way that would better reflect their experiences of using a 
microscope. The challenge faced by the DM team was to build larger scale images that 
allowed the viewer to scan across, as they would do when viewing a blood film, 
without losing any quality of resolution required to look at cells in detail when 
necessary.  
Unlike histopathology, where the architecture of the tissue sample and the 
relationship of cells within the structure are important diagnostic criteria, 
haematologists view blood cells which have been smeared on to a slide, so while the 
number and type of cells are diagnostic the spatial arrangement is not structured. The 
different approach required for imaging these preparations is that the histopathologist 
requires capture of that architecture, thus large scale images are required, whereas 
the morphologist in haematology only needs to examine an area of the preparation 
large enough to contain the diagnostic features. The problem is deciding how big an 
area is sufficient to capture those features. In blood films where the white cell count or 
platelet count are abnormally raised, or the diagnostic morphology markedly 
abnormal, a relatively small area of view, equivalent to a couple of fields, may contain 
all key diagnostic criteria. In a blood film, however, where the white cell number is 
reduced, or when abnormal cells only represent a small proportion of the total, a 
larger number of fields will need to be examined.   
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For images to be used for education purposes criteria are required to determine how 
large an image should be and what features it must contain. The advantage of not 
having to image the whole smear must then be balanced against ensuring that the final 
image is of sufficient magnification to capture essential cellular morphology. A 
disadvantage of large images may be increases in download time for the viewer, if 
moving across the image is slow or problematic the user will simply lose enthusiasm 
for the whole process. 
For the UK NEQAS(H) DM project exercises all images had been checked for 
morphology content and image quality by at least two morphologists and all images 
were then submitted for critique and validation by at least two other members of the 
UK NEQAS(H) morphology SAG. This process was seen as essential by UK NEQAS(H) 
who, by definition, are an organisation with professional quality as their business.  The 
previous work had also confirmed that, for haematology, the ability to focus on the 
finer morphological detail of cells with an image was deemed more important than 
attempting to replicate the entire smear or very large fields of view. 
2.3 Demands for the virtual slide: stitching images 
The DM team and morphology SAG had accepted that large images produced at low 
magnification do not provide the cellular detail required for haematological 
morphology. Images would need to be large enough for users to feel confident that 
they had covered sufficient cells to make a successful assessment of features and that 
40 stitched fields was the lowest limit of acceptance. Using the Zeiss Axio Imager M1 
microscope system with semi-automated stage, HRc camera and plan Apo x63 oil 
immersion objective lens at 1.4 magnification the team implemented a project to 
produce morphology cases made of between 50 and 120 individual sequential but 
stitched images.  Each field would be checked and manual adjustments made to focus 
as required (Figure 2.3).  
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Figure 2.3 Creating a large stitched image from sequential high power fields. The 
single field view (top left of screen) can be magnified so that the operator can check 
and alter the fine focus to perfect the definition of an individual cell, and then click to 
take the image. By moving the stage manually to the next field of view, but watching 
the screen, the operator can ensure there is sufficient overlap between the fields for 
the sequential images to be stitched later on a PC using the adobe software. For the 
DM project at least six rows of nine images each would be required. 
2.4 Expectations of the image from potential participants 
A product aimed at delivering images for teaching and training in the modern 
healthcare environment must not only have a reliable software delivery system with 
established security guarantees but must deliver quality images (Goasguan et al., 
2006). No matter how sophisticated the software tools or how interactive the product, 
if the images are not of a high quality it will fail to deliver the service required by 
professionals and users will lose interest. Time is precious, both to managers and staff, 
so professionals must perceive that the selection of cases to examine and the quality 
of image meets their training requirements. If quality is low, interest not sustained, or 
benefit to the user not proven the product will fail. 
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Adobe Photoshop CSv5 photomerge function would be used to stich the large scale 
images required by participants.  Post-processing included adjustment to image 
brightness and contrast, colour balance (Curves function) and sharpness (Unsharp 
Mask) to ensure that reproduction matched the corresponding glass slide 
appearances, then images were uploaded to the viewing software (Digital SlideBox, 
Leica BiosystemsTM). 
2.4.1 Manipulation of the image: adding and removing features 
Careful consideration has to be given when selecting cases so that images meet the 
expectations of the user i.e. an experienced morphologist will have different needs to 
a trainee. The images must contain any and all necessary morphological features of the 
clinical condition they are attempting to depict. Moreover the features displayed must 
be in a realistic proportional relationship to each other as would be seen in a blood 
film. This may be difficult to achieve if image size is to remain manageable for the user 
and requires skilled manipulation of the image, it is essential that the image contains 
all the salient features needed to report the condition it represents, but that these do 
not appear unrealistic in their quantity or relationship. 
Following taking the original sequential images for a case, extra single shots are taken 
from different areas of the blood film to capture any important features that might not 
have appeared in the area of film being captured for the stitched image. It is essential 
to take these extra single images at that time so that the camera settings and 
environmental conditions are the same. Going back to take extra images at a later 
date, even using the same settings, can produce mild but noticeable differences in the 
colour balance, meaning that when trying to add those features to a completed 
stitched image they will not blend correctly and look unrealistic. If taken correctly 
features may be added in to an image using Adobe Photoshop version 3, and 
subsequently versions 4 and 5, to ensure the final image contains the required 
elements. This process requires patience and should not be used indiscriminately; an 
example is given in the following Figures 2.4 and 2.5 panels A and B.  
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Figure 2.4 Large image created by stitching eight rows of eleven single sequential 
images. Following this process careful manipulation to remove faults in the image or 
add further features will be required.  The area marked (black box) is selected for 
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Panel A: Post stitching of image but prior to manipulation 
 
Panel B: Image after manipulation 
Figure 2.5 Magnified section of image pre manipulation (Panel A) and post 
manipulation (Panel B).   Panel A shows dark reflective marks, probably dirt in the oil, which 
detract from the image quality and may confuse users. Panel B shows the faults removed and 
replaced with additional features typical of the case including red cell fragments, acanthocytes, 
a large platelet, a red cell containing a Howell-Jolly body, more neutrophils and large 
polychromatic red cell. These features reinforce the pathology shown; the Howell-Jolly body is 
a significant feature that was missing from the area captured originally but was present in the 
blood film.  
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The DM development team submitted this image preparation format to UK NEQAS(H) 
to be used for image generation for the proposed national DM scheme and the 
morphology SAG sanctioned this at the annual meeting 2007.  
2.5 Criteria for case selection 
Criteria for case selection required additional considerations specific to display in the 
digital image format that had already been agreed for use. A case must contain all the 
essential features of a condition, whilst the image must also appear natural so that the 
viewer can search for a rare feature even though only a representative area of limited 
size is being presented. The agreed image size was sufficient to allow the viewer to 
examine the morphology in realistic manner. As the whole slide would not be captured 
the morphological features representing the clinical condition from which the image is 
taken must be present. To achieve this some manual manipulation of the image may 
be carried out to ensure specific cells, not present in the fields selected, are added to 
the final view, as described in section 2.4.  
The scheme would be aimed at all laboratory professionals who are either reporting 
blood films or training to do so. As the scheme would be for individuals, rather than 
institutions, the cases need to offer engagement with the participant whether that 
person is relatively new to morphology or whether they are an experienced reporter of 
blood films on a regular basis. The cases need to be of varied morphological complexity 
and have to offer challenges that appeal to the differing experience levels of the 
participants. The criteria for case selection required by the development team were: 
 Is the case morphologically interesting? i.e. are there a variety of features to 
examine. For example cases which contain abnormalities in more than one cell 
type such as myeloproliferative disorders. 
 Is there a clinical complexity to the case that will allow the inexperienced 
trainee to identify basic morphological features correctly but ensure an 
interpretive element to engage the more experienced morphologist? For 
example chronic lymphocytic leukaemia (CLL) with treatment associated 
haemolytic anaemia or a case of myelofibrosis in transformation to AML.  
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 The process of manipulating the image may include adding specific cells such 
as blast cells or Howell-Jolly bodies, required to achieve the correct outcome, 
but the image must appear to be as realistic as possible. Pasting in too many 
features or too many abnormal cells can negate the reason for selecting the 
case in the first instance and may lead participants to expect that 
concentration of abnormality in a real patient. 
 The creator of the image is selecting the morphological features that the 
viewer will examine. It is essential the image creator understands exactly 
which features need to be present in the image to fully represent the case.  
To satisfy these criteria early cases were chosen by the DM team and their selection 
and presentation agreed with the consultant lead, as the scheme became established 
possible cases were reviewed at the UK NEQAS(H) annual slide selection meeting, with 
experts from the morphology SAG agreeing the cases. Possible cases had to be of good 
quality staining as any flaws in the original film such as dirt, or artifact, would become 
more prominent when presented as an image on a computer screen. After preparation 
all images were checked by a member of the DM team and authorised by the 
Consultant lead prior to the case being built and then tested by at least two members 
of the team.  
The first case selected for the DM scheme, beta thalassaemia intermedia post 
splenectomy (0801DM) had originally been used in the UK NEQAS glass slide scheme 
(0501BF2). This allowed UK NEQAS(H) to compare returns for the morphology features 
selected  with previous consensus data from the glass slide scheme. Both schemes 
showed the same top five consensus morphology features, thus enhancing validation 
and provided reassurance to the morphology SAG that the process of image capture 
was fit for purpose.  
In order to provide some feeling of familiarity for participants the presentation of data 
with the cases mirrored that of the conventional scheme in that brief clinical 
information was presented with the image alongside minimal FBC results (usually 
white cell count and haemoglobin concentration).  
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2.6 The requirement for secure and robust data management 
All NHS Trusts and most independent laboratories have IT protection systems which 
can prevent users from downloading data from unauthorised internet addresses. The 
problems with access to QuickTimeTM demanded a solution; navigation over the image 
gave participants a positive experience as they could move around the image and gain 
a more representative “feel” for the morphology. QuickTimeTM was freely available but 
there were other limitations, the actual viewing of the image did not expand to cover 
the PC screen but was limited to a window covering less than half of the screen. During 
the DM pilot scheme the team had used the remaining space to present clinical data 
alongside the image but feedback had shown that this was not entirely satisfactory, 
users wanted the image to fill the screen.  
The DM pilot scheme had used a series of single images to negate the problems by 
allowing simple viewing software to be used but the demand by participants for larger 
stitched image was a clear driver for change. Concurrently with the development of a 
suitable image, the DM team worked to resolve such problems and develop interactive 
viewing to allow users to examine images in a way which could mimic the movement 
of a microscope, without the need for downloading commercial software. To ensure all 
individuals could participate, the DM team looked at independent software companies 
with experience in EQA to host the images on a secure server and provide a secure 
data management system. In 2007 UK NEQAS(H) announced a contractual link with the 
software development company SlidePathTM and the team began development of a 
DM product for EQA use. 
The introduction of an electronic proforma for morphological feature selection and the 
use of computer software to automatically create consensus data and provide 
participants with real-time feedback was seen as essential. The operational issues UK 
NEQAS(H) headquarters had experienced during the two year pilot scheme had left no 
doubt that to continue with paper feedback reports was not practical for large 
numbers of individual participants. Paper reports also introduced unnecessary delay; 
users require at least a portion of immediate feedback to gain a sense of achievement 
on submission and to retain interest. 
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Previous exercises, including the DM pilot scheme all involved paper returns as part of 
the feedback. If a digital scheme were to be introduced, and be open to all, then the 
entire process must be electronic, with data input by the participant immediately 
incorporated into a result bank and instantaneous production of a report presenting 
the participants responses alongside pre-entered expert data.  
2.7 Challenges designing the question format 
The challenge of setting questions relevant to the image needed addressing from two 
different aspects; firstly developing a case format that would be workable 
operationally by those building cases and also for participants interacting with cases, 
as well as enabling UK NEQAS(H) to organise reports. Secondly; ensuring that the 
content of the case and the workflow process provided a worthwhile and enjoyable 
experience for the participant, if not participation would be short lived.   
2.7.1 Technical development of an electronic question format 
Developments were worked through with potential participants at the UK NEQAS(H) 
annual participants symposia and demonstrations and exercises held at the IBMS 
congress morphology sessions (2009, 2011, 2013 and 2015). Feedback was then used 
to develop the format for questions along with SlidepathTM via monthly teleconference 
and bi-annual meetings.   
Once users viewed an image they needed the question to appear alongside the image 
so they could check their responses against the image, with the ability to view either 
the image separately or the questions separately if they preferred. The structure of the 
questions needed to follow the same overall format for each case so that users would 
become comfortable with the format. Three main areas were agreed for the questions. 
A. Question one. Format for selecting morphological features: As the majority of 
potential participants were expected to be BMS and, therefore, familiar with 
the successful UK NEQAS(H) glass slide scheme for blood cell morphology, it 
was decided to base the on-line morphological feature selection list upon that 
already in use for the glass slide scheme. Some alterations were required, for 
example more single abnormal cell options were required as the images were 
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of smaller area than a glass slide, and the parasite options were omitted for 
consideration at a later date.  
Rather than recreate the table format already used by the glass slide scheme, it 
was decided to create a decision tree to encourage those reporting morphology 
to think about cell development in a stepwise process i.e. to consider the 
lineage, maturity, shape and granularity of cells rather than selecting from an 
alphabetic list. It was anticipated that participants would examine the image, 
decide what features they thought important to report and then open the tree 
by category of morphology feature.  
 
Figure 2.6 Decision Tree. Representing one line from the selection of 
leucocytes, to altered maturation, to myeloid, to the morphological features 
selectable.     
There would be no limit, or minimum requirement, for the number of 
morphology features that could be chosen from the available 74 in the system 
but, after submitting their selections the system would demand participants 
gave a priority rank to their top five (1 being most important and 5 being least). 
This would encourage participants give consideration to their findings and only 
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B. Question two: multiple choice question (MCQ). The question would include up 
to five possible pre-set answers for the participant to select their one preferred 
or most appropriate option. This enabled the format to be designed once by 
SlidepathTM and enabled the DM team to set a different, appropriate question 
to suit each case. The person actively building the case needed only to type in 
their question and the 5 possible answers in to the template. The question 
could be about clinical or scientific interpretation e.g. “what clinical condition 
do you think most likely to be represented by the features you have chosen” 
with a series of options; or the question could be about subsequent action e.g.  
“From the features you have selected what further action might you take?” 
Inevitably the MCQ was designed to ask the user to interpret their findings in 
order to reach a decision about what subsequent action they would take.  This 
was a totally unexplored area of morphology reporting by BMS, yet interpreting 
the features they see is essential if they are to supply information to the clinical 
teams to fully support patient care, or to refer abnormal cases appropriately to 
medical colleagues for clinical interpretation. 
 
C. Question three: free format summary. This final element of user interaction 
caused the most debate amongst the development team and morphology SAG 
prior to go-live and remains a challenge in the current scheme. It was agreed 
that, as in the glass slide scheme, participants should be encouraged to suggest 
a morphological diagnostic category for the image they had just examined.  This 
would further encourage participants to consider the morphology features they 
had selected and the pathological processes involved and should be related to 
their actions taken in the MCQ.  
The attraction of a free format text box to participants is that they feel no 
pressure to be precise and can be as broad with their interpretation as 
necessary. There are no constraints. In order to support CPD it was anticipated 
that participants might want to present their final reports in the workplace as 
proof of morphology education. They may, therefore, want to include extensive 
comments to demonstrate their understanding of a particular morphological 
condition. For the glass slide scheme, where laboratories are encouraged to 
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suggest a morphological diagnosis and where there are no penalty points for an 
incorrect entry, more than 50 % of laboratories complete this part. As the new 
scheme, however, would be aimed at individuals, the total number completing 
DM cases was expected to be much higher. This anticipated quantity of free 
text would be difficult for the expert reviewing the reports to filter into 
diagnostic groups and also for UK NEQAS(H) compiling the final reports.  The 
more people enlist to the scheme the harder this is to cope with. 
 
The alternative to a free format text box was a list of possible morphological 
diagnoses that could be selected from a drop down list, however, this proved 
more complicated than the initial thought might suggest. For a preselected list 
of diagnoses to have a true non-bias effect on the participant it would need to 
cover every possible diagnosis that might be received and every way that they 
might be expressed. Unlike diagnostic bone marrow reporting which may 
follow reporting guidelines (Arber et al., 2016) blood films are examined on a 
myriad of conditions and various combinations of conditions that make 
generating an exhaustive list impossible. It would also be difficult to include 
complex cases where more than one pathological process was shown e.g. 
haemoglobinopathy SC with concurrent acute monoblastic leukaemia. If 
participants had to trawl through lists, even if they were alphabetical, this 
might prove frustrating and reduce user satisfaction. The team decided they 
had no choice but to allow free text for the scheme launch with a view to 
reviewing options at a later date, this problem has remained on the agenda for 
every morphology advisory group meeting since 2008.  
 
2.7.2 Setting the questions: clinical and scientific relevance 
To appeal to the widest range of laboratory-based professionals the format of the 
questions had to be inclusive to all levels of morphology expertise. If the questions 
demanded very specific responses, such as an exact diagnosis, those learning to report 
might be reluctant to express an opinion and so not submit. There also had to be an 
element of personal achievement, if the person got the correct morphology features 
or overall diagnostic group but not the specific diagnosis the scheme did not want to 
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put them off trying again for the next case. In the laboratory BMS refer difficult and 
clinically abnormal films to clinical colleagues, so should not be penalised for refraining 
from fully interpreting their findings in a quality assurance and educational setting.  
2.8 Designing the feedback mechanism 
From the early exercises (section 1.7.2) participants wanted educational feedback, this 
was seen as an important value added element for the new DM scheme and would 
need to be available once they had evaluated a case. The SlidepathTM system for this 
project had to allow images to be annotated and for hyperlinks to educational web 
sites to be included. When reviewing unattached hardcopy reports a user cannot 
guarantee that they are reviewing the same cells the expert opinion is referring to, but 
with an electronic narrative attached to an image the exact cells described can be 
located at the click of a button. For inexperienced morphologists, unsure as to the 
significance of the features described, related hyperlinks can transport them 
immediately to the relevant further information. The team worked with SlidepathTM to 
provide a customised system for both the educational narrative and the annotations to 
be linked at the touch of a button to elements within the system and also to external 
sources of educational material (these are shown diagrammatically in Figure 2.7). 
2.8.1 Preparing the narration and annotations 
The narration must be written with the image already prepared and accessible to the 
case builder on the SlidepathTM system, whilst not visible to other users, to ensure 
the narrative accurately reflects all the key features in the image. When reporting for 
the glass slide scheme the expert can make general comments about the overall 
morphology as everyone has a different slide to view, but when narrating an image of 
finite size the narrative has to be specific about the cells that everyone is going to 
examine.  
There must be a logical flow to the narrative, initially referring to an overview of the 
general morphology at low power, then providing more detailed explanation 
covering the key elements of red cells, white cells and platelets both from a numeric 
and a morphological stance. The narrative and its conclusion must tie together the 
features seen without disclosing the definitive morphological diagnosis, as that will 
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be added to the narrative after the case has closed. This may be difficult, for example 
avoiding use of the term “blast cell” as this might be too specific, but describe the 
detail of the morphology of “possibly primitive cells”. The narrative and annotations 
are made available to a participant as soon as they have completed their submission; 
but the case may be open to others for at least 3 weeks. The scheme is not a 
proficiency test so BMS may, and indeed are encouraged to, share their experience 
and to discuss their findings with colleagues, but the ability to provide some 
immediate feedback is seen as essential by those taking part.  
Annotating key morphological features on the image is time consuming for the case 
builder but must be done accurately and precisely. These annotations are the 
teaching element of the scheme and aimed primarily at those learning or trying to 
improve their morphological skills. The annotations must then be linked to the 
narrative so that as the description unfolds a click of a computer mouse can take the 
user to the exact cell being described and by hovering the mouse over the cell of 
interest an annotation displays extra information. In order to encourage experts to 
write narratives for cases the DM development team supported the creation and 
linking of the annotations, which then adds an extra step in the testing and checking 
procedures. 
For the experienced morphologist the narrative supplies the information they need 
to see if it agrees with their own report but a trainee might then use all the 
annotation links to access the extra morphological information. 
Once prepared both the narrative and annotations are checked by a second person 
familiar with building cases and agreed with the Consultant lead before being passed 
to members of the morphology SAG for testing and comment. 
Page | 84  
 
 
Figure 2.7 Diagrammatic flow of how the scheme operates as viewed by a participant 
(Brereton et al., 2010).    
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2.8.2 Professional validation mechanisms 
As described in this thesis the operation of the DM scheme has a strict protocols for 
case preparation, validation prior to release, data handling and communication with 
participants, all of which is under the control of UK NEQAS(H) via the morphology SAG. 
This, in turn, reports to the UK NEQAS(H) steering committee. All processes comply 
with the UK NEQAS(H) policy for ethics concerning sample collection (Appendix A). 
Communication with participants is via UK NEQAS(H) or via the annual symposium for 
participants where there has been a feedback morphology session on the agenda 
every year since 2000. Complaints and suggestions from participants are reported back 
via regular meetings with the DM team and the annual morphology SAG. 
2.9 Implementation of the UK NEQAS(H) digital morphology scheme for CPD 
The launch of the world’s first internet-based digital morphology scheme for CPD, 
aimed at individual professionals, was launched by UK NEQAS(H) in March 2008 with 
the first case, 0801DM, live in April 2008. 
                      
 Figure 2.8 UK NEQAS(H) leaflet announcing the launch of the DM scheme for CPD 
Copies were distributed at the participants’ symposia and sent to laboratory managers 
participating in the conventional glass slide scheme. 
This unique scheme was designed to provide high quality images of blood cell 
morphology, set with an educational narrative, for laboratory-based professionals to 
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examine (Figure 2.9). Laboratories were encouraged to register individual participants 
rather than as a laboratory team. The scheme was accredited with the IBMS for CPD 
and participants gained a certificate for each case completed. It was anticipated that 
laboratories would be prepared to fund the cost of their own staff, as evidence that 
they were supporting CPD, costs for registration were to be kept at a minimum and UK 
NEQAS(H) offered laboratory managers a discount for buying registrations in blocks of 
10 or more. As of 2015 managers became able to purchase DM scheme registrations as 
part of their routine annual renewal of EQA services. This streamlined the registration 
process for laboratories and made budgeting easier to manage. Importantly the 
administration software allows managers to see which of their staff are actively 
registered and who is completing cases, but they cannot access the registrants 
morphology reports, this meets the requirement of UK NEQAS(H) to retain the 
anonymity of participant reports. If the laboratory manager wants to see the printed 
reports from their staff, as part of an appraisal or evidence based practice, that 
remains an in house issue for the laboratory and is not influenced by UK NEQAS(H). 
Individuals may also register independently for the scheme via the UK NEQAS(H) 
website. 
Participation rose from 219 individuals completing the first case (0801DM) to 603 
registrants completing the second case and by the middle of the second year (2009) 
more than 1,000 professionals were regularly completing cases (Brereton et al., 2010). 
All this occurred with very little active promotion. There was initial concern regarding 
the administration of the scheme and the workload for UK NEQAS(H) dealing directly 
with individual participant queries, rather than from just the laboratory manager, but 
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Figure 2.9 Composite snapshot of an actual case from the DM scheme. The red arrow 
indicates how the image looks at high power, the clarity of the nucleoli proving the 
quality of the original image. The black boxes show examples of morphology features 
that have been annotated by the expert which will show additional text when the user 
hovers the computer mouse as indicated by the blue arrow. The text box at the top 
(green arrow) shows the beginning of the narrative which has links to the annotations 
to aid user navigation. The grey box (black arrow) shows the tool available to 
participants to enable them to shift the colour balance to suit their own laboratories 
style of staining.  
 
 
Further examples of image quality are shown in Figure 2.10 panels A and B, depicting 
one of the cases actually selected for examination in this thesis. It was important that 
the viewing software controlled the maximum zoom facility to avoid loss of image 
quality whilst still allowing the viewer to see nucleoli and cellular inclusions. 
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Panel A: snapshot from Case 5 in this thesis               
 
Panel B: Snapshot at maximum “zoom”, Case 5 examined in this thesis. 
Figure 2.10: Snapshots from Case 5 (UK NEQAS(H) DM 1204DM) Panel A: snapshot 
represents approximately one tenth of the image available for participants to view, the 
green box in the image map (top right corner indicated by green arrow) shows the 
location being viewed in relation to the total image. The red cell (box with red outline) 
shows attached annotation as would be seen after completion of a case as part of the 
educational aspect. Panel B: Maximum zoom allowed by the software to prevent 
pixilation of the image. Image taken with x63 oil immersion objective.  
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For all cases used in this thesis an example snapshot image and the original case 
description given to participants with the case at the time of participation are shown in 
Chapter 4.  
 
2.10 Early evaluation of the UK NEQAS(H) Digital Morphology scheme for CPD 
Recognising the level of commitment required by both Dr John Burthem and myself to 
the preparation of cases UK NEQAS(H) proposed to broaden the expertise of those 
writing educational narratives and, in so doing, increase the number of individuals able 
to build cases for the scheme. Members of the UK NEQAS(H) morphology SAG, who 
were already involved in testing cases before release to participants, were invited to 
undertake training for case preparation and in 2011 Dr Keith Paterson was the first 
SAG member outside the development team to provide narratives. 
 
To strengthen the case selection process and to increase the opportunity to acquire 
suitable material DM scheme participants were asked to submit possible cases on a 
glass slide for consideration. As only one slide is needed the opportunity to use rare 
cases is increased although the first case to be selected by this method was an 
excellent example of a megaloblastic anaemia in 2011. As other morphology experts 
have volunteered to support the case preparation glass slide blood films are being 
reviewed by the team at the annual slide selection meeting held each year in January. 
A review of early cases showed that a good mixture of morphological disorders was 
being represented with both white cell and red cell disorders featured (Brereton et al., 
2010).  
 
2.10.1 Participant feedback at the end of year one 
The scheme ensured, by design, the anonymity of participants. Up to launch the team 
had used the annual exercises to develop the system but once the scheme went live 
the early feedback from participants was via individual queries to UK NEQAS(H) and 
was mainly anecdotal. After one year UK NEQAS(H) circulated a questionnaire to all 
participants (n = 649), 411 completed returns were received, of which 49% stated they 
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were BMS, 36% were senior or chief grade BMS, 11% said they were in a primarily 
managerial role and the remainder (4%) were either trainee BMS, clinical scientists or 
medical staff (Eke et al., 2010).  
Whilst responses about the actual cases were positive with more than 95% 
appreciating the quality of the images and the range of morphology, the team were 
interested in problems around the access and completion of cases and the needs of 
participants, 27% said they had contacted UK NEQAS(H) with queries. Of those 
regularly accessing cases around 5% did not actually submit before the deadline and 
nearly 40% had failed to complete all the cases they had access to.  
Reasons given by participants for not completing cases (Eke et al., 2010): 
 Time constraints 
o annual / sick leave 
o unaware / forgot deadline 
o poor staffing at work / no time allowed  
 Computer and IT issues 
o Trust network problems 
o Struggle with SlidepathTM software for data entry 
 Lack of confidence with the morphology 
 Forgetting, lack of reminder 
 Late registration 
Following the feedback the team introduced several developments including the 
emailing of all participants with information on case closure dates and reminder emails 
one week prior to closing. The team also concentrated with SlidepathTM on the data 
entry and handling experience and key performance indicator targets were introduced 
to be monitored at the regular telephone meetings. To help with registration problems 
for new users an on-line video was added with visual demonstration of how to 
complete a case. 
Of note was the response to the question on the level of reporting skill the participants 
perceived themselves to be, with 13.8% reporting films outside of core hours where 
advice or support from colleagues would be low. These were exactly the people the 
scheme was aiming to support. 
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Figure 2.11 Responders statement on the frequency of their film reporting. Bars show 
the self-assessed morphology reporting level of responders (total = 411) who regularly 
complete cases on the morphology CPD scheme. (Eke et al., 2010). 
 
2.10.2 Workshop at the end of year two 
At two years’ experience, with a dozen cases released, around 2,000 individuals 
registered and over 1,200 regularly completing cases the team wanted to know how 
successful the current cases had been in meeting the needs of participants and what 
should the priorities be going forward so that the scheme continued to thrive. 
At the annual UK NEQAS(H) symposium October 2010 in Birmingham a workshop was 
held (led by Dr Burthem and myself) to review the standing of the DM scheme and to 
gain more information from participants and laboratory managers on their concerns 
and expectations. As scheme participation is anonymous we had no knowledge of the 
skill level or experience of participants (junior, non-practising or expert), so the 
workshop aimed to gain feedback from users and also from those who had chosen not 
to register. UK NEQAS(H) issued additional specific invitations to participants from 
whom they had received particularly strident comment or negative criticism as the DM 
team were particularly interested to address any issues that were detracting from the 
schemes appeal. Prior to the workshop a questionnaire was prepared and issued to 99 
registrants, the 75 completed returns used as the basis to drive discussion. The entire 
process for accessing and answering cases by participants was walked through at the 
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workshop in an interactive session to allow the ninety-nine attendees to input and 
critique the process independent of whether they, or their staff, were participants 
(Brereton et al., 2011). 
Regarding complexity of the cases 70% of responders believed the DM scheme was 
meeting their expectations, during discussion some felt that simple cases such as iron 
deficiency should be presented more frequently, whilst accepting that the scheme 
needed to appeal to both trainee and experienced morphologists. This feedback 
strengthened criteria for case selection; cases needed to contain morphology that will 
not put off the novice but will also appeal to the more advanced practitioner. To 
achieve this a mixture of cases is needed of which some need to contain something 
beyond that which may be routinely found. 
The educational narrative attached to cases scored very highly with both participants 
and managers, and the professional validation of cases prior to their release was seen 
as a value added component with 95% of responders scoring this as useful (Figure 
2.12). 
                  
Figure 2.12 Usefulness of narrative as scored by workshop responders.  The majority 
of responders (n = 75) considered the educational narrative assigned to a 
morphological case as useful. Valued of 0 to 8 where 0 = not at all useful, 4 = useful, 8 
= very useful. (Brereton et al., 2011). 
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Three responders (2.3%) had a negative opinion of the schemes impact on training for 
morphology skills (graph not shown) but did not elaborate. Encouragingly 93% stated 
that it had increased their own interest in morphology (Figure 2.13). That the scheme 
had raised the profile of morphology within the laboratory amongst staff might not be 
measurable but it was seen as a positive outcome by the majority.  
               
Figure 2.13 Improved interest in morphology as scored by workshop responders. 
Responders (n = 75) gave an agreement score (0 to 8) on the statement that 
completing cases of the DM scheme had improved their interest in the subject of 
morphology; where 0 = strongly disagree, 4 = agree, 8 = strongly agree. (Brereton et 
al., 2011). 
When asked about training 71% believed that the scheme produced a novel 
morphology resource for individuals and discussion from training officers within the 
workshop suggested that as the case list grew the back catalogue of annotated cases 
would provide an important library for morphological education.  
It was noted that only 8% felt strongly that the awarding of CPD points was the main 
value of the scheme and importantly the vast majority saw the main benefit being the 
maintenance of their morphological skills (Figure 2.14). The DM project team had seen 
the accreditation of the scheme with the IBMS as a key attraction for potential 
participants so it was encouraging to realise that those participating acknowledged an 
actual professional benefit beyond the collection of CPD points. Since 2010, the 
demands of inspection bodies that individuals show evidence of CPD has substantially 
increased and the DM scheme continues to acknowledge the importance of the 
educational aspect in case preparation.   
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Figure 2.14 “Do you see the main value of the DM scheme to be maintaining 
morphology skills?”  Responders (n = 75) gave an agreement score (0 to 8) on the 
statement that the main value they received from participating in the DM scheme was 
that their morphology reporting skills were maintained; where 0 = strongly disagree, 4 
= agree, 8 = strongly agree. (Brereton et al., 2011). 
Discussion about the style of MCQ was positive, there was considerable debate over 
the style of question, feedback suggested participants liked the questions that made 
them consider their morphological findings and offered an element of interpretation. 
(Figure 2.15).  There were no suggestions on how that might be improved.    
                        
Figure 2.15 “What is your preferred type of MCQ from the 3 most used at this 
point?”. Participants were asked to give their preferred style of MCQ and to give their 
second and third (least favourite) option. Choices of MCQ style were based on Action, 
Diagnostic summary (conclusion) or Pathological process. (Brereton et al., 2011). 
It was, however, accepted that the question would be set by the DM team dependant 
on the case. Knowing whether participants considered certain findings warranted 
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urgent or routine referral was something the DM team felt might be important to 
know. It was encouraging to have participants engaging with the process so positively 
about the pathological and clinical aspects of their DM reports. 
2.11 Examining a stitched image: the viewing experience  
Alongside the feedback from the workshop and from the participants who contacted 
UK NEQAS(H) directly, the team also had the information in the reports completed for 
each DM case. If participants did not report key features or did not identify the 
pathological condition correctly there were many possibilities; skill levels were not 
known, equally the team did not know how participants approached examination of 
morphology on a PC screen. Indeed the question of how users approach and examine 
stitched morphology images on a computer remains largely unstudied as there were 
no equivalent schemes in operation.  
Biomedical scientists are taught to examine blood films on glass slides using a standard 
protocol such as the “battlement” approach, generally accepted as the logical way to 
approach viewing films via a microscope (Bain, 2005). Even so, they may choose to 
ignore or avoid cells they are unsure about (Houwen, 2001), which is more difficult to 
do when viewing a preselected stitched image. A microscope provides both physical 
and mental constraint in that the field of view is finite and controlled.   
 A blood film covers most of the glass slide, a defined field of view can be seen 
at any one time, so if the microscopist has to seek to find certain features they 
do not feel pressured. For DM, however, if a large image is presented the 
viewer may feel disheartened by the sheer size of the area they are presented 
with or simply unsure where to start.   
 It is unnecessary to view an entire film every time by microscopy, so the fastest 
method of seeking the correct view is needed. The microscopist seeks an area 
where the red cell are just touching but not completely overlying each other. 
This is not the case for a digital image where the area of cells to view has 
already been selected and presented. 
 As cells are distributed unevenly in a blood film, with larger white cells possible 
dragged to the edges of the film the viewer starts close to one edge of the film 
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and moves across, so as to get the correct representation of smaller and larger 
white cells. Again this is probably not required in an image of limited size where 
the user can quickly navigate and will know exactly where they are. It is 
essential; therefore that the person creating the image has considered what 
cells must be present within it. 
 Looking down a microscope the magnification of view is tightly controlled, it 
can be increased or decreased to set levels by changing the objective but the 
microscopist usually will remain at one level of magnification for most of the 
examination. This does not apply to viewing an image where the use of a 
“zoom” facility enables the viewer to change the magnification smoothly and 
with ease at any point. 
All these aspects remain fairly untested and must be considered by those presenting 
morphology images to users. 
2.11.1 Examining a stitched image: actual practice 
The way people view digital images was has been studied showing a different 
approach to that taken using microscopy (Raghunath, Braxton & Gangnon, 2012). 
User-tracking software was not part of the DM scheme so testing the approach taken 
by participants to viewing images was not possible. With the support of SlidepathTM a 
version of the same software but with user-tracking facility was made available for an 
exercise designed specifically to consider how users view DM on a PC screen. The 
software would trace the movement of the image in view, record the zoom views and 
record the time spent on each view and the magnification used. This information 
would then be stored as `heat’ maps which could be laid over the image 
retrospectively to show where the users had been viewing and how long they had 
spent on an area. Two cases were prepared with large scale images exactly as 
prepared for the DM scheme; one a malaria species P. ovale and the second a case of 
Burkitt’s lymphoma. Both had already been circulated by the conventional UK 
NEQAS(H) glass slide scheme and had also been used in small scale digital format (40 
field images) in exercises for UK NEQAS(H) participants (the P. ovale case formed part 
of the 2004 exercise detailed in section 1.8.2). The new exercise was trialled at the 
International Society of Laboratory Haematology (ISLH) congress in Sydney, Australia in 
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2008 and was completed by 134 individuals over three days. The results were 
compiled for presenting back at the meeting as a lecture on the final afternoon. The 
audience was different to that regularly participating in the UK DM scheme with the 
majority being clinical (medical doctors) rather than technical scientists or BMS, 
additionally the majority were non-UK based so unfamiliar with the DM scheme. 
This was an informal, interactive event for congress attendees from various countries 
and clearly not a controlled scientific trial, the viewing software mapped the 
experience of the user, where they looked and how long they spent on each area. 
Despite the informality of the exercise, the substantial number of enthusiastic 
attendees attempting the exercise made it interesting to see how different the viewing 
patterns were compared to the standard expected approach to microscopy. Of those 
who took part in the exercise no-one used the standard “battlement” approach to 
viewing the images, instead users “zoomed” to high magnification directly on features 
they thought might be interesting from the low power view. They zoomed to high and 
low resolution to move across to find features of interest but rarely viewed the entire 
image. The heat maps showed where on the image users concentrated their attention, 
in most cases this was on just a couple of key features before reaching their 
conclusions; possibly because they were experienced or felt they had sufficient 
information to make a quick decision or possibly because this was a “fun” exercise and 
lunch was calling. The heat maps below are from three individuals who completed the 
P. ovale case and are typical of the user viewing experience; these demonstrate the 
realities and pitfalls of viewing morphological images via a computer.  
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Area 1: fimbriated red cell with trophozoite. Area 2: shizont infected red cell. Area 3: 
two trophozoite infected enlarged red cells. 
Figure 2.16  User A: Heat map and the parasites most viewed. Outcome correct 
identification of P. ovale 
The heat map overlies the entire stitched image presented for the P. ovale case.  
Heat map area colour codes:  Cerise = Not viewed at high power. Lilac = Scrolled across 
area but did not spend time stopped. Green = spent more time on area or viewed area 
more than once.  spent more time on this area or repeated viewing of same 
area. 
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Figure 2.17  User B: Heat map and the parasites most viewed. Outcome incorrect 
identification of P. vivax 
The heat map overlies the entire stitched image presented for the P. ovale case.  
Heat map area colour codes:  Cerise = Not viewed at high power. Lilac = Scrolled across 
area but did not spend time stopped. Green = spent more time on area or viewed area 
more than once.  spent more time on this area or repeated viewing of same 
area. 
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 Figure 2.18 User C: Heat map showing areas viewed with at least 8 key features 
examined (areas in yellow). Outcome incorrect identification of P. falciparum 
The heat map overlies the entire stitched image presented for the P. ovale case.  
Heat map area colour codes:  Cerise = Not viewed at high power. Lilac = Scrolled across 
area but did not spend time stopped. Green = spent more time on area or viewed area 
more than once. spent more time on this area or repeated viewing of same 
area. 
Despite not viewing all of the image available, and only examining 3 infected red cells 
in depth (yellow blocks Figure 2.16), user A came to the correct morphological 
diagnosis. User B examined less of the image coming to an incorrect conclusion of P. 
vivax (Figure 2.17). The species of P. vivax and P. ovale, however, are similar in 
morphological appearance, there was no additional clinical information to aid 
diagnosis and only viewing two parasite infected red cells may have proved insufficient 
to reach the correct outcome. User B did not examine any comet shaped infected red 
cells, which were present and might have positively influenced the outcome. User C 
spent a lot more time on the image and examined nearly every parasite infected red 
cell present (yellow blocks Figure 2.18), despite this user C then reported an incorrect 
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outcome of P. falciparum. Having viewed sufficient key features to negate this 
outcome it might be that user C had limited experience of malaria morphology.  
So the problem remained that without knowledge of the skill level of the user it is 
difficult to measure the success of process, but the exercise supports the concept that 
user approach to digital morphology is different to the user approach to microscopy 
just as the opportunities, constraints and limitations are different. If the approach is so 
different there is concern that information gleaned from studying responses to DM 
might not be transferable to morphology education using glass slides. Having used the 
malaria case both in the UK NEQAS(H) glass slide scheme and in a DM exercise 
(Chapter 1.8.2 Figure 1.8.) where the outcomes appeared similar, it was interesting to 
add the outcomes from this larger image, viewed by professionals in an international 
setting. Figure 2.19 shows this data and suggests that the outcome is comparable from 
DM and microscopy, as the same proportion of users (< 40%) attained the correct 
diagnosis. 
           
Figure 2.19 Comparison outcomes of species of malaria selected by different 
professionals viewing a case of P. ovale in different formats. ISLH attendees (n = 134) 
provided large stitched image, UK NEQAS(H) participants (n = 256) provided glass slide 
and UK NEQAS(H) DM exercise participants (n = 162) provided small scale stitched 
image. Individuals selected the species of malaria they identified as present. Correct 
outcome was P.ovale. (Presented as Conference oral presentation at the ISLH, Sydney, 
Australia, 2008; Brereton and Burthem). 
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Although fewer users (71 of 134) completed the second case the responses to the 
image of Burkitt’s lymphoma also mirrored outcomes from previous UK survey data. It 
is not known whether users found this case more challenging or less interesting than 
the malaria case. With the addition of an MCQ asking what immediate actions the user 
would take (similar format to the UK NEQAS(H) DM scheme) that had not been part of 
previous exercises for this case, it was noted that those who had diagnosed the case as 
viral infection (30%), rather than lymphoma, were less likely to have selected that the 
case be sent for urgent referral. 
          
Figure 2.20 User outcomes for the Burkitt’s Lymphoma image at the ISLH congress 
Australia 2008. ISLH participants (n = 71) outcome diagnosis selected by individuals. 
(Presented as Conference oral presentation at the ISLH, Sydney, Australia, 2008; 
Brereton and Burthem). 
 
This was the first time that an exercise linking the morphology report to an outcome 
action had been considered by professionals at an international meeting. It is a real 
concern that clinically significant findings might be missed if a wrong conclusion is 
drawn.   
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2.12 The UK NEQAS(H) DM scheme for CPD at 4 years: proposal to examine 
participant responses 
This chapter has described the successful introduction and early analysis of the UK 
NEQAS(H) DM scheme for CPD. By March 2014 a total of 34 cases, approved by the UK 
NEQAS(H) Morphology SAG had been issued to, and examined by participants. 
Completion of cases ranged from 219 to 1318 individuals, median 995 (details of 
surveys issued with diagnosis and completion rate see Appendix C). 
2.12.1 Current status and future requirements 
The criteria put in place for case preparation continued to be employed as originally 
agreed (section 2.5) and generally by the same small team. Although feedback 
mechanisms remained in place and Dr Burthem and myself presented at every annual 
UK NEQAS(H) participants symposium, there was a wealth of data that had not been 
considered. Case returns were examined in order to prepare the consensus reports for 
participants, as part of the schemes function (Brereton et al., 2012), but an in depth 
examination of the data being generated by participants had not been undertaken.   
2.12.2 Evaluating the reporting process to inform future direction 
The blood film report is still the final arbiter when abnormal results are found in a FBC. 
Digital morphology has opened a world of tools available for education and support, 
but the interpretation of the morphological features still requires experience and skill. 
The interpretive element of the examination and the resultant actions can have 
significant clinical impact but these have not been widely studied and are not 
understood. In a time pressured laboratory the need to prove competency is ever 
present, so it is important that the different skills sets required to produce a useful 
morphology report are investigated. Professionals need to understand what errors 
occur in the decision making process and whether this could be improved using the 
DM scheme. 
It might be assumed that once trained to take a standardised approach to reporting a 
blood film via microscopy that this technique would always be applied. There is no 
published evidence to support this (Sinclair 2005) and no major studies of how blood 
film reporting is completed. We have shown that the approach adopted for examining 
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digital images does not reflect those used via microscopy, however, the ability to 
recognise morphological features and the skill of distilling those into a final report are 
essential, whether that be by microscopy or by examination of a digital image.   
It might also be assumed that the quality of reporting morphology improves with 
experience and that the interpretive skills of individuals likewise improve. Equally, that 
errors in interpretation and reporting reflect lower skill levels and that this may reflect 
inexperience and a lower level of knowledge. However, as morphology reporting has 
not been examined on a large scale the types of error that occur are unclear.  
The DM scheme had not been designed to evaluate the decision making process 
required to produce a report. The structured format of the cases, however, meant that 
they were examined in a standard process and as large numbers of professionals 
participated suggested that data generated from their reports might have value. 
Structured format of the participant experience: 
1. identify and select important morphology features 
2. rank the features in priority order 
3. interpret features to answer the MCQ on action to take  
4. free format question to interpret the features in to a pathological process or 
morphological diagnosis 
2.13 Proposal to evaluate participant data to test the association between feature 
selection and report outcome 
Aim of the evaluation as proposed to the Morphology SAG: 
Evaluation of the case data to inform the priorities for development of the DM scheme 
required to take it forward over the next 10 years and to determine if the educational 
narrative could better support skills for reporting morphology. Evaluate whether 
participants produce informative reports from the images they were presented with.  
The proposal to evaluate participant reports was an attempt to answer these 
questions with a view to setting future objective for how the scheme might progress 
and reach new users. As a minimum outcome this was an opportunity to consider any 
changes needed to keep the DM scheme relevant to current participants. 
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2.13.1 The questions for my research are: 
 To examine how participants reach their interpretive conclusions from the 
observations they record. 
 To examine whether the conclusion participants reach influences their 
subsequent actions. 
 To identify successful strategies used to produce a correct and informative 
report. 
 To identify sources of errors made by participants when producing their 
reports.  
2.13.2 Ethical considerations and governance of research 
No patients were to be bled for this work, all case material for the DM scheme was 
already controlled by UK NEQAS(H) procedures. The very nature of the schemes data 
collection system ensured no participant data could be linked back to an individual and 
data extraction would follow the same governance system as data supplied by 
SlidepathTM required to complete the case reports for the DM scheme. Governance of 
the research came under the scope of the DM project started in 2000 and would by 
controlled by the Schemes Director and Manager, via the Morphology SAG with the 
added provision that should there be any evidence that the research would put either 
the anonymity of participants or the reputation of UK NEQAS(H) at risk the project 
would be stopped (Figure 2.21). 
Ethical issues considered by both the Morphology SAG and by UK NEQAS (H) 
management and was approved by them as not requiring further application 18th June 
2011 under two main categories: 
a/ The preparation of morphology cases as covered by the policies applied to the 
collection of all material for EQA purposes in that samples may only be used if they are 
discard material from routine testing which has been fully anonymised and is not 
traceable back to a patient. For the use of images in the digital morphology scheme 
clinical details and patient demographic data are also altered from the original, i.e. 
patient ages and test results are altered from the original source data. 
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 b/ The extraction of participant input from the CPD scheme is totally anonymised and 
not traceable. It is not possible to associate extracted data to any individual. No 
participant demographic data will be extracted nor made available. The participants 
are not being tested, this data extraction is to interrogate the scheme design and 
ensure it is meeting objectives.  
 
A clear governance pathway was proposed to ensure the research remained within 
approved remit. My commitment is shown in brown and that of my internal supervisor 
in blue below: 
 








UK NEQAS(H) DM 









UK NEQAS(H) MSAG. 
Annual 
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Chapter Three: Methods used to evaluate 
participant responses 
3.1 Selection of DM cases for data examination 
The morphology depicted in the cases presented for the UK NEQAS(H) DM scheme 
varied in complexity and was dependent on the clinical conditions represented. This 
variety was deliberate as the scheme aimed to appeal to participants of all skill levels 
from those in training to those with many years of experience reporting morphology.  
It was important to select cases for examination that represented the morphological 
diversity occurring in laboratory practice and that also challenged the skill sets across 
all levels of experience. The cases selected tested the widest possible range of 
morphological reporting skills representative of: 
A. A single but distinctive morphological feature (related to white cell lineages) 
that indicated a specific diagnosis of clinical importance for patient treatment. 
B. A combination of morphological features involving different cell lineages which 
demanded more complex interpretation but which depict combined clinical 
conditions that are directly related and might be expected to be found 
together. 
C. Complex case involving abnormalities in different cell lineages and which 
represented more than one significant pathological process occurring 
independently. These were separate and unrelated clinical conditions occurring 
simultaneously that would not be expected to be found together. 
The process for this examination set out below was agreed with the morphology SAG 
and the UK NEQAS(H) Scheme Manager and Director. The selection of the specific 
cases was agreed with the consultant lead.  
At the time of case selection the only cases analysis data already published to 
participants was that which formed part of the consensus DM scheme report.  
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Morphological diagnosis Number of 
participants 









3 0903DM Microangiopathic 






4 1201DM Haemoglobin SC with 




related by an external 
contributing factor 
(therapy).   
Skill level known 
5 1204DM Oxidative haemolysis 






3.2 Data extraction, coding and methods of analysis 
The case data requested from SlidepathTM were extracted from the secure database 
and arrived as XML files without participant identification information. A separate 
excel spread sheet was then assembled for each case and the data imported, there 
was no link of participant identification between cases. 
For each case every participant data set included: 
 A time stamp number to link each participant’s responses across the various 
elements within that one case. (No link to an individual’s responses between 
cases). 
 The morphological features that the participant had selected, up to a maximum 
of five, listed in order of the priority they had chosen i.e. 1 = most important, 5 
= least important. 
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 The MCQ answer selected by that participant for the associated question 
(generally the outcome action they would take). 
 The free text (characters unlimited) interpretative element at the end of the 
participants report for morphology diagnosis. 
Each participant’s data set had to be manipulated to align the information on the 
spread sheet prior to coding for analysis. Submissions that had corrupt, ruined or 
incomplete data sets were removed prior to analysis i.e. partial submissions where 
individuals had not fully completed their report by the closing date of the case (for 
example did not complete the MCQ). Numbers are given in the results section for each 
case.  
Coding strategies are detailed below and were developed for all points in agreement 
with the Lead Morphologist (Dr John Burthem) and verified by the UK NEQAS(H) 
Director (Professor Keith Hyde).  
3.2.1 Coding morphological features 
The morphological features selected by participants had been chosen from a set of 
options which were standardised across all cases. Participants were permitted to select 
any combination of red cell, white cell and platelet features or from just one lineage.  
The morphological features they selected were then coded to allow statistical analysis 
and comparisons of red cell, white cell and/or platelet choices. White cell codes were 
assigned the prefix 1XX; platelet codes 2XX and red cell codes 3XX so that cell types 
could be compared. Participants were asked to prioritise up to a maximum of five 
features from the 74 options available to them, these are shown in Appendix D. 
Once coded the morphological features selected by each participant were kept in 
separate columns on the spread sheet to maintain the priority rank assigned to them, 
so that the importance of features was not lost during manipulation and could be used 
in the analyses. Where participants had selected fewer than five features their 
selections were ranked from one downwards with remaining fields being coded as zero 
entry. During analysis the assigned priority enabled those features given high priority 
(one and/or two) to be separated from those given less important weighting. It was 
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anticipated that for simple cases some participants would not need to select five 
features to complete their report. 
Where a single feature was considered of prime diagnostic significance e.g. Pelger 
neutrophils, the feature was coded as a single data element. For the complex cases, 
with multiple individual morphological features across all cell lines, there were several 
feature options that would be considered analogous or represent a similar outcome. 
Where a combination of features indicated one pathological process (e.g. microcytosis, 
hypochromia and pencil cells may all be present in a case of iron deficiency) following 
initial coding, the elements were placed in to feature-groups to represent that 
associated process. This condensed the large number of related features selection for 
analysis and was expressed as the mean number of features selected (from a 
maximum of five) with standard error of the mean (SEM).  
A “priority score” was then generated from the rank the participant had assigned each 
feature: for single elements e.g. Pelger neutrophils this was the priority rank assigned 
by that participant, for feature-groups this was the highest rank given by that 
participant for any feature of that group.  
Statistical evaluation was directed by Dr Burthem and employed GraphPad Prism 
software (v6.04) using contingency table analysis to perform a comparison of 
morphological feature selection or diagnosis employed (Chi-square test: Fisher’s exact 
test, two-tailed T test for means assuming unequal variance). Priority scores for 
frequency of choice were compared between multiple groups using a non-parametric 
ANOVA test (Kruskal-Wallis test with multiple comparisons of means). For two sets of 
observations a two tailed Mann-Whitney test was employed. Significance is indicated 




3.2.2 Coding the multiple choice question 
The answer selected by participants from the MCQ had been from pre-set options 
specific to each case.  Although the phrasing of the MCQ questions varied for each 
case they generally asked the participant to select a course of subsequent action based 
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on their findings and the interpretation of the conclusion they had reached. The 
answers were then coded A to E for analysis with A being the ideal or expected action 
and E being the most inappropriate action or detrimental in terms of patient care. The 
MCQ options for each case are shown in Chapter 4.    
For each case the MCQ answers were assessed against the morphological features 
selected by the participant, the priority assigned to those features and their free text 
responses attributable to morphological diagnosis or outcome. The action taken by the 
participant was a key element indicating the level of urgency or clinical significance 
they associated to their findings. 
 
3.2.3 Coding the free text interpretative comments: morphological diagnosis 
Coding of free text responses presented the greatest challenge to the analysis of data. 
The morphological diagnosis submitted by participants was in unlimited free text, 
which produced a vast range of possibilities with participants using combinations of 
varied terminology and acronyms along with reflective comments on their reaction to 
the case or evidence of their own further reading on the subject. Participants would 
also discuss features they did not find to show they had considered or excluded certain 
diagnoses so word recognition software could not reliably be used.  
In total over 4,300 free text comments were examined, distilled and a coded option 
applied, this was a labour intensive exercise as all comments were checked more than 
once. The free text question had been different for every case so the treatment of the 
answers for each had to be considered independently.  In order to achieve this and to 
reduce bias, the first 100 answers of each case were examined and the common 
outcomes considered for coding. The initial coding was undertaken in specific 
diagnostic categories where they were given, which were combined to broader 
categories where feasible and reviewed by the lead morphologist Dr Burthem to 
ensure the coding encompassed the essential elements of each participant’s 
comments. For example in Case 4 responses such as follicular lymphoma and mantle 
cell lymphoma were combined as lymphoid neoplasms. Following this process the 
common outcomes were modified or refined to reduce the effect of random answers 
and to ensure the key diagnostic or interpretative information that the participant had 
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reported was maintained for analysis. Once agreed the process of coding all free text 
for that case was then undertaken. The total number of options depended upon the 
complexity of the case. Finally where interpretation of the free text was problematic 
those comments were again reviewed by myself, jointly with Dr Burthem. The final 
diagnostic categories and the number of participants are shown in the results section 
for each case. 
 Although participants were encouraged to suggest an overall summary of their 
morphological comments they were not required to do so and were not penalised for 
omitting this. As the free text data field was not mandatory for those participants 
where no conclusion was completed or where distillation of the free text to a 
diagnostic conclusion was not possible, the morphological diagnosis was coded as “not 
available”. This allowed the other sections of the data (priority of features and MCQ) 
to be analysed independently. 
The free text questions for each case and the coded outcomes are given individually in 
Chapter 4 against the appropriate case.  
 
3.3 Limitations of data analysis 
The UK NEQAS(H) DM scheme for CPD is unique, with no national or international 
equivalent of similar scale and no precedent for how to approach the data analysis.   
 
3.3.1 Professional skill level for morphology reporting of participants 
The UK NEQAS(H) DM scheme had been developed to provide educational support for 
professionals who report blood cell morphology. The “carrot” for participation being 
that the scheme was accredited by the IBMS for CPD and that it also guaranteed 
anonymity of participants. UK NEQAS(H), therefore, had no information stored on the 
skill level of participants. During the data analysis of the first case selected for this 
thesis (scheme 0902DM), the fact that the level of morphology experience was 
unknown became a concern when analysing participant responses. It might be 
assumed that those providing the more correct reports were those with more 
experience and higher skill level but the DM scheme operated with the morphology 
experience of participants simply not known. Whilst this had always been a factor for 
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consideration when producing cases it now presented a problem for analysis of 
participant performance. After discussion and agreement via the morphology SAG the 
problem was presented during a feedback session to participants at the annual UK 
NEQAS(H) symposium and delegates were asked if they would support the 
incorporation of experience levels into their individual reports, their response was an 
overwhelming majority in favour. Permission was then sought and obtained from the 
Morphology SAG, prior to the release of Case 5 (Scheme 1204DM), to tailor the MCQ 
for that specific case in order to obtain information about the perceived skill level of 
participants. As participant data cannot be individually identified between cases the 
skill level question relates solely to Case 5. Participants were asked to select from a list 
of options the one which they felt most accurately represented their professional 




3.3.2 Lack of trial conditions 
Completion of morphology cases by DM scheme participants was not completed under 
conditions normally associated with research studies, the data was extracted 
retrospectively. Participants had not completed cases in order to take part in a study 
but to complete educational exercises, during feedback sessions at the annual 
symposia the team had actively encouraged participants to share their knowledge of 
morphology for training purposes. 
 
Some participants may complete cases simply to gain the CPD points without much 
care for what they submit and others do so because their workplace requires it. It must 
be recognised, therefore, that some feature selections must be random or made with 
little professional consideration. It is not possible to totally remove this effect, 
however where consensus agreement those selections are considered in the data 
analysis but where numbers for features selected are low (less than five individuals) 
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3.3.3 Bias at coding of data 
The free text interpretative morphological diagnosis given by participants reflected not 
only their summary report of the actual morphological features of the case but 
required them to interpret those features they had selected. For some cases it should 
have been possible to get an exact morphological diagnosis from the image, e.g. Case 
2: Pelger–Huët anomaly as the key feature is a diagnostic one. This made coding a 
relatively simple process, separating those that specifically selected Pelger neutrophils 
from those who did not. In other cases e.g. Case 4: ATLL, a full diagnosis would have 
required other results including leucocyte immunophenotyping, however, the less 
experienced morphologist should recognise that the abnormal lymphoid cells were 
neoplastic, not simply reactive, this was key to providing a correct overall 
interpretation. The number of different selections for features associated with reactive 
or neoplastic lymphoid cells is broad so diagnostic options were agreed prior to coding 
and then revised further in light of actual participant reports to reduce the bias of 
expectation. The aim was to group free text reports by how close they were to an ideal 
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Chapter Four: Results with interpretative 
comment 
The number of participants who completed the selected cases for examination ranged 
from 732 to 1,108 individuals (median 878, Table, 3.1). 
Images representing the cases studied are shown for each case in the appropriate 
results section. Each gives a limited stitched field section at low power on the left 
(representing between four to six fields) and a single field section at high power on the 
right which depicts the key morphological features (original stitched images presented 
to participants were 60 to 120 fields taken with a x63 oil immersion objective). The 
limited clinical or technical information originally presented to participants with the 
DM images are reprinted directly from the UK NEQAS(H) scheme shown beneath each 
image. 
4.1 Single morphological feature Case 1: viral infection (EBV causing glandular fever)   
Typical reactive polymorphic T lymphocytes found in a patient with a viral infection 
(EBV) against an otherwise normal cellular background.   
 
Figure 4.1.  Case 1: viral infection (EBV causing glandular fever).     
Original DM scheme information:  
“For this film we have not provided any blood count parameters. This blood film was prepared 
from a sample sent from the Accident and Emergency Department marked: skin rash, enlarged 
lymph glands, and palpable spleen. ?leukaemia or lymphoma. ” Narrated by J Burthem and M 
Brereton”.  
Originally distributed by UK NEQAS(H) as DM Scheme 0902DM. The key morphological 
feature was the atypical lymphocytes; they have a varied appearance but are generally 
larger and with a more square outline than seen when lymphocytes are in a normal 
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state. They have large amounts of basophilic cytoplasm that spreads outwards towards 
the surrounding red cells and a nucleus, which although large, appears mature (Figure 
4.1). Importantly the abnormal lymphocytes are situated against an essentially normal 
background of other blood cells.  
When reviewing the image participants should have considered any alternative 
explanations for the abnormal lymphoid cells, which lacked features associated with 
neoplastic or primitive cells, and they should also have noted that the other cells (red, 
white and platelets) were normal in appearance. Building this picture should have 
directed participants to a morphological diagnosis of a viral infection. In a real 
laboratory situation staff would usually perform a simple rapid diagnostic test (RDT) 
for the heterophile antibodies associated with glandular fever, to confirm their 
suspicions and direct their subsequent actions. A smaller number of laboratories may 
also have access to immunophenotyping and may be able to run simple lymphocyte 
markers to establish the nature of abnormal lymphocyte populations. When reporting 
on the DM case participants did not have access to these supplementary tests and 
endeavoured to reach their conclusion on morphology alone, this lack of 
supplementary information may then be reflected in their free text comments.  
To obtain the correct morphological diagnosis in this case the participant needed to 
successfully demonstrate that they were able to:  
1. detect the atypical lymphocytes. 
2. correctly identify the atypical lymphocytes as reactive rather than neoplastic. 
3. prioritise the atypical lymphocytes as rank 1 (the most important morphological 
finding in the image). 
4. interpret correctly and conclude that the morphology was suggestive of a viral 
infection (lymphoid cells classed as the sole abnormality with or without recording 
the additional presence of normal morphology in other cell lines). 
5. recognise that the addition of a simple screening RDT test (for glandular fever) 
should be the immediate action. 
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Number of participants reported as completing this Case = 732. Participant data 
removed due to incomplete, ruined or corrupt data sets = 17.  Total remaining for 
detailed analysis = 714. 
4.1.1 Morphological feature selection 
Table 4.1 Variety of morphological features selected by cell lineage 







Morphological feature ranked as 1 
(Top priority) by participants 
6 25 3 34 of 74 
options 
Total number of features selected by 
all participants (all ranks 1 to 5 
inclusive) 
276 2,160 352 2,788 
 Feature selections: 64 different morphology features were selected by at least 
one participant in their top 5 from the 74 options available.  
 There were varied options for abnormal lymphocyte morphology which 
accounts for the high number of different white cell features selected 
(Appendix D). 
Despite the overall variety of features selected abnormal lymphocyte features were 
selected as the top rank priority by 696 (97.4%) participants. Of those, 230 (one third), 
had incorrect selections e.g. blast cells or neoplastic. 
4.1.2 Free text diagnosis question 
“What is your preferred diagnosis based on the blood film appearances, you are 
allowed 3 options but please put your preferred option first”. 





Page | 118  
 
Table 4.2 Summary of morphological diagnosis grouped by overall conclusion 
reported 
Morphological diagnostic summary Total % 
1/ Correct: Reactive lymphocytes (viral infection) 459 64.0 
2/ Neoplastic lymphocytes (leukaemia, lymphoma, lymphoproliferative) 137 19.1 
3/ Reactive or Neoplastic (combined, or neoplastic) but would complete 
RDT for glandular fever. 
52 7.4 




It was encouraging that most participants felt able to offer a morphological diagnostic 
summary and that, importantly, the majority were correct. The immediate question 
raised by the data being that if an incorrect diagnosis was made what was the nature 
of the misinterpretation? Examining the feature selections the key was correctly 
identifying the atypical lymphoid cells as reactive and not as blast cells; 106 
participants (15 %) stated blast cells or neoplastic lymphoid cells as their top priority. 
An important factor in issuing a correct report being that 32.2% selected blast or 
neoplastic cells amongst their feature selections but only 26.5% included these in 
there summaries so not every participant who selected blasts or neoplastic cells went 
on to interpret them as a neoplastic disorder. Whilst the selection of blast cells was 
incorrect, it is not acceptable to report blast cells as a feature and then fail to account 
for them in an interpretative report; this could cause concern for the clinical team. 
Feature selection for this case was also about recognising that the other cell types are 
normal in appearance and in normal quantity and so not selecting features such as 
thrombocytopenia which was an incorrect finding. It can be shown that the selection 
of incorrect features was then used by those participants to support the incorrect 
interpretation of a neoplastic condition (Figure 4.3 panel A). The building of an 
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incorrect report by over-reporting of absent features to support an incorrect 
assumption about the priority features seen will be discussed. 
It is not known whether or how the clinical details given with this case (Figure 4.1) 
influenced the participants thinking. The clinical team recognised an unwell patient 
with enlarged lymph nodes, and their query over whether leukaemia or lymphoma was 
present should have made the film report an urgent matter in the laboratory.  Whilst 
such clinical information is very useful in guiding the morphologist to consider possible 
diagnosis it must be the actual morphological features seen that are used to produce 
the report.  
4.1.3 Action selected 
The multiple choice question:  “This blood film has arrived in the laboratory at the end 
of the day, what would you do?” (Participants were asked to select their preferred 
option see Table 4.3). 
Anticipated action: The abnormal lymphocytes and the other normal morphology 
features, along with the age of the patient, should have led participants to consider 
the possibility of a viral infection (glandular fever being the most likely) and thus 
consider performing the simple and quick kit test. This would have enabled an 
immediate diagnostic cause for the abnormal cells to be available same working day, 
some participants may also consider immunophenotyping if their laboratory offers 
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Table 4.3 MCQ:  Participants preferred action 
Action selected Total % 
A/ Request a further test or tests 277 36.8 
B/ Refer to a more experienced colleague or medic 220 30.8 
C/ Issue a report describing the appearances and your diagnostic 
impression 
111 15.5 
D/ Describe appearances and ask for a repeat sample after an interval 29 4.0 
E/ Issue a report and contact the referring clinician urgently 77 10.8 
 
In private laboratories the cost of additional tests may prohibit staff from considering 
option A. It is not known how many participants this might apply to. 
Inexperienced morphologists may refer a suspected viral infection to a colleague 
(action B), however it would be normal practice to report such a film directly, so the 
question of whether the action is linked, not only to experience, but to the 
interpretation of the morphological features seen is key to deciding whether this 
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Table 4.4: Actions taken for each morphological diagnosis summary group 
Diagnostic summary Action A 
(Further 
test) 
Action B  












55.5% 11.1% 21.1% 5.4% 6.8% 
2/ Incorrect 
Neoplastic 
5.8% 67.9% 4.4% <1% 21.1% 
3/ Incorrect 
Both options 
19.2% 55.8% 9.6% 0.0% 15.4% 
4/ None or unable to 
conclude 
9.1% 69.7% 3.0% 4.5% 12.1% 
Actions selected are shown as a % of participants who selected the diagnostic 
summary in column 1.  
Action E, urgent contact with the referring clinician, is only of value if the correct 
report (viral infection) is being relayed, if the report is a neoplastic condition the effect 
of that phone call could have serious implications and cause unnecessary further tests 
to be performed, along with possible distress to the patient.  
Those considering a neoplastic cause for the atypical lymphoid cells were far more 
likely to refer the film to another colleague; this should have corrected any 
inappropriate comments or actions but might be considered a disappointing finding for 
an image of such a common condition.  
Those not considering a viral diagnosis were also less likely to suggest the addition of 
an RDT for glandular fever which would have allowed them to adjust their report and 






Page | 122  
 
4.1.4 Case 1: summary findings from data 
Examination of this case showed that: 
A. It is essential to correctly identify a significant feature 
B. The identification of the feature (whether correct or incorrect) impacts on the 
reporting of other features (which may not be correct) and thus bias the 
emphasis of the final report. 
C. The interpretation of the features seen will influence the outcome action (even 
when a diagnostic summary is not reported).  
This last finding is important, it can be generally and professionally assumed that BMS 
provide a predominantly technical report of the morphological features they have seen 
and refer to a clinical lead any findings that require clinical interpretation. These 
results suggest that it is actually their interpretation of the features they see that 
control the subsequent actions. 
To retest these findings another case was chosen for detailed analysis which had also 
depicted a single abnormal feature against an essentially normal background. The case 
selected had an abnormality of the neutrophils rather than the lymphocytes and was 
an inherited abnormality rather than an acquired transient phenomenon.    
As both Cases 1 and 2 represented one abnormality the data from Case 1 is presented 
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4.2 Single morphological feature Case 2: Pelger-Huët anomaly   
Typical bi-lobed Pince-nez like nuclei of neutrophils with condensed chromatin. The 
neutrophil granulation and cellular appearance are normal and so not supportive of 
either a septic or dysplastic conclusion. 
 
Figure 4.2. Case 2: inherited Pelger-Huët anomaly 
Original DM scheme information:   “This film was made following a routine blood screen 
prior to elective surgery. The blood film was prepared in response to ‘flagging alerts’ from the 
analyser. The full blood count indices were all within reference limits.”  Narrated by M 
Brereton and J Burthem 
Originally distributed by UK NEQAS(H) as DM Scheme 1206DM. Similarly to Case 1 the 
image of this blood film (Figure 4.2) contained one highly significant feature, the 
abnormal neutrophil of Pelger-Huët anomaly, in the morphological context of 
otherwise normal blood cells.  
Unlike Case 1 which depicted a commonly seen viral infection (abnormal lymphocytes) 
Case 2 depicts a rare congenital condition (typified by the abnormal neutrophils), 
whilst far fewer participants would have seen a blood film of Pelger-Huët in their own 
laboratory it is a well described abnormality and examples are depicted in professional 
text books (Bain, 2005). It would be expected that this disorder is taught during 
training, the neutrophil is the most common leucocyte present in peripheral blood and 
changes in its appearance must be recognised. The morphological diagnosis carries no 
clinical implications for the patient, however, alternative potential explanations of the 
appearance needed to be considered by participants before reaching this conclusion. 
In particular the appearances had to be distinguished from the pseudo-Pelger 
neutrophil associated with myelodysplastic syndromes (MDS), a disorder which would 
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have significant clinical implications for the patient. Pseudo-Pelger cells found in MDS 
are often hypo-granular, found along with neutrophils with more nuclear lobes and are 
usually associated with abnormal features found in red cells or platelets. The true 
Pelger neutrophils also needed to be distinguished from the left shifted neutrophil 
associated with infection and sepsis, which would also have a potential significance for 
a pre-operative patient. Neutrophils with left shifted nuclear lobes (hypo-segmented) 
tend also to be more variable in appearance than true pelger cells and often have 
more prominent granulation due to increased myeloperoxidase activity.   
To obtain the correct morphological diagnosis in this case the participant needed to be 
able to:   
1. detect the abnormal neutrophils. 
2. correctly identify the abnormal cells true Pelger neutrophils (as the sole 
abnormality with or without recording the additional presence of other normal cell 
lines). 
3. prioritise Pelger cells as rank 1 (the most important morphological finding). 
4. recognise that urgent action was not required as the condition has no clinical 
implications, but that the report should be brought to the attention of clinicians so 
that the correct interpretative report is made to the medical team. 
Number of participants reported as completing the case = 1,108. Participant data 
removed due to incomplete, ruined or corrupt data sets = 80. Total completing all 
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4.2.1 Morphological feature selection 
Table 4.5 Variety of morphological features selected by cell lineage 







Morphological feature ranked as 1 
(Top priority) by participants 
9 14 4 27 of 74 
options 
Total number of features selected 
by all participants (all ranks 1 to 5 
inclusive) 
988 1,748 1,284 4,020 
 541 (52.6%) participants made less than 5 morphology feature selections 
(lowest number for any case studied).   
 A total of 40 different features were selected by at least one participant from 
the 74 options available (lowest number for any case studied).  
 Total number of morphology features in rank 1 was 27. 
 Number of participants who selected abnormal neutrophils as their top feature 
= 861 (83.8%) of which 725 (70.5%) specifically chose Pelger cells as their top 
feature. 
A morphological diagnosis was offered by 905 participants (88%) and most correctly 
reported Pelger-Huët anomaly (n = 584, 56.8%). However, two other clearly defined 
groups were apparent: MDS (n = 142, 13.8%) and infection (n = 54, 5.3%) see Table 4.3. 
Those reporting true Pelger-Huët also made the fewest selections (mean 3.6 from 
possible 5) which is appropriate as the other cells were essentially normal. This 
statistically differed from those selecting MDS (4.3 of 5, p = 6.7 SEM-6) where 
additional selections around red cell changes were selected, and from “reactive” (4.0 
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4.2.2 Free text diagnosis question 
“What is your preferred diagnosis based on the blood film appearances” 
Table 4.6 Summary of morphological diagnosis grouped by overall conclusion 
reported and showing participants ranking Pelger neutrophils as rank 1 
Diagnostic summary Total % Ranked Pelger neutrophils at rank 1 
(feature of top priority) 
1/ Correct: Pelger-Huët 
anomaly  
584 56.8 499 (85% of group A) 
2/ Myelodysplastic 
Syndrome 
142 13.8 116 (82% of group B) 
3/ Reactive or infection 54 5.3 8  (14.8% of group C) 
4/ Other (malignant)  84 8.2 38 (45% of group D) 
5/ Other (non-malignant) 41 4.0 7 (17% of group E) 
6/ None 123 12.0 56 (45.5% of group F) 
 
The abnormal neutrophils were noted by virtually all participants. Unlike Case 1, where 
participants reported the abnormal lymphocytes as either reactive or neoplastic; here 
there were three main outcomes for the abnormal neutrophils: Pelger-Huët, dysplastic 
or reactive so four categories, based on the selected features were created and scored 
so that they could be separated:  
A. Feature selection appropriate for a diagnosis of true pelger cells (no other 
features or normal features selected).   
B. Feature selection appropriate to MDS including thrombocytopenia, tear drop 
poikilocytes, macrocytosis and hypogranular neutrophils with pseudo-Pelger 
neutrophils. None of these additional selections were correct. 
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C. Feature sections suggesting a left shifted or reactive population of normal 
neutrophils (e.g. toxic granulation of neutrophils, thrombocytosis).  None of these 
additional features were correct. 
D. Feature selections suggesting other causes for the appearances (e.g. neoplastic 
lymphoid cells, microcytosis). Incorrect features resulting in an incorrect report. 
Scores given to distinguish morphological features per participant: 
1. Diagnostic (Pelger neutrophils identified): required observation +0 
2. No selection made (appropriate as film otherwise was normal) +0 
3. Non-specific (codes associated with normal film also appropriate) +0 
4. Reactive (features associated with reaction amongst myeloid cells): incorrect +1 
5. Dysplastic (features that imply a diagnosis of myelodysplasia): incorrect -3 
6. Features not in any category above but also not present on film: incorrect -2 
Although fewer morphological features were selected than for other cases studied (n = 
40) this was still a wide selection. To facilitate analysis, these feature selections were 
grouped into three sets that reflected their pathological significance:  
 Group 1 (assigned score = 0) were consistent with the correct diagnosis Pelger-
Huët on a normal background. 
 Group 2, choices indicative of a reactive state were assigned a score of +1 (e.g. 
toxic granulation, thrombocytosis). 
 Group 3, choices most consistent with possible myelodysplasia were assigned a 
score of -1 (e.g. hypogranular neutrophils, thrombocytopenia, tear drop 
poikilocytes). 
Thus a score of 0 indicated a morphological syndrome entirely indicative of Pelger-
Huët anomaly with no other abnormal features. Deviation from this with positive bias 
indicated features suggestive of a reactive blood film, while a negative bias indicated 
features most consistent with myelodysplasia. Using this system, participants who 
chose a diagnosis of Pelger-Huët selected features whose morphological score was 
closest to 0 (mean = 0.3, SD = 1.1). Where MDS or infection were chosen, both had an 
additional bias. For MDS this was not significantly different from the features selected 
by the Pelger-Huët group (mean = 0.5, SD = 1.2 p> 0.05); however for those of the 
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group choosing infection the positive bias was highly significant (mean = 1.4, SD = 1.3 p 
= 1.2 SEM-12). The different scores between the “infection group” and the Pelger or 
MDS groups might arise solely because of a misclassification of Pelger cells (scored 0) 
as left shifted neutrophils (scored +1) by these participants.  
To address this, analysis was repeated with left shifted neutrophils assigned a score of 
0 (equivalent to Pelger neutrophils). This reduced the positive score of the infection 
group, but the score difference compared with the Pelger group remained significant 
(mean 0.7 +/- 1.0, p = 0.007) suggesting that additional features were being sought to 
support the assumption of infection. This data is shown in Figure 4.3 panel B. 
 
4.2.3 Action selected 
Multiple choice question: Which one of the following options best describes how you 
would manage the review of this case? 
Anticipated answer: As a routine pre-operative case the participants should have 
recognised the congenital abnormality and otherwise normal blood cells and selected 
option “A” to report the film and then refer non-urgently for clinical comment. 
 
Table 4.7 MCQ:  Participants preferred action 
Action selected  Total % 
A/ Film for medical comment/referral (non-urgent) 619 60.1 
B/ Requires referral of film to haematologist (urgent). 188 18.3   
C/ Report film appearances; no further action required. 201 19.5 
D/ Urgent contact with referring clinical needed. 16 1.6 
E/ No film report needed* 5 0.5   
*Those selecting action E: no film report needed, did not offer a diagnostic summary 
and had not selected Pelger neutrophils amongst their morphological feature 
selections. They, therefore, had regarded the case as “normal”.  
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Although correctly reporting the findings of Pelger-Huët is the aim, not referring the 
film (option C) misses the opportunity for a clinical colleague to add valuable 
interpretation and advice to the medical team who may not be familiar with this 
condition or how to discuss the diagnosis with the patient. 
As seen for Case 1, urgent referral to a clinical haematologist is unnecessary, could 
cause undue alarm and take the clinician away from more important matters. It might 
be acceptable if the participant is inexperienced but might imply the participant has 
misinterpreted the findings as MDS. The relationship between the participants’ actions 
and their diagnostic summary is presented in the following table 4.8.  
Table 4.8  Actions taken for each morphological diagnosis summary group 












1/ Correct Pelger-Huët 
 
67.6% 8.6% 23.3% 0.3% 
2/ Incorrect MDS 
  












43.9% 19.5% 26.8% 9.8% 
6/ No diagnostic 
summary 
58.5% 17.9% 19.5% 0.8% 
Actions selected are shown as a % of participants who selected a diagnostic summary 
as coded in column 1.  
Action B; urgent referral due to incorrect classification of the main abnormal feature 
may cause unnecessary disruption to the clinical lead but should allow the report to be 
corrected before release, however, if the report had been issued then the patient 
could be caused unnecessary distress. Also of concern is the release of incorrect 
reports due to misclassification of the Pelger neutrophils as a reactive feature (action 
C). This incorrect action not only misses the opportunity to provide a correct diagnosis 
but may result in either an unnecessary treatment for a sepsis that doesn’t exist or a 
delay in a planned procedure. 
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4.2.4 Case 2: summary findings from data 
An examination of data from Case 2 showed that: 
 Selection of this case for examination was shown to have been a fair test. 
Despite knowing that participants might not have seen Pelger-Huët in their 
own laboratory the correct diagnostic selection was high and most participants 
were correct. 
 Neutrophil features (Pelger or left shift) were consistently given the highest 
priority, irrespective of diagnosis, i.e. initial assessment of the case was 
correctly carried out.  
 Those reaching the correct actual diagnosis made the fewest selections of 
morphological features i.e. consistent with diagnosis and did not over report.  
 The morphological diagnosis reached by participants depended almost 
exclusively on their interpretation of neutrophil morphology, although where 
infection was diagnosed there was a tendency to report supporting features 
that were either not there or not present sufficiently to justify reporting (i.e. 
the neutrophils did not have a significant level of toxic granulation).  
 The actions taken by participants were strongly influenced by the 
interpretation of this single feature.  
The data summary is consistent with that found for Case 1. Outcome data from these 
cases were then compared.  For this analysis the actions for Case 2 were assigned 
scores (1 to 5 respectively). Thus those reports considered most clinically significant 
would receive the lowest overall score. When applied to the three groups those 
diagnosing MDS chose responses that were significantly different from the other 
groups and reflected the highest urgency (mean = 2.55 SD = 0.52, p = 1 SEM-25), whilst 
the finding of reactive or Pelger had lower urgency scores which were not significantly 
different (Pelger-Huët: mean = 3.14 SD = 0.59, infection: mean = 3.14 SD = 0.96). 
 
The data for the single feature cases (1 and 2) are further explored in the following 
Figure 4.3 (Brereton, De la Salle, Ardern, Hyde, & Burthem, 2015). 





Panel A:      Case 1 (viral infection: EBV)                   Panel B:  Case 2  




Figure 4.3 Panels A and B: Morphology features selected by participants for each case 
according to the interpretative diagnosis made. Bars represent the mean number of selections 
for the indicated feature or feature group (for groups, variability is indicated by bars 
representing SEM). Significant differences of selection frequency are indicated on the panels 
(Chi-square test). Statistical differences between cases are indicated on figure (ANOVA test). 
p< 0.05 *, p< 0.01 **, p< 0.001 *** 
Panel C:      Case 1 (viral infection: EBV)                      Panel D:   




Figure 4.3: Panels C and D: Priority score for first selected feature from a morphological group 
shown according to the diagnosis made (1 is the highest priority and significant differences are 
indicated on the figure (Mann Whitney test)). 
 
Figure 4.3 Analysis of participant responses from the 2 cases with a single 
morphological feature.  





Panel E:      Case 1 (viral infection: EBV)                    Panel F:  Case 2  




Figure 4.3 Panels E and F: Priority for action ascribed to case according to diagnosis (1 is 
highest priority). 
Figure 4.3  Analysis of participant responses from the 2 cases with a single 
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4.3 Complex morphology Case 3: Microangiopathic haemolysis and viral infection 
 
Microangiopathic haemolysis showing features of thrombocytopenia, keratocytes, 
fragmentation and polychromasia. Reactive lymphocytes are seen in both panels.  
 
Figure 4.4 Case 3: Microangiopathic haemolysis with reactive lymphocytes of a viral 
infection 
Original DM scheme information: “This image represents the blood film from a non-
pregnant 23 year old female attending an evening clinic. An earlier blood count carried out by 
her General Practitioner had shown results within reference range for all parameters, however 
on the present occasion the platelet count was found to be 10 x 10^9/l. No clot was present in 
the sample. An urgent blood film was performed and the digital image is from part of this film” 
 Narrated by M Brereton and J Burthem 
 
Originally distributed by UK NEQAS(H) DM scheme as 0903DM. Actual diagnosis of 
thrombotic thrombocytopenic purpura (TTP) causing a microangiopathic haemolysis 
with human immunodeficiency viral (HIV) infection.   
 
Cases 1 and 2 had depicted a single morphological abnormality, yet in a real reporting 
situation professionals are also expected to be able to identify and interpret the 
features found in complex clinical conditions. Case 3 depicts two different but related 
conditions, the first being the patient’s blood response to a viral infection (new HIV 
infection). The second, an acute haemolytic process triggered inappropriately by the 
immune system in response to the treatment of that infection. The morphology shows 
a high number of large atypical lymphocytes caused by the immune response to a viral 
infection, coincident with the striking abnormal red cell morphology caused by the 
mechanical structural cell damage seen in microangiopathic haemolysis and associated 
thrombocytopenia (shown in Figure 4.4).  
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Iatrogenic conditions are a rare but a well recognised part of medicine, so a 
morphologist should be alert to the possibility that certain combinations of abnormal 
morphology may appear together. 
Basic diagnosis in this case required the participants to be able to:   
1. identify the thrombocytopenia. 
2. correctly classify and rank the order of red cell features.  
3. examine all cell lines (red cells, white cells and platelets) in order to identify the 
abnormal lymphocytes having recognised the haemolytic process. 
4. recognise that urgent action is required.  
 
The questions raised by this case are complex: can participants process such a 
complicated set of morphological features to distill essential information for the 
clinical team and make a correct, concise report? If not where do participants fail?  
 
Number completed according to scheme data sheet = 752.  Participant responses 
removed due to incomplete or corrupt data sets = 6. Total remaining for analysis = 747. 
4.3.1 Morphological feature selection 
Table 4.9 Variety of morphological features selected by cell lineage 







Morphological feature ranked as 1  
 (Top priority) by all participants. 
13 9 1 23 of 74 
options 
 Total number of features selected by 
all participants (all ranks 1 to 5 
inclusive) 
2,279 616 721 3,616 
A total of 63 different morphological features were selected by at least one participant from 
the 74 options available. 
 The number of features ranked 1 (most important) by participants was lower 
than for any other case studied. 
 Case 3 had been distributed by the DM scheme to participants directly 
following Case 1 as presented in this thesis, and so had been completed by 
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largely the same participant base. With similar numbers completing both cases 
(747 for Case 3 and 714 for Case 1) it is interesting that the total number of 
features selected here (3616) is notably higher than for Case 1 (2788) and 
reflects the markedly abnormal morphology of Case 3. 






*Abnormal lymphocytes: There were several possible morphology feature options for 
participants to select Appendix D) which reflect abnormal and reactive lymphocytes so these 
have been combined. 
4.3.2 Free text diagnosis question 
 
“Suggest your preferred diagnosis based on your morphological observations and the 
supplied clinical details”. 












Platelet Thrombocytopenia 700 93.7 60.0  
red cell Fragmented red cells 672 90.0  30.3 
white cell Abnormal lymphocytes* 446 59.7 1.9 
Page | 136  
 
Table 4.11 Summary of morphological diagnosis grouped by overall conclusion 
reported  
Diagnostic summary Total % 
1/ Correct: MAHA plus viral illness 125 16.7 
2/ MAHA alone 385 51.5 
3/ Haemolytic process: non-specific or other cause e.g. 
haemoglobinopathy 
157 21.0 
4/ None given or unable to give summary 80 10.7 
 
 No participants selected only reactive lymphocyte features, or gave a 
diagnostic report that summarised only abnormal lymphoid cells. All 
participants selected at least one abnormal red cell feature amongst their five 
choices including those who chose not, or were unable, to give a morphological 
diagnosis. 
 The experience level of those unable to correctly interpret their findings is not 
known (groups 3 and 4), however, virtually all participants ranked 
thrombocytopenia highly so in a real laboratory situation the film should have 
been referred allowing a more experienced morphologist to correct the report. 
 Considering the complexity of this case it is not surprising that so many chose 
not to summarise their findings (group 4). 
The immediate question raised by this data is why did so few include the abnormal 
lymphocytes in their summary report? (group 1). Over half of participants had selected 
abnormal lymphocytes amongst the features they reported yet this is not reflected in 
their summary reports. Arguably BMSs do not provide interpretive reports so have a 
limited skill set in this part of film reporting. The film would have been referred for 
clinical review so a clinical interpretation for the lymphocytes would have then been 
added. It must be considered, however, that having realised the significance of the 
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haemolytic process the atypical white cells were simply ignored as they did not fit in as 
part of the red cell haemolysis. 
4.3.3 Action selected 
 
Multiple choice question: How could you best describe your reaction to this film? 
Please select your preferred option. 
Anticipated answer: The acute thrombocytopenia and presence of fragmented red 
cells and keratocytes indicate an acute mechanical haemolytic event, delay in 
communicating these findings could contribute to the death of the patient by delaying 
appropriate intervention; immediate action could have a positive impact on patient 
outcome. 
Table 4.12 MCQ:  Participants preferred action 
Action selected Total % 
A/ Emergency immediate action is required 694 92.3 
B/ Urgent referral – action next working day 44 5.9 
C/ Referral – requires further opinion, non-urgent 8 1.1  
D/ Issues a routine report 1  
With virtually all participants taking appropriate action there was no requirement to 
compare actions against their summary reports.   
4.3.4 Case 3: summary findings from data 
Examination of Case 3 showed: 
 The high level of urgency given to this case with only 53 participants not 
understanding the need for immediate action. 
 A high number prioritised thrombocytopenia and nearly everyone selected this 
as an important feature, explaining why the total number of features selected 
as top priority was low for this complex case. 
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 In a laboratory situation the detection and communication of 
thrombocytopenia is clearly well recognised but the additional message 
concerning the specific nature of the haemolysis would have added value to 
the report. The data suggests the level of skill required for this is not as high.  
 Despite the high recognition of the thrombocytopenia some participants either 
did not, or were unable to, include thrombocytopenia in their interpretation 
and thus did not reach a correct morphological diagnosis. 
 Fragmented red cells were selected correctly by the vast majority of 
participants (90%) but again many either did not, or could not, interpret the 
importance of this feature in to their final morphological diagnosis (Table 4.11). 
 Importantly, most participants selected both thrombocytopenia and abnormal 
red cells, but only 59.7% of participants selected abnormal lymphocytes as a 
feature (suggesting nearly 40% either missed them, did not consider them 
important, or did not examine the white cell morphology). Furthermore only 
16.7% included the abnormal lymphocytes in their morphological summary.   
The important question raised by this case data is why did the participants not 
comment on the abnormal white cells? The implication has to be that having found the 
haemolytic process they stopped the examination. This question is considered in the 
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Figure 4.5 Panel A: 
 
Panel A:  Frequency of abnormal lymphocyte selection by diagnostic summary.  Major 
morphological feature groups shown as the mean number of selections for the indicated 
feature. These features are divided according to diagnosis and variability are represented by 




Panel B: Priority of thrombocytopenia                                 Panel C: Priority of fragmentation 
Figure 4.5 Analysis of participant responses in a complex case with related 
morphological features. Case 3: Microangiopathic haemolytic anaemia associated 
with viral illness (acute HIV infection). Significance is indicated as follows: p < 0.05 *, p   
< 0.01 **, p< 0.001 ***. 
 
Page | 140  
 
 
Panel D: Priority of haemolytic features                  Panel E: Priority of reactive lymphocytes 
Figure 4.5 Panels B to E: Priority score given to the first selection of any feature from a feature 
group (1 is the highest priority), selections are divided according to the given diagnosis. 
Significant differences are indicated on the figure (Mann Whitney test). Figures represent each 
major morphological feature groups: platelets (A), fragmentation (B), haemolytic features (C), 
reactive lymphocytes (D).  
Figure 4.5 Analysis of participant responses in a complex case with related 
morphological features. Case 3: Microangiopathic haemolytic anaemia associated 
with viral illness (acute HIV infection). Significance is indicated  as follows: p < 0.05 *, 
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4.4 Complex morphology Case 4: Haemoglobinopathy and acute leukaemia  
A haemoglobinopathy showing frequent target cells, contracted red cells, 
polychromasia, folded boat-shaped red cells and nucleated red blood cells. There is 
also abnormal neutrophil morphology and primitive leucocyte precursors (blast cells) 
indicating acute myeloid leukaemia. 
 
Figure 4.6 Case 4: Haemoglobin SC disease with acute myeloid leukaemia 
Original DM scheme information:  “A 72 year old man. This blood count was sent from a 
hospital clinic. The count shows Hb7.5g/dl, WBC 18.0 x 10^9/l, platelets 310 x10^9/l. The 
image presented is from a blood film is made at the time.  Narrated by M Brereton and J 
Burthem”. 
Originally distributed by UK NEQAS(H) as DM Scheme 1201DM. Actual diagnosis of the 
inherited disorders haemoglobin sickle cell (Hb S) combined with haemoglobin C (Hb C) 
termed HbSC plus acquired acute myeloid leukaemia (AML).  
 
In Case 3 the two separate sets of abnormal morphological features were derived from 
two clinical conditions that were pathologically linked. Arguably this is the most likely 
scenario found in the laboratory, examples being haemolytic anaemia found in 
patients being treated for chronic lymphocytic leukaemia, lymphoproliferative 
disorders arising in heavily immunosuppressed patients post renal transplant, or 
thrombotic thrombocytopenia developing in patients post allogeneic or non-related 
donor stem cell transplant. The morphologist, however, must report what they see, 
not just what they expect to see, they must be aware of what is acceptable in a clinical 
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condition and what is not, they must be alert to scenarios that are rare or unique and 
they must never assume that an unexpected finding can be ignored.  
Case 4 depicts a rare (possibly unique) and complicated blood film with many notable 
and reportable features (Figure 4.6). In Case 3 the numerous red cell features 
appeared to distract some participants from providing a full report, in Case 4 there are 
also multiple red cell abnormalities. In this instance, the key erythroid feature is the 
target cell, as found in a variety of haemoglobinopathies. Other causes for the target 
cells must be considered and it important that participants consider the size of the 
target cells and the other abnormal features they are associated with. If the target cells 
were those seen in liver disease then one would expect them to be larger than those 
usually found in haemoglobinopathies and a larger number of stomatocytes might also 
be present. Additionally there is a thrombocytopenia, which might also be seen in liver 
disease, but is associated with the presence of a secondary clinical condition which is 
unrelated to the haemoglobinopathy. In this case, however, that secondary condition 
is the onset of acute myeloid leukaemia, for which blast cells are the key 
morphological finding. This case demonstrates an acute pathological condition 
evolving separately over a pre-existing chronic condition.  
Therefore, Case 4 requires the participants to be able to:  
1. find abnormalities in all cell lines.  
2. correctly identify those abnormalities 
3. correctly associate abnormalities with their clinical cause. 
4. correctly prioritise the abnormalities found and stratify according to the underlying 
pathology. 
5. recognise that blast cells are not an expected or acceptable feature of a 
haemoglobinopathy.  
Participants must have the knowledge and skill to identify features and be able to 
separate those features which they might expect to see from those that are not 
associated with condition. 
Number of participants reported as completing the case = 1,011. Participant data 
removed due to incomplete, ruined or corrupt data sets = 68.  Total completing all 
elements for data examination = 948. 
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4.4.1 Morphological feature selection 
 
Table 4.13 Variety of morphological features selected by cell lineage 







Morphological feature ranked as 1  
Top priority by participants. 
15 23 3 42 of 74 
options 
Total number of features 
selected by all participants (all 
ranks 1 to 5 inclusive) 
2,894 1,434 318 4,646 
Total of 64 features selected from the 74 options available. A notably high variety of 
feature selections were chosen as the top priority. 
Table 4.14 Top features selected by priority for each major cell lineage 
Cell lineage 
 




Platelet Macrocytic platelets  225 23.7 0.5  
red cell Target cells 811 85.5 23.8 
white cell Neoplastic Leucocytes* 529 55.8 42.7 
*Neoplastic leucocytes is combined from participant selections recognising 
myeloblasts, lymphoblasts or neoplastic abnormal leucocytes. 
Whilst the majority of participants recognised the presence of red cell abnormalities 
far fewer went on to select features of the abnormal white cells (Table 4.14), however, 
if they did participants ranked their importance above that of the abnormal red cells 
(Table 4.13). 
4.4.2 Free text diagnosis question 
 
“Suggest your preferred diagnosis based on your morphological observations and the 
supplied clinical details.” 
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Interpretation and subsequent coding of the diagnostic comments was complicated, 
despite more than half of participants selecting both red cell and white cell abnormal 
features in their five choices only a quarter considered both when summarising their 
report.  
 Diagnostic summary considered both red cell and white cell abnormalities: 237 
= 25.0% 
 Red cell conclusion only: 283 = 29.8% 
 White cell conclusion only: 264 = 27.8% 
 No diagnostic summary or stated would be unable to interpret. 164. = 17.3%. 
As the urgent clinical finding is the presence of an acute leukaemia the morphological 
diagnostic summaries were grouped as to whether participants actually reported acute 
leukaemia. 
The preferred diagnosis was coded in to the groups shown in the following table. 
Table 4.15 Summary of morphological diagnosis grouped by overall conclusion 
reported 
Diagnostic summary Total % 
1/ Correct:  Acute leukaemia and a haemoglobinopathy 84 8.9 
2/ AML but either no red cell conclusion or an incorrect red cell 
conclusion 
121 12.7 
3/ Other neoplastic causes for the abnormal white cells (e.g. lymphoma) 232 24.5 
4/ Sepsis or reactive (non-neoplasm) 227 23.9 
5/ No abnormal white cells reported – Red cell only diagnosis made 283 29.8 
 
 Those correctly interpreting their report as acute leukaemia = 205 (21.6%) 
 Notably 24.5% made an incorrect interpretation of the blast cells but did 
suggest a neoplastic cause, whilst this is not correct it would have ensured 
further review. 
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 Those completing feature selections and answering the action MCQ but either 
not entering a free text diagnosis or stating that they unable to make a 
morphological diagnosis was, not surprisingly, high compared to Cases 1, 2 and 
3 n = 164 (17.3%).    
Examination of red cell comments: 
 Of participants who reported the correct morphological summary of 
Haemoglobinopathy (281 = 29.6%) most either failed to incorporate abnormal 
leucocytes in to their summary or reported an incorrect white cell conclusion 
which did not include a neoplastic element (197 = 20.8%).  
 Other causes for the abnormal erythrocytes (e.g., liver disease, hyposplenism, 
megaloblastic anaemia) were suggested by 300 participants (31.6%) who did 
not consider a haemoglobinopathy. 
 
 
4.4.3 Action selected 
 
Multiple choice question: Based on the information you have and your interpretation 
of the film what is the most appropriate course of action?  Please select your preferred 
option. 
Anticipated answer: Based on the unexpected finding of myeloblasts the film should 








Page | 146  
 
Table 4.16 MCQ:  Participants preferred action 
Action selected Total % *Neoplastic 
ranked at 1 
(top priority) 
% 
A/  Refer immediately- Patient may need to be seen 
urgently 
573 60.0 55.8 
B/ Report directly to medic within 24 hours – may need 
review next working day. 
208 21.9 33.7 
C/ Important – film findings need communication to 
clinician, non-urgent. 
120 12.8 11.7 
D/  A routine report is sufficient as patient is under 
haematological review 
44 4.6 6.8 
E/  No report required, this is a known chronic condition 3 0.3 0 
*Neoplastic ranked at 1: Percentage of participants who reported case as neoplastic 
against the action category they selected. 
 
The majority of participants would have referred this film and so the acute leukaemia 
would, at some point, have been recognised, but most were referring the film for the 
abnormal red cell morphology. In a real situation the haemoglobinopathy would 
probably have been already known so the case may not have been referred. The 
participants who did not select abnormal white cells referred the film with a lower 
level of urgency. 
 
4.4.4 Case 4: summary findings from data 
 
 The red cell features caught the attention of participants, although the majority 
struggled to interpret them correctly. It should be noted that although HbSC is 
a well described haemoglobinopathy such patients are often monitored in 
specialist centres and so many participants may not see such blood films 
routinely. 
 The lack of skill shown in interpreting the red cell features resulted in poor 
summary reports; most participants chose to refer the film for review.  
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 The abnormal white cells were “missed” by almost half of participants but 
where they were reported they were correctly given a high priority. 
 Despite the high priority given to the abnormal white cells this did not 
automatically trigger an urgent communication of these findings or appear as 
part of the interpretive summary report. 
 
These findings are shown in detail below in Figure 4.7 panels A to E. 
 
 
Figure 4.7 Panel A:  Morphology features selected by participants reporting a 
diagnosis of AML. Major morphological feature groups represented according to 
whether a diagnosis of acute leukaemia was made, bars represent mean selection 
number with error bars (SEM) and significant differences are indicated on the figure 
(Chi-square test). Significance is indicated: p < 0.05 *, p < 0.01 **, p < 0.001 ***. 
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Panel B: Priority when AML Diagnosed     Panel C: Priority for other WBC diagnosis  
Priority score given to the first selection of any feature each feature group (1 is the 
highest priority), panels reflect whether acute leukaemia was diagnosed (B) or not 
diagnosed (C).   
 
Panel D: Action according to diagnosis    Panel E: Red cell diagnosis against WBC diagnosis 
Panel D: Priority for action taken according to diagnosis suggested (1 is highest 
priority).  Priorities indicated reflect whether acute leukaemia was diagnosed, a third 
broken line (blue) represents the subset of participants who recorded the presence of 
blast cells but did not diagnose acute leukaemia in their summary report.  Panel E: Red 
cell diagnoses offered according to whether acute leukaemia was diagnosed. 
Statistically significant differences are indicated on the figure (Mann Whitney test).  
Figure 4.7 Case 4: Analysis of participant responses where morphological features 
reflected two separate unrelated pathological disorders (HbSC disease with AML). 
Significance is indicated as follows: p < 0.05 *, p < 0.01 **, p < 0.001 ***. 
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4.5 Complex morphology Case 5: skill levels known  
 
Numerous bite cells and hemi-ghost red cells are distinctive features of oxidative 
haemolysis and are seen alongside other general features of haemolysis such as 
polychromasia and red cell damage. Also present are the abnormal primitive lymphoid 
cells of ATLL, the right panel shows a typical example with basophilic cytoplasm, 
lobulated and folded nuclei. 
Figure 4.8 Case 5: oxidative haemolysis (G6PD deficiency) and adult T-cell 
leukaemia/lymphoma 
Original DM scheme information:   “A 60 year old male admitted as an emergency several 
days earlier and recently commenced on medical treatment now develops a change in clinical 
condition. Full blood count at the time of the sample was WBC 44 x 10^9/L, Hb 93 g/L, 
Platelets 72 x 10^9/L.  “ Narrated by M Brereton and J Burthem”. 
Originally distributed by UK NEQAS(H) as DM scheme 1204DM. Actual diagnosis of 
adult T-cell leukaemia/lymphoma (ATLL) on treatment, with therapy related acute 
oxidative haemolysis due to exacerbation of an undiagnosed deficiency of the enzyme 
glucose-6-phosphate dehydrogenase (G6PD). 
As in Case 3 this also shows a rare occurrence of two separate pathological disorders 
which are linked by treatment. In this instance the genetic deficiency of G6PD leads to 
an acute oxidative haemolytic process when exacerbated by clinical therapy given to 
treat the ATLL. The clinical team had no prior knowledge of the inherited G6PD 
deficiency as they had not tested for this. The subsequent acute haemolytic crisis was, 
therefore, avoidable but created a dangerous clinical situation for the patient. The key 
morphological features are those of atypical lymphoid cells with neoplastic features; 
notable folded, flower shaped nuclei against a background of markedly abnormal red 
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cells with distinctive “bite” shape and hemi-ghost cells which are distinctive features 
associated with acute oxidative haemolysis (Figure 4.5). This information requires 
urgent communication to the clinical team and the nature of the report should lead 
them to consider G6PD deficiency as the probable cause and intervention should be 
immediate. Failure to communicate these specific features of oxidative haemolysis 
could lead to delay in correct treatment and a catastrophic haemolytic destruction of 
the patient’s red cells. 
 
For this case participants were asked to state their perceived skill level from options 
provided.  The case required the participant be able to:  
1. find abnormal features in all cell lines   
2. correctly identify those abnormal features.  
3. correctly prioritise the abnormal features found 
4. to recognise that the specific features which identify the oxidative process as cause 
of the haemolysis require immediate communication, especially as at this point the 
haemoglobin concentration may not be sufficiently abnormal to cause undue 
concern for the clinical team. 
Participants must have the knowledge and skill to identify features and be able to 
separate those features which they might expect to see in one abnormality from those 
that are not associated with the primary condition. 
 
 
Number of participants completing this case = 789. Participant data removed due to 
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4.5.1 Morphological feature selection 
 
Table 4.17 Variety of morphological features selected by cell lineage 







Morphological feature ranked as 1 
(Top priority) by participants 
15 18 1 34 of 74 
options 
Total number of features selected 
by all participants (all ranks 1 to 5 
inclusive) 
1,647 1,409 450 3,506 
Total of 63 features selected from the 74 options available.  A high variety of feature 
selections were chosen as the top priority. 
Table 4.18 Top features selected by priority for each major cell lineage 




Ghost/Hemi ghost red cells  546 70.7 45.2 
Thrombocytopenia 387 50.1 2.3 
Neoplastic Lymphocytes* 270 35.0 13.6 
*Neoplastic lymphocytes is combined from participant selections for the multiple 
options which indicate neoplastic lymphoid features. 
 A high proportion recognised the key red cell destruction feature correctly. 
 Neoplastic lymphoid features were poorly categorised. 
 
4.5.2 Free text diagnosis question 
 
“Suggest the diagnosis or diagnoses that, in your view, best fit the morphological 
appearances in this case.” 
The diagnostic summaries were coded by whether participants referred to the 
oxidative haemolysis (usually suggesting G6PD deficiency as the cause) and whether 
they also summarised the abnormal lymphoid disorder.  As this is the only case where 
participants gave their assessment of their own skill level at morphology reporting the 
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diagnostic summary is shown against the skill level they indicated in the MCQ (see 
section 4.5.3). 
4.5.3 Skill level selected 
 
Multiple choice question: Following feedback from last year’s participants’ symposium 
and to help us with future film selection and question setting we would like to know 
which general statement best describes your day to day activity.  
Anticipated answer: It was assumed that the majority would be BMS, but it was not 
known how many, if any, clinicians participated in the scheme. The question also 
enabled us to see the proportion of non-reporting biomedical scientists who 
participated in the scheme for CPD purposes only. An option to allow participants to 
retain total privacy was also included. 
Table 4.19 MCQ:  Participants self-selected skill level 
Participants selection Number % 
A/ Biomedical scientist issuing unsupervised reports (R-BMS) 505 65.0 
B/ Biomedical scientist issuing supervised reports (S-BMS) 119 15.4 
C/ Biomedical scientist. Non-reporter. (NR-BMS)* 58 7.5 
D/ Medic issuing unsupervised morphology reports 14 1.8 
E/ Medic issuing supervised morphology reports 15 1.9 
F/ Medic non-reporter 2  
G/ None of the above  16 2.0 
H/ Prefer not to say 43 5.6 
*NR-BMS included participants stating they were in managerial roles, BMS working in 
multidisciplinary or non-microscopy areas e.g. blood transfusion and BMS not 
currently practising e.g. on maternity leave or left the profession.  
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As the numbers for non-BMS participants (groups D, E, F, G and H) were relatively low 
these are not included in the table of comparison with diagnostic summary shown 
below in Table 4.20  
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Table 4.20  Diagnostic summary by self-selected skill level 
 
Morphology diagnostic summary   Total % 
Correct. Both lymphoid malignancy and acute oxidative haemolysis 
 R-BMS – unsupervised 
 S-BMS – supervised for reporting 









No conclusion or participant stated they were not able to interpret 
 R-BMS – unsupervised 
 S-BMS – supervised for reporting 









Incorrect for both white cell and red cell summary or an incorrect 
summary for one cell lineage with no mention of second condition 
 R-BMS – unsupervised 
 S-BMS – supervised for reporting 











Correct summary for oxidative haemolysis (irrespective of white cell) 
 R-BMS – unsupervised 
 S-BMS – supervised for reporting 









Correct summary for lymphoid malignancy (irrespective of red cell) 
 R-BMS – unsupervised 
 S-BMS – supervised for reporting 









Summary for red cell features only (irrespective of experience level) 
 Correct summary of oxidative haemolysis 








Summary for white cell features only (irrespective of skill level) 
 Correct summary for lymphoid malignancy 







Total absolute number and percentage are shown for the 772 participants who 
completed the case.   
Absolute number and percentage for sub categories are given for: 
R-BMS –unsupervised = 505 (65% of all participants who completed). 
S-BMS – supervised for reporting = 119 (15.4 % of all participants who completed). 
NR-BMS – in a non-reporting role = 58 (7.5% of all participants who completed). 
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4.5.4 Case 5: summary findings from data 
  
The UK NEQAS(H) DM Scheme for CPD is aimed at BMSs, however, other professionals 
may register, for this case 47 individuals (mainly clinical staff) stated they had 
completed the case. The morphology SAG had been aware of the participation of 
medical staff anecdotally via clinical colleagues but had no knowledge of prevalence 
before this data. Currently there is still no direct equivalent scheme for medical staff 
who report morphology. 
 
As the non-biomedical staff groups were small, it would not be possible to draw robust 
conclusions from this data and so they are not considered in further figures. Data in 
Table 4.20 suggests: 
 Those BMS reporting unsupervised appear more able to issue a correct 
summary report. 
 Those BMS in non-reporting roles appear less able to produce an overall 
correct report. 
 Those BMS in supervised roles are less likely to offer a summary report than 
those routinely reporting. 
 Whilst 68.5% correctly identified the red cell abnormality only 22.8% correctly 
reported the white cell condition. 
 
For statistical purposes two major groups were selected for analysis: unsupervised 
BMS who stated they regularly issued morphological reports (R-BMS) and BMS who did 
not work in a reporting role (NR-BMS), the non-reporting group included BMS who 
specialised in multi-disciplinary teams, other areas of haematology and those with 
lengthy experience but who had moved in to managerial or other linked careers. Detail 
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Panel A:                                                                    Panel B: 
Erythroid features according to skill level         WBC features according to skill level  
 
Comparison of erythroid (panel A) or white cell (panel B) features selected according to the 
self-selection level of reporting experience, error bars represent SEM. No significant 
differences were detected in selections for either cell type (Chi-square test).  
 
Panel C:                                                                     Panel D: 
Erythroid priority according to skill level           WBC priority according to skill level  
A comparison of the priority assigned to erythroid features (C) or white cell features 
(D), separated according to the reporting experience of participants. Significant 
differences are indicated on the plot (Mann Whitney test).  
Figure 4.9 Case 5: Analysis of reported features according to the self-selected skill 
level of participants. Panels A to D. Significance is indicated on Figures 4.9 as follows: p 
< 0.05 *, p < 0.01 **, p < 0.001 ***. 
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Panel E: Comparison between the suggested diagnosis and experience of the 
reporter. 
Figure 4.9 Case 5: Analysis of reported features according to the self-selected skill 
level of participants, where the morphological features represented two separate 
pathological disorders (adult T-cell leukaemia/lymphoma and acute oxidative 
haemolysis). Panel E. Significance is indicated on Figures 4.9 as follows: p < 0.05 *, p < 
0.01 **, p < 0.001 ***. 
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present on image 
Major diagnostic subgroups 
analysed.  
Closest to ideal answer shown 










Reactive lymphocytes a. Reactive lymphocytes 
b. Neoplastic lymphocytes 












a. Pelger Huët anomaly 
b. Myelodysplastic syndrome 


















a. MAHA and viral illness 
b. MAHA 









SC disease (HbSC) 





a. Acute leukaemia diagnosed 
b. Leukaemia not diagnosed 















Changes of oxidative 
haemolysis affecting 
erythrocytes 
a. Biomedical Scientists 
regularly reporting blood films 
b. Biomedical scientists 
reporting in a supervised role 
c. Biomedical Scientists not 
reporting blood films 
505 
 
  119 
 
   58 
Note: For Case 5 participants were asked to select a professional category that most 
represented their daily work from a selection of five alternatives, the three most 
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Chapter Five: Discussion  
The examination and reporting of a blood film is a complex and subjective process 
performed by an individual who must make a number of assessments in a pressured 
time frame. They must prioritise these, make a judgement about what the outcome 
report should state and what, if any, actions are required. Most of this process occurs 
without the individual consciously or deliberately considering the actual process itself 
or the skills involved to complete it. Assuming some basic haematology knowledge 
they:   
1. Assess that all cell types are present in appropriate number and in appropriate 
relationship; this assessment requires the skills of recognition and classification.   
2. When abnormalities are recognised the individual must assess the significance 
of the abnormalities and prioritise them relative to each other. Alongside 
knowledge of clinical conditions this process involves the skill of being able to 
appropriately weight findings. 
3. In order to produce a succinct and effective report for the clinician the 
individual will need to distil their findings by interpretation using the skill of 
decision making. The outcome will depend on the experience and knowledge of 
the individual. The level of previous experience creates a background 
expectation which they may use to speed the process but could lead to a wrong 
conclusion. 
4. Additionally there will be a time pressure element of workload waiting and the 
expectation of colleagues, as the workload between individuals is compared 
either subconsciously or actually in the form of laboratory and user targets.   
 
5.1 Cases with a predominant single morphological feature 
The morphological features present in the image for Cases 1 and 2 (Chapter four, 
Figures 4.1 and 4.2) affected a single cell type, and were not accompanied by other 
abnormalities. Irrespective of the diagnosis made, almost all participants correctly 
identified and then prioritised the affected lineage (97.4% and 83.8% respectively); 
concentrating their comments on the abnormal lymphocytes for Case 1 and the 
neutrophils for Case 2 (Figure 4.3 panels C and D). However, within that lineage the 
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precise classification of the abnormal cells differed significantly between participants 
in each case. The classification could be divided into distinct subgroups that were 
linked to the diagnostic summary of the abnormal cell type (Tables 4.2 and 4.6).  
For Case 1, those answering the case correctly identified and classified the abnormal 
cells as reactive lymphocytes, but other subgroups of participants incorrectly classified 
the abnormal cells as neoplastic, or reported the presence of both neoplastic and 
reactive cells (Figure 4.3 panel C). Case 2 showed similar findings, with abnormal 
neutrophils being identified as the most significant feature by almost all participants. 
Those participants correctly interpreting the case classified the cells as having Pelger-
Huët morphology, while those participants incorrectly interpreting the case selected 
either pseudo-Pelger morphology (classing the cells as having dysplastic features and 
subsequently diagnosing myelodysplasia), or classed the neutrophils as “left-shifted” 
(assigning a reactive condition as the diagnostic summary) neither of which were 
correct (Figure 4.3 panel D).  Additionally morphological features affecting other 
lineages were consistently reported depending upon the initial classification of the 
main abnormal cell. The nature of these additional features was linked to the diagnosis 
subsequently proposed in each case. In Case 2 (Pelger-Huët) those participants 
incorrectly diagnosing a reactive process more frequently (but incorrectly) reported 
reactive changes affecting other cell lineages.  
In both cases where a neoplastic disorder was incorrectly diagnosed, participants 
selected a higher number of other morphological features, but did not identify 
supporting evidence from other cell lineages. Whereas those correctly diagnosing 
either case made the fewest additional selections; appropriate the abnormality sat 
against a relatively normal morphological background.  
 For both these cases, when examining the outcome from the MCQ actions chosen, 
participants were influenced by their morphological interpretation, and consequently a 
diagnosis of neoplasia was associated with a higher need for urgent action (Figure 4.3 
panels E and F).  Urgent action due to an incorrect conclusion could cause undue 
concern for either the clinical team or the patient; whilst not as dangerous as missing 
the important feature, there could still be significant consequences.  
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These first two cases analysed had shown the importance of recognising and correctly 
classifying a feature, once classified the feature dictated the outcome action. 
Interpretation of the morphological features seen is not formally recognised as a 
function of blood film reporting by BMS, it is assumed they will refer abnormal findings 
for clinical comment, their interpretation in these cases, however, strongly influenced 
their subsequent action. 
5.2 Cases combining complex morphological features 
The next cases to be examined; Cases 3 and 4, had greater morphological complexity 
so were a greater test of the ability to classify features but also of the importance of 
prioritising those features to reach an outcome. Case 3 demonstrated a 
microangiopathic haemolysis accompanied by reactive lymphocytes, reflecting an 
actual pathological diagnosis of thrombotic thrombocytopenic purpura arising during 
acute HIV infection (Figure 4.4). Consistent with this increased complexity, participants 
reported a greater number of morphological feature selections (mean 4.8 from a 
possible 5 compared to mean 3.9 for Case 2) Table 4.9 
Three separate diagnostic groups were identified: microangiopathic haemolysis with 
concurrent viral infection (the ideal report), MAHA alone without comment of viral 
features, and haemolysis without specifying a microangiopathic process (Table 4.11). 
This latter group included various suggested causes for the haemolysis including 
haemoglobinopathy or nutritional deficiency. The morphological triad associated with 
MAHA (thrombocytopenia, red cell fragmentation, and general features of haemolysis) 
was consistently identified by all participant groups (Figure 4.5 panel A) but the major 
difference lay in the priority ascribed to those features. All groups prioritised 
thrombocytopenia as the most important aspect of the case (even for those failing to 
diagnose MAHA) (Figure 4.5 panel B); however, where non-specific haemolysis was 
diagnosed a significantly lower priority was attached to erythrocyte fragmentation and 
higher priority to general haemolytic features such as polychromasia. (Figure 4.5 
panels C and D).   
Participants were less likely to report the abnormal white cells in this complex case 
with lymphocyte abnormalities reported by only 59.7% (Table 4.10), compared with 
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97.0% when present as a sole abnormality (Table 4.2) (p < 0.001 verses. Case 1, Chi 
Square test). Similarly, lymphocyte related features were included in the suggested 
diagnosis of the complex case by only 16.7% of participants (Table 4.11), compared 
with 97.4% when they were a sole abnormality in Case 1 (p < 0.001 vs. Case 1, Chi 
square test).  
In Case 4, an acute myeloid leukaemia arose independently in an individual with an 
inherited haemoglobinopathy (HbSC disease) causing a plethora of abnormalities 
affecting red cell, platelet and white cell lineages (Figure 4.6). Unsurprisingly there was 
a high use of permitted feature selections (mean 4.9 of 5) (Table 4.13) but only a 
quarter considered both red cell and white cell abnormalities in their summary and 
only 8.9% were entirely correct (Table 4.15). As the emergence of an acute leukaemia 
is a critical event, the diagnostic summaries were collated into sub groups. The main 
three were examined: firstly those who suggested an acute leukaemia, secondly those 
who noted significant white-cell abnormal features but did not report acute leukaemia, 
and finally those who did not consider white cells in their diagnostic summary (Table 
4.21, Figure 4.7). 
 As seen with Case 3, the reported red cell features did not significantly differ between 
the sub groups (Figure 4.7), however, for white cell features the ability to recognise 
and the subsequent classification of the abnormal white cells was crucial. Participants 
diagnosing acute leukaemia had reported blast cells with a high frequency, while the 
presence of blast cells was not (in general) reported by those diagnosing a different 
white cell disorder or offering no white cell diagnosis (Figure 4.7 panel A).  In terms of 
priority, where blast cells were reported they were correctly assigned the highest level 
of importance (Figure 4.7 panels B and C), and this was irrespective of whether 
leukaemia was diagnosed (Figure 4.7 panel D). It was noted whilst coding data that 
some participants reported blast cells but then did not incorporate them in to a final 
report. Of the 55.8% who selected blast or neoplastic cells (Table 4.14) 46.1% included 
them in their summary (Table 4.15). Not drawing attention to such an important 
feature was surprising but BMS generally report the features they see but might not 
offer an overall summary, leaving the clinician to draw a conclusion. There was no link 
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between the abnormal white cell features reported by participants and their 
interpretation of red cell abnormalities (Figure 4.7 panel E). 
5.3 Effect of experience on morphological reporting skills  
For Case 5 participants were asked to specify their level of reporting responsibility as a 
surrogate for experience or seniority. There are no national proficiency standards for 
reporting of morphology and participants opinion of their own skill levels is open to 
interpretation; some may have looked at many films but from a mainly well patient 
population where as others may consider their length of experience low but might 
have been exposed to a far higher proportion of abnormal blood films.  
A complex morphological case was selected for use containing abnormal lymphoid 
cells of adult T-cell leukaemia/lymphoma together with features of treatment-induced 
oxidative haemolysis (due to an underlying deficiency of G6PD) (Figure 4.8). It is noted 
that a case of oxidative haemolysis due to G6PD deficiency had been presented as a 
DM case previously and it might, therefore, have been expected that some participants 
would more readily recognise the rare red cell morphology. Indeed this occurred with 
more than 68% correctly suggesting an oxidative haemolysis in their summary 
compared to less than 60% previously (DM scheme 1103DM which had no additional 
abnormal white cell features), although it is not known how many of the same 
participants had completed both these cases.   
Overall the participants made a high number of morphological selections (4.5 of 5), 
reflecting the large number of features present. A correct diagnosis of lymphoid 
malignancy was made by only 176/772 (23%), and specifically stating oxidative 
haemolysis by 528/772 (68.3%), with an entirely correct diagnosis including both 
disorders made by 139/772 (17%).  
For both red cells and white cells, those stating they regularly report films (R-BMS) 
showed a trend to report features more relevant to diagnosis than the non-reporting 
BMS (NR-BMS) groups where the features reported were less specific, with a 
statistically significant difference demonstrated for white cell forms (Figure 4.9 panels 
A and B p = < 0.01).  
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For prioritisation, R-BMS again demonstrated more effective prioritisation of abnormal 
forms; this was significant for both red cell and white cell features (Figure 4.9 panels C 
and D p = < 0.05 and < 0.01). The skills of classification and ability to “rank” in order 
were linked to a higher overall rate of diagnosis both of oxidative haemolysis and of 
neoplasia by the R-BMS group (Figure 4.9 panel E). However it is noted that, consistent 
with Cases 3 and 4, some participants from each group failed to identify the neoplastic 
white cells. Analysis suggested that (at least for the R-BMS group) the features were 
actually missed rather than the being misinterpreted as reactive cells as there was no 
increase in the selection of the reactive lymphocyte code when neoplastic features 
were not selected. This indicates that the reporting skills demonstrated by experienced 
morphologists were more targeted; although errors were still evident and the pattern 
of error similar for both groups. 
 
5.4 Understanding the process of providing a morphology report 
Improvements to the way morphology education is given should be enhanced by 
understanding the nature of the reporting process. As each case in this thesis was 
examined the data raised questions about an individual’s previous experiences 
producing bias which supported efficient reporting but affected outcomes and which 
were unexpected. The following table suggests a simple model for the reporting 
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Table 5.1 A seven-stage model to understand how professionals arrive at a final 
morphology report 
       Process Elements required to complete stage within process 
1. Familiarity  Initial assessment of film content, where to start, what 
to look at. 
2. Recognition Able to assess what appears normal and abnormal 
3. Classification Able to classify abnormalities correctly 




Able to prioritise clinically significant abnormalities 
6. Interpretation Understands the significance of how abnormalities are 
related and can formulate a succinct report which draws 
the correct conclusion  
7. Action Report outcome leading to the correct clinical action 
being taken with appropriate communication. 
 
5.5 Reducing the effort when associating observations in context, consideration of 
heuristic techniques 
Judgment and decision making, in a time pressured environment, are integrated into 
every aspect of laboratory practice. Only when an incorrect action causes an incident 
do professionals fully investigate how conclusions were reached, in order to prevent 
reoccurrence of the error.  
The techniques our brains employ to arrive at a decision with the minimum of effort 
have been defined as “heuristic” methods (Simon, 1990; Shah & Oppenheimer, 2008). 
These are usually a mixture of conscious and sub conscious processes which combine 
to produce a quick and satisfactory outome on most occasions. Research has shown 
that young children are quickly able to differentiate different animals when given 
pictures; by contrast computers are unable to reproduce the same level of accuracy 
(Zhang, Sun, & Tang, 2011). Equally people with poor vision can correctly identify 
people they know in a crowd when all faces and movements are indistinct. This is 
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because our brains employ “fast and frugal” heuristics enabling us to outperform 
computers in these complex situations. These techniques, however, may introduce a 
source of bias, which usually goes unrecognised by the individual, but can lead to 
mistaken conclusions. In daily life we may glance at someone and think we recognise 
them but when a stranger turns we have made a mistake in identity recognition. Some 
mistakes made quickly before all available evidence has been considered can lead to 
serious error.  
Recognition of objects and people require skills based upon two separate but linked 
processes; the first being the ability to perceive something as familiar or unfamiliar 
(this is a rapid intuitive process based on previous experience). The second process is 
the skill of recollection (a slower conscious recall of learnt knowledge) (Henson, Rugg, 
Shallice, Josephs & Dolan, 1999; Wagner, Desmond, Glover & Gabrieli, 1998).  In 
everyday life there are countless situations that require prompt action without much 
deliberation, in which experience of a situation is integral to making a quick decision.  
5.6 Heuristic techniques in morphology reporting 
Morphology reports have a key diagnostic role; poor quality reports, over reporting of 
non-critical features or missing of important features can be queried by clinical teams, 
picked up by senior staff checking reports or detected by other staff reviewing test 
results. Those involved learn from these experiences which will influence their future 
decisions when reporting whether they realise this or not. Such trial and error 
techniques of learning may be considered heuristic.  In order to complete each 
morphology report the individual will consciously and subconsciously apply various 
techniques or strategies which simplify these complex processes. They are unlikely to 
realise that they are using heuristic methods to interpret the morphology and 
complete their report, but it is the very techniques the morphologist employs to make 
fast and safe decisions that may also lead them to produce poor or misguided 
conclusions. The level of impact for the patient may be low, although morphology 
reports are an important diagnostic tool, so an incorrect or misleading report may be 
distressing for the patient but could also be catastrophic should an acute clinical 
condition be missed.  
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The question of how a heuristic approach impacts on blood film reporting has never 
been assessed, however, the examination of participant submissions enabled analysis 
of the responses of many hundreds of professionals who report blood cell morphology 
as a routine part of their practice. In doing so it was possible to analyse their ability to 
arrive at correct or incorrect conclusion for a range or representative cases and to 
detect common patterns of bias. Acknowledging the varied levels of experience the 
examination has revealed common patterns of approach to interpretation, but has also 
highlighted patterns of error shared by the different groups of participants. These data 
have relevance to indicate how support mechanisms could be better designed to 
improve the interpretation skills of individuals who report haematological morphology. 
As the examination of data from each case was undertaken it was intriguing to see 
how the morphological features selected were then interpreted to give a succinct final 
report and it became noticeable how the outcome report strongly influenced the 
actions taken. Due to the very nature of microscopy, morphology reporting is a largely 
unregulated process; those performing it are working in a pressured environment and 
must make their decisions efficiently but safely. They must be able to recognise that an 
abnormal feature is present and then be able to recall from their experience the 
correct classification. When reporting blood cell morphology familiarity is likely to 
drive the initial recognition of any abnormality, and in this research there was 
generally substantial agreement on the affected cell lineage irrespective of any 
conclusion reached. However, subsequent evaluation of the chosen classification made 
by participants of the abnormality they perceived requires active recollection, and this 
conscious process revealed an interesting variability.  
For Cases 1 and 2 where a single abnormal feature was present the majority 
recognised the abnormality but far fewer correctly classified this abnormality leading 
to correspondingly different outcomes chosen for further action. The data also showed 
that abnormal erythrocyte forms were more often classified correctly and, therefore, 
reported in consensus agreement but the classification of abnormal white cells varied 
markedly between participants. It is probable that the ability to classify red and white 
cells is influenced by the very nature and appearance of these cell types. Abnormal 
erythrocytes are often present in large numbers so our brains see multiple similar 
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occurrences re-enforcing our decision whilst they are simple forms, usually geometric 
and without much central structure, it a fact that such shapes are known to be rapidly 
and accurately recognised and classified by the human brain (Larson, Aronoff, 
Sarinopoulos, & Zhu, 2009; Bar, 2003).  By contrast, abnormal white cells are usually 
relatively infrequent so, it is less likely that examples will been viewed directly 
together, they are also individually complex containing both nuclear and cytoplasmic 
structures. When the Cases 1 and 2 were originally prepared for the DM scheme care 
had been taken to ensure the images contained sufficient examples of the relevant 
classic abnormal white cells required.  The assessment of abnormal white cells requires 
us to recognise subtle changes of specific features, our ability to achieve this will 
depend strongly on conscious evaluation (Di Carlo, Zoccolan & Rust, 2012).  However, 
when considering all cases the more consistent classification of erythroid features seen 
by participants failed to translate into an improved morphological conclusion, 
suggesting that additional factors were also involved in distilling their findings in to a 
diagnostic summary. 
Irrespective of the nature or frequency of any abnormalities present in a blood film, 
the data obtained through morphological assessment by microscopy is inevitably 
complex.  Each of the five DM images examined by the scheme participants comprised 
50 to 90 separate fields and so depicted 3000-4000 cells giving many possible 
morphological descriptions to consider. In Case 5 (Table 4.17) participants made 63 
different morphological selections (of 74 available). Distilling a conclusion from this 
complexity presents the morphologist with a problem as there are simply too many 
different cell features for each to be considered individually. This was confirmed by the 
heat-map exercise in chapter 2 (section 2.7.1) showing that users viewed images 
without following a set protocol but went immediately to features of interest. 
Professionals reporting blood films must arrive at a conclusion in a pressured time 
frame but that conclusion needs to be as accurate and informative as possible, so to 
achieve this, strategies that simplify and direct the analysis of the film must be 
employed.  Specific conscious evaluations, such as cell classification and prioritisation 
of abnormalities, are central to the analysis; additionally the often unconscious 
mechanisms of heuristics are employed. These techniques may be highly effective at 
supporting fast and frugal decision making (Goldstein & Gigerenzer, 2002), or may 
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introduce bias (Croskerry, 2013; Dawson & Arkes, 1987). Heuristic processes have been 
widely reported in other areas of medicine (Klein, 2005, Crowley et al., 2013; 
Wegwarth, Gaissmaier & Gigerenzer, 2009; Murray et al., 2015) and are recognised to 
be prevalent in image based interpretation in radiology, (Gunderman, 2009) but have 
not been studied in laboratory haematology before. Considering the findings from the 
analysis of the DM cases in this thesis heuristic processes appear to be potentially 
relevant. They should, therefore, be considered in the study of haematological 
morphology as summarised along with their associated cognitive biases and are 
summarised in Tables 5.2 and 5.3 (derived from Shah & Oppenheimer, 2008; Tversky & 
Kahneman, 1974; Blumenthal-Barby & Kreiger, 2015).  
 
Table 5.2 Summary of the processes used by participants enabling them to complete 
a morphological report 
Panels A to D. Table includes examples of the linked forms of error or bias that arose:   
 
A. Classification 




Assigning related observations to a discreet `class’. The cells 
comprising that class are then considered together as a single diagnostic 
feature. Example: the class ‘target cells’ can be related to other 
erythrocyte classes such as basophilic stippling, microcytosis and 
hypochromia to be a combined larger class of related observations 




Using the known pathological significance of an identified class to 
direct examination to seek evidence of a specific disease state.  
Example: the presence of target cells may direct a search for 
macrocytosis, thrombocytopenia and stomatocytes suggestive of liver 













B. Simplification heuristics 
(techniques employed to reduce the complexity of datasets) 
i. Weighting Attributing a relative importance to each individual class based on the 
perception of its diagnostic significance.  
Example: frequency of forms belonging to that class (target cells might 
be of importance if numerous rather than occasional), or the perceived 
pathological importance of the features (occasional fragmented red 
cells may be considered of more significance than occasional target 
cells). 
ii. Elimination Using the class assigned, and the weighting attributed to them to 
identify those features considered to have low importance to 
diagnosis and excluding them from further analysis. 
Example: if occasional target cells are considered of low significance 
they will simply be excluded from the features selected for reporting. 
iii. Sources of 
bias 
a. Bias of imaginability: complex findings are simplified by the 
morphologist to remove elements considered less important for 
diagnosis: this may not follow objective criteria. 
Example: complex red cell morphology may be distilled to two or three 
elements suggesting differing pathological processes.  
b. Inattention error: being distracted by multiple elements in a 
complex picture, therefore failing to notice or consider specific 
important features.  
Example: in complex cases the morphologist may fix on a key feature 
such as the presence of a haemolytic picture and entirely miss the 
presence of leukaemic blast cells. 
c. Associative thinking: belief that events occurring together are likely 
to be linked; leading to placing unlinked observations into a single 
class.  
Example: Linking extreme thrombocytopenia as a feature of a 
haemolytic process so missing that there is bone marrow failure due to 












C. Context heuristics 
(actively seeking other data that supports a particular decision) 
i. Framing Reinforcing a diagnostic impression through the identification of 
supporting features or other classes that are consistent with the same 
pathological process.  
Example: seeing Pelger-Huët cells and interpreting them as left shifted 
neutrophils then looking for toxic granulation in order to support the 
conclusion of a reactive process. 
ii. 
Availability 
Interpreting features based on a perceived likelihood for a particular 
disease process.  




a. Framing bias and inattention error: the preconceived diagnosis is 
inappropriately favoured by overemphasising features that support 
the diagnosis and giving less weight to features that do not fit.  
Example: considering a haemoglobinopathy (when one is not present 
but a haemolytic event is) may report target cells even when numbers 
are not significant and ignore the presence of more frequent hemi-
ghost cells. 
b. Availability bias: “common things are common” so less likely 
explanations are given less consideration.  
Example: spherocytes are associated with haemolytic anaemia so the 
irregularly contracted cells seen in a G6PD deficiency haemolytic crisis 
may be misinterpreted as spherocytes leading to an incorrect report.  
c. Anchoring bias: becoming rooted in an idea (e.g. “this is a 
leukaemia”) this interpretation is then maintained even where no 
further evidence is present. Anchoring is associated with “loss 
aversion”: observations with high potential significance, such as 
“features of possible neoplasm” are not eliminated even where the 
observer considers the diagnosis unlikely. Example: participants 
selecting blast cells as a top 5 feature but then not considering them in 
their summary reports. 
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D. Completion heuristics 
(techniques that support completion of task) 
A report must be issued and the mind cleared for the next report. 
i. Attribute 
substitution 
Simplifying the task. Changing the question from the objective “what 
is the diagnosis?” to the subjective “do the features fit with my 
preferred diagnosis?” Loss of “open mind” rather than reporting what 
is seen or if unable to interpret findings but needing to make a 
conclusion fit.  
Example: some individuals found features to support a conclusion of 
myelodysplastic syndrome in the Pelger-Huët when none were 
present. 
ii. Sources of 
bias 
Premature completion of task. When a conclusion is reached that is 
deemed sufficient to stop examination (`satisfying’), this may lead to a 
premature conclusion before all evidence has been discovered.  
Example: having successfully reported the extensive red cell features 
of the haemolytic process from a G6PD deficiency crisis some 
individuals concluded their report without considering any white cell 
features and so completely missing concurrent malignancy. 
  
Page | 173  
 
Cases 1 and 2 reflected disorders that affected a single lineage with no accompanying 
abnormalities and the error pattern differed from those in more complex cases. 
Essentially, knowledge-based skills of recognition and classification had primary 
importance and the subsequent diagnosis and actions taken were strongly linked to 
the choice of cell classification. The data also suggested that participants additionally 
sought to support their decision through contextual heuristic processes (Table 4.21 
and Table 5.2). In particular, incorrect diagnoses were associated with reporting a 
greater number of morphological feature selections and with evidence of biases 
associated with seeking supportive context. Experience suggests that the novice 
morphologist tends to report more features, fearing to miss an important feature, 
anecdotally over-reporting, in part because their skills of interpretation are limited.  
For participants who favoured a reactive diagnoses the use of “framing bias” led to the 
incorrect reporting of reactive features in other lineages that were not present in 
sufficient number to warrant reporting or were simply not there. Those participants 
concluding a malignant diagnosis were “anchoring” to a neoplastic interpretation 
despite lack of supporting evidence, and with “loss aversion” where participants 
reported both reactive and neoplastic features on the film but then did not question 
the clinical likelihood of their findings (summarised in Table 4.21).   
Where the DM images were of complex combinations (Cases 3 to 5), the participants 
analysis predominantly employed strategies that simplified the observations. The 
knowledge-based stratification of findings and the elimination of less important 
features allowed many participants to deliver more relevant interpretation (hence 
even though many different features were selected, participants were often able to 
correctly narrow their options to the most clinically relevant). Despite this, errors 
related to prioritisation were found. For example in Case 3, there was widespread 
agreement, with the presence of thrombocytopenia as the most frequently selected 
feature, although some participants entirely failed to consider the low platelet count in 
their interpretation. Importantly some participants gave a low priority ranking to the 
key feature of red cell fragmentation, resulting in an incorrect conclusion of general 
haemolysis rather than the more specific diagnosis of microangiopathic haemolysis. If 
that were a real patient situation the importance of providing the right information in 
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an urgent manner to the clinical team is imperative; as the haemoglobin concentration 
may be normal. Poor prioritisation of multiple features will dilute the specific nature of 
the haemolytic process and potentially detract from a conclusion of acute haemolysis. 
The question of whether participants had sufficient background training in 
haematology to correctly prioritise thrombocytopenia and red cell fragments was 
unknown but those actively reporting morphology have usually already gained general 
haematology experience authorising FBC results. The presence of the keratocytes and 
fragmented red cells are specific to the mechanical nature of the acute haemolytic 
event, reporting these features adds valuable clinical information that the medical 
team cannot determine from the numerical values of the FBC parameters alone.  
Significant error also arose from the application of simplification heuristics (Table 5.2 
panel B):  “Associative thinking” led to very significant morphological features being 
assumed to form part of an existing class rather than having independent significance.  
This could have minor effect e.g. the failure to include viral disorder in the conclusion 
to Case 3 where the clinical urgency would be communication of the haemolytic 
process. Failure to recognise two unrelated condition could also have a major effect, 
notably when participants failed to include leukaemia in the conclusion to Case 4 
(haemoglobinopathy) even when some had identified that blast cells were present and 
as a consequence would not have referred the film for urgent clinical review.  
Biases associated with the need or desire to complete their examination were also 
seen (Table 5.2 panel C): In Cases 4 and 5, a significant group of respondents failed to 
report the presence of neoplastic white cells. These errors were likely to derive from 
the complexity of the features and the requirement to finish the case, resulting in 
“inattention error” or the associated bias “premature completion of task” 
(summarised in Table 4.21). Having found a series of complex features it is possible 
some participants thought they had “found the abnormality” and discarded the 
mantra of blood film reporting “red cells, white cells and platelets, never forget to 
examine all areas”. Ignoring this mantra can also lead to the same error in a real 
patient situation.  
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Table 5.3 Morphology reporting skills and the types of error or bias shown in the five 
cases studied 
A. Cases 1 and 2 
(simple morphological features) 
Case 1: Viral infection related reactive morphology 
Case 2: Pelger-Huët anomaly with all other morphology normal. 
Primary skills: Recognition and classification            Relevant heuristic group: Context 
Error group Incorrect classification.             Source: Knowledge/skills-based error 
Supporting bias 
1 
Case 1: Overemphasis of reactive features to support a reactive 
diagnosis.                                     Source: Framing bias 
Supporting bias 
2 
Cases 1 & 2: Favouring malignant diagnosis without supporting 
evidence                    Source: Anchoring bias and consequence bias 
B. Cases 3 to 5 
(complex morphological features) 
Case 3: MAHA in a new case of HIV positive viral infection. 
Case 4: Acute myeloid leukaemia arising in a Haemoglobinopathy (HbSC) 
Case 5: Oxidative haemolysis of G6PD deficiency in a case of ATLL being treated. 
Primary skills: Recognition classification, prioritisation  
Relevant heuristic groups: Simplification and completion 
Error group Incorrect classification.  Source: Knowledge/skills 
based error 
Cases 4 and 5  
Error group Incorrect prioritisation and interpretation.     





Failure to report significant feature.  





Failure to include an observed feature in the 
interpretation:  
Source: associative thinking, attribute substitution 
All Cases 
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The reporting responsibilities and experience of participants in the UK NEQAS(H) DM 
scheme for CPD varied. However, blood film analysis is always interpretive even when 
the decision concerns whether (or when) to seek a colleague’s help. Cases 1 and 2 
clearly showed that the action taken in response to morphological appearances is 
tightly linked to the perceived diagnosis. In both those cases participants had a simple 
but key question to consider; is the abnormality malignant or not with the outcome 
action being totally different. Accuracy is an important facet of post-analytical quality 
ISO 15189. This research showed that while cell recognition is an important part of this 
process, the techniques of blood film interpretation also depend on effectively using a 
range of heuristic methods. These methods are hugely valuable in driving effective 
conclusion, and the data from Case 5 suggests that experienced morphologists apply 
these unconscious techniques more accurately than those with less experience. 
However, biases related to heuristics are also evident with the experienced group 
whose reports are less likely to face a second review. With internet-based material so 
widely available individuals can seek their own support (Ceelie et al., 2007; Lee et al., 
2013; Crowley et al., 2013) it becomes essential that we actively seek to understand, 
and address how we arrive at rapid accurate conclusions and where the errors occur 
(Hamilton, van Diest, Williams & Gallagher, 2009).  
The complexity of some of the cases studied were beyond that which most 
morphologists would see in day to day practice, although all cases were genuine and 
so could have presented to most laboratories. The image size was limited and the 
viewing experience not equivalent to that of examining a blood film so the findings in 
this thesis have to be considered with caution. It does appear, however, that heuristic 
processes do assist the knowledge base of the morphologist when producing a report 
so should be considered when designing training and morphology support. Semi-
automated cell recognition systems are being increasingly used in laboratories, these 
can produce auditable reporting and certainly reduce errors around cell classification 
but without acknowledging the complexity of the decision making process those 
reporting are still vulnerable to bias and error. 
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5.7 Digital images and morphology education beyond the UK NEQAS(H) scheme 
There are many respected haematology professionals now translating their teachings 
from conventional to digital formats. Notably the interactive ImageBank available on 
disk by Professor Barbara Bain (Bain, 1999) and Gillian Rosenberg, a respected scientist 
practising in Australia, has released an on-line teaching package which is related to her 
previous conventional publications and is validated by the Royal College of 
Pathologists of Australasia Quality Assurance Program (RCPAQAP, 2016). Unlike the UK 
NEQAS(H) DM scheme for CPD, these products contain mainly single frame images 
rather than large stitched images.  
There are training packages designed for use via the internet such the French led e-
hematimage training program which has translations in eight languages (e-
MEDICINimage, July 2017). With professionally validated educational information this 
system uses single images in composite form (not stitched) thus its main attraction is 
for those wanting to learn white cell differential skills. CellaVisionTM, the largest 
supplier of DM technology for laboratories across Europe, publish an on-line blog of 
interesting morphological features for others to comment upon (CellaVision, 2017a). In 
addition, CellaVision have published an atlas application of unstitched images 
(CellaVision, 2017b) which provides images of mainly single cells and so concentrates 
on white cell morphology and this technology forms the basis for a digital morphology 
EQA service in Sweden. As nations start to include the use of digital images in their 
own blood cell morphology EQA services, as seen in Spain, they must consider both the 
technical aspects and quality aspects of their services to engage with participants 
(Gutierrez, Merino, Domingo, Jou & Reverter., 2008).     
The internet has increased the opportunities to access training material but there 
considerations for users when making their choice; these include subscription costs 
and, for international options, spelling and terminology. The ICSH has recently 
published guidance on morphology nomenclature, (with supporting single feature 
images available on-line) although unless national professional bodies raise awareness 
amongst their membership standardisation might be slow (Palmer et al., 2015).  
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Digital images are already being used to support professionals across geographic 
divides, the International Network for Cancer Treatment and Research community 
(INCTR) use the telemedicine system by iPATHTM for users to upload images of bone 
marrow smears in order for colleagues to share, view and pass opinion (INCTR, 2017). 
Whilst keen to state that professionals are not providing a diagnosis their opinions may 
influence the outcome of the final report. This system, arising from the European bone 
marrow working group in Basel, is available internationally to support professionals 
who need expert advice, any professional can register and upload an image of a film 
and ask for expert comment. The DM team has also worked on projects with the World 
Health Organization using images to support the education and quality of malaria 
morphology reporting in Africa (Tatum et al., 2008; Ahmed et al., 2016) where there 
are considerable challenges for meeting user needs. Understanding what professionals 
want as a user experience is just as important as providing good quality images.  
That users of the UK NEQAS(H) DM scheme for CPD appreciate the quality of the 
product is confirmed by their continued participation. Although, some aspects of how 
they actually respond to the cases was unknown, this work has shown that an 
understanding of the reporting process needs to be considered when developing the 
service further. User experiences with digital imaging for morphology are now well 
established, although this is the first time those experiences have been examined in 
depth for a large user group. The findings from this work should be considered by 
those striving to educate professionals who report blood cell morphology.     
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Chapter Six: Conclusion 
The modern laboratory faces ever greater pressures for efficiency as service users also 
face the requirement to diagnose and treat patients quickly. Within the 24/7 working 
environment the important skill of reporting blood cell morphology must occur in a 
timely manner and cannot be left for those perceived as experts working other shifts. 
Reporting of blood films must be carried out at nights and weekends, by those who 
may cover multi-disciplines and may not even be haematology specialists. As labour 
intensive methods of teaching morphological skills become less widespread, the 
computer-driven decision-support mechanisms are becoming more widely available. 
Laboratories and the staff reporting morphology have no choice but to grasp new 
technologies to support their learning and so those providing training, or managing 
laboratories, must understand how best to support staff.  
In this thesis the responses of a large number of laboratory professionals, who 
examined the same blood films using a virtual microscope, were explored. It was found 
that the participants supported their knowledge-based decision making process by 
incorporating a range of additional techniques that helped reinforce or simplified their 
analysis. These “heuristic” approaches were used subconsciously in a similar process to 
those used in many other areas of human decision-making in order to support rapid 
accurate decision making about everyday situations. However the very techniques 
used to help make fast and precise decisions may also lead to an unrecognised bias 
and are a source of error. Moving forward with the UK NEQAS(H) DM scheme for CPD 
the morphology SAG will need to consider these effects and incorporate decision-
support systems to identify and reinforce the positive aspects of these skills, while 
seeking to minimise associated biases. 
Participants of the UK NEQAS(H) DM scheme undertake cases to show evidence of CPD 
and do so under uncontrolled conditions using an internet-based image system 
different to reporting blood films by microscopy. Undoubtedly there will also be 
differences in their attitude to completing CPD compared to their approach to patient 
blood films. For this research, however, the numbers participating are large and with 
no equivalent studies on blood film reporting using microscopy the outcome data is 
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important. This work has shown that skills of white cell and red cell identification differ 
(with erythrocyte identification being simpler and therefore easier to learn) and that 
simple and complex films are examined differently with different heuristic tools 
applied. Reporting accuracy in Cases 1 and 2 was relatively high, which offers 
reassurance to participants, those managing the laboratory service and to patients; 
that said reporting accuracy should have been high for Case 1, which depicted a 
condition that every individual reporting blood films will have seen in a patient 
situation. The latter cases studied depicted rare conditions which would not normally 
be encountered by the majority of this participant group, so the error rate might be 
expected to be high. The size of the images used is not directly comparable to viewing 
a whole blood film and so could, therefore, be criticised as unrepresentative of routine 
practice. Accepting that these factors may have added to the errors made and that the 
findings cannot be literally translated to the microscope on the laboratory bench, this 
study has provided an unequalled insight in to the reporting of morphology by a large 
number of laboratory-based professionals. Despite some limitations of the data 
analysis a lower accuracy for identifying morphological features was linked with 
evidence of heuristic, rather than knowledge-based, error although the correct 
outcome action (to refer to a senior colleague) was almost exclusively taken in these 
cases.   
The data demonstrate that mechanisms of error associated with heuristic processes 
are highly important in morphological decision making. Decision-support mechanisms 
and training interventions must recognise the different facets of achieving a 
morphological diagnosis, and actively address both the knowledge-based and heuristic 
processes that combine to drive rapid and accurate decision-making. There is a 
significant part to play for effective decision support tools in blood film reporting but 
these must be easily accessible and understandable to users. With limited time 
allocated to training, the erosion of one to one teaching and an increased reliance on 
internet-based information, the new morphologist is less likely to reach for a text book 
and more likely to access the internet for training support material.  
Although there has been a growth in automated cell-recognition systems, aimed 
primarily at white cell classification, the national uptake of these systems in routine 
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use, even by the large automated laboratories, is slow. These systems may reduce 
errors associated with premature completion and inattention (human traits), however, 
reporting a blood film effectively requires the integration of multiple facets of the 
morphological features and considers how the information is refined down to a range 
of diagnostic outcomes. Equally the automated systems classify white cells but a 
trained human then needs to interpret the significance and the relationship of the 
features seen and formulate this in to a succinct report.    
6.1  Research in context 
Without ensuring staff reporting morphology are proficiency tested, or training 
provided to standardise the format and quality of the morphology report itself, it will 
be a challenge to move the DM scheme from pure CPD to a scored proficiency scheme. 
UK NEQAS(H) has yet to introduce a robust scoring element to the conventional glass 
slide scheme, although as a UKAS requirement, it should be considered that future 
developments for DM include a proficiency element. Indeed, when participants of the 
UK NEQAS(H) annual symposium in York 2014 were asked whether they would be 
prepared to see skill levels introduced to the DM scheme the response, by a show of 
hands, was overwhelming positive. Caution has to be shown when translating the 
findings from this research to blood film reporting via microscopy, however, the 
exercises using images prepared from blood films previously distributed in the glass 
slide scheme gave comparable results; suggesting that these research findings are 
relevant to routine laboratory practice.  
It is important to remember that the number of semi-automated cell recognition 
systems in use is slowly increasing and the morphology SAG are considering whether 
an EQA scheme for these systems is also required. The use of digital images in 
morphology reporting is gaining momentum and quality assurance for their use is 
required.  
Laboratory-based BMS are not alone in needing new initiatives to demonstrate 
proficiency in blood film reporting; clinicians working in pathology laboratories must 
also consider how they demonstrate, to the public, that they are maintaining and 
raising professional quality standards as the debate over revalidation for pathologists 
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continues. The UK NEQAS(H) DM scheme was not aimed at clinical haematologists yet 
29 chose to participate independently (Case 5) and it must be acknowledged that they 
have no nationally accepted method for collecting evidence of their own skills for 
reporting morphology.  
Importantly, despite UK NEQAS(H) only promoting the DM scheme to BMS in the UK, 
the use of the internet allows access to the system internationally and this has 
exploited by some non-UK based professionals. There are quality assurance and 
educational schemes, using digital morphology, in other countries e.g. Spain, Sweden, 
Australia and the United States of America, so the data from this research has 
relevance to a specialised international audience. This data can help inform education 
of morphologists, develop proficiency and improve standards of morphological 
reporting both abroad and in other allied professions. 
6.2 Future work 
The UK NEQAS(H) DM scheme for CPD must evolve to stay relevant to current 
participants and to consider new opportunities. The IT system housing the images is 
being re-developed, taking into account the lessons learnt from this research, with a 
re-launch planned for April 2018. One objective is to link the morphology cases to 
improved educational content recognizing the common causes of error, the narrative 
will be strengthened to advise morphologists on possible bias in their summary 
reports. By explaining to participants the common patterns of error seen it may be 
possible to positively influence their future reporting and, in doing so, improve 
morphology reporting nationally for patient care.       
Future developments of the scheme also include the introduction of leucocyte 
differentials, whilst the introduction of skill level comparison groups has not been 
ruled out, that could be a first step towards individual performance assessment for 
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Chapter Seven: Reflection 
Following 12 years working in a stem cell therapeutics laboratory, with protected time 
for research, I accepted my current managerial position with the encouragement that 
a research element to my role would be welcomed. Initially I was able to develop my 
long held interest in blood cell morphology which, led to an invite to the IBMS 
Haematology Advisory panel and also to lead the morphology session at the bi-annual 
congress. Professor Hyde, Director of UK NEQAS(H) saw the potential of emerging 
internet-based technologies and asked me to chair meetings of a small team of 
interested professionals in Manchester to investigate possibilities for incorporating 
digital images in education for participants. The digital morphology project evolved by 
working with and for UK NEQAS(H) to create exercises participants and then present 
the findings back to them at the annual symposia.    
I underestimated the personal commitment that would be needed from me, to fully 
commit to this work, whilst employed in a busy role with substantial demands on my 
time. The ever increasing drive for efficiency in the NHS puts particular pressures on 
activities beyond those required to provide a routine service and this pressure 
continues to increase.    
Collaborating with UK NEQAS(H): 
The reputation of UK NEQAS(H) could not be placed at risk, every step of the 
development (chapters 1 and 2) involved a small team, was discussed in meetings or 
teleconference and then had to be agreed at the morphology SAG. Some 
developments moved more slowly than I would have liked or were greeted with less 
enthusiasm than anticipated, but each step and every proposal had, quite rightly, to be 
considered by national experts and those responsible for the good reputation of UK 
NEQAS(H). I learnt patience and that accepted wisdoms could be challenged and that 
when the evidence was found, robust support was available and progress was assured. 
When preparing the final case reports for the DM scheme it seemed to me there was a 
lot of data that was not being fully considered, notably the free text responses allowed 
participants to comment on any and all aspects of morphology reporting. This was an 
opportunity to examine part of the DM scheme away from the collaborative process 
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but under the regulation of UK NEQAS(H). At that point I had was unsure as to what 
the data would show, however if the outcome would improve the scheme for 
participants I would have considered the process worthwhile.  
Getting authorized agreement for the extraction of data from the scheme was, 
justifiably, a protracted process and a nervous time for me. The UK NEQAS(H) Manager 
and Director (and the morphology SAG) had to be confident that no information could 
be traced back to individuals. Should the process have caused any issues, ethical or 
technical, at any point then the project would have been cancelled. Getting the original 
agreement took more than a year and data extraction occurred under close scrutiny.  
Technology: 
I did not have any technical expertise as far as photography was concerned and initially 
found the process of stitching, colour correcting, manipulating images, creating 
annotations and attaching narratives, stressful and laborious. Hours could be spent 
creating an image that might not be approved for use. I found, however, letting 
someone else annotate an image I’d prepared just as difficult, experts volunteering to 
build cases invariably underestimate the care and time needed, so the creation of 
cases has remained primarily at CMFT with John Burthem and myself.   
Data handling and analysis: 
When the data was extracted, the format was not exactly user friendly, and it took 
many hours to simply get the data aligned for each case prior to coding. Coding (due to 
the high number of participants) was laborious but fascinating as clear patterns of 
reporting emerged. Coding of the free text proved extremely challenging, I was 
astounded that there could be so many ways to reach a conclusion and shocked and 
intrigued by some of the outcome reports. The very solitary nature of providing a 
morphology report by microscopy had not enabled investigative study of this process, 
so it was important to regularly discuss the findings, as they immerged, with the 
Consultant lead. This enable me to approach the SAG asking to release case data for 
the complex cases and to ask UK NEQAS(H) to ask participants to select a skill level for 
one case.   
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My stress level increased on finding the statistician at Portsmouth left precisely as I 
arranged to see him and I failed to find the access I needed from his successor. Being a 
distance student can be problematic when regular or intense discussion is needed. The 
statistician at CMFT, who had offered support, then took a post elsewhere and it took 
Dr Burthem considered time and effort to ensure statistical support locally. Ensuring 
that the statistics and data examination was robust was essential but again delayed 
the project.     
Making a difference: 
I have never received payment for my role creating and producing cases for the DM 
project although the work has enabled me to attend meetings with like-minded 
professionals without seeking funding from my employer. I’ve felt privileged to have 
represented UK NEQAS(H) DM scheme internationally and had to become familiar with 
the workings of the organisation to do so.  I have carried out most of the work outside 
of my employed hours in order to have the professional freedom and control of my 
input to NEQAS(H). This has taken a time commitment that I could not have given 
without the support of my family. Most professionals cannot or will not put aside such 
a quantity of time for extra work activities. Involvement in developing my profession 
remains the most exciting part of role. Challenging the unknown may have less formal 
responsibility, but it has been more rewarding. 
Debating the issues that surround reporting blood cell morphology has placed me in an 
arena that is predominantly that of the clinical haematologist and so I’ve had to justify 
my opinions and the role of the laboratory scientist, this ensured I had considered all 
aspects and I have generally enjoyed the challenge.   
I have never considered myself ambitious but I am passionate about the laboratory 
haematology work carried out by BMS and providing a quality service for patients. The 
DM project gave me an opportunity to be involved in developing something that has 
impacted positively on my profession nationally and internationally.  
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Appendix A: UK NEQAS(H) ethical form for sample collection 
 




Appendix B: Letter of Ethical Approval and Governance 
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Project Proposal Professional Doctorate Candidate 381533. 
 
Project Working Title: 
Digital Morphology: A National Scheme Supporting Continuous Professional 
Development. 
 
Consideration of Ethics: 
 
The UK NEQAS scheme for General Haematology has overall governance for 
the Digital Morphology Scheme. This project was initiated in 2000 and is 
reviewed by the national Scientific Advisory Panel at the annual meeting of the 
Morphology Scientific Advisory Group. The overall development of the Digital 
Morphology scheme is governed by UK NEQAS (H) of which this project forms 
part. Ethical issues have been considered by both the Morphology SAG and UK 
NEQAS (H) under two main categories:   
 
a/ The preparation of morphology cases is covered by the policies applied to the 
collection of all material for EQA purposes in that samples may only be used if 
they are discard material from routine testing which has been fully anonymised 
and is not traceable back to a patient. For the use of images in the digital 
morphology scheme clinical details and patient demographic data are also 
altered from the original, ie patient ages and test results are altered from the 
original source data. 
 
 b/ The extraction of participant input from the CPD scheme is totally 
anonymised and not traceable. It is not possible to associate extracted data to 
any individual. No participant demographic data will be extracted nor made 
available. This project will use only the morphology features selected and the 
diagnosis input. Once data is extracted, it will not be possible to associate data 
with any individual. The participants are not being tested, this data extraction is 








Professor  Keith Hyde PhD, FIBMS, FRCPath 
Director United Kingdom External Quality Assessment Scheme for  
General Haematology [UK NEQAS(H)] & 
Director World Health Organisation (WHO) 
Collaborating Centre for Quality in Haematology 
  
Clinical Director (Joint) Greater Manchester Laboratory Medicine 
(Pathology) Network 
  
Consultant Clinical Scientist 
Manchester Royal Infirmary Medical Centre 
 
  
Page | 198  
 
 





Case diagnosis Number of 
Participants 
Prepared by 
0801DM Haemoglobin HbA/ 
HbBarts 
219 J Burthem & M Brereton 
0802DM T-PLL 603 J Burthem & M Brereton 
0803DM PK deficency 590 J Burthem & M Brereton 
0804DM Acute Myeloid Leukaemia 
(Therapy related 
alkylating agent) 
563 J Burthem & M Brereton 
0805DM Burns Victim 659 M Brereton & J Burthem 
0901DM APML 649 M Brereton & J Burthem 
0902DM Glandular Fever 732 J Burthem & M Brereton 
0903DM HIV with associated TTP 752 M Brereton & J Burthem 
0904DM CML 862 J Burthem & M Brereton 
0905DM Haemoglobinopathy (Hb 
SC disease) 





1088 J Burthem & M Brereton 
1001DM Primary polycythaemia 
with dimorphic 
erythrocyte populations 
1103 J Burthem & M Brereton 
1002DM Myelofibrosis 
transforming to acute 
leukaemia with previous 
splenectomy 
1318 M Brereton & J Burthem 
1003DM Hereditary 
Pyropoikilocytosis 
964  J Burthem, Z Eke & M 
Brereton 
1004DM Hairy cell leukaemia with 
previous splenectomy 
1050 M Brereton & J Burthem 
 
1101DM Vitamin B12 deficiency, 
megaloblastic anaemia 
1154 J Burthem & M Brereton 
1102DM Sickle cell disease (HbSS) 1013 J Burthem & M Brereton 
1103DM G6PD 1142 M Brereton & J Burthem 
1104DM Plasma Cell leuk 999 J Burthem & M Brereton 
1105DM MAHA & Leuco-
erthyroblastic picture 
1237 J Burthem & M Brereton 
1201DM Haemoglobin SC with 
Acute Myeloid Leukaemia 
1011 M Brereton & J Burthem 
1202DM CLL with Autoimmune 
Haemolysis 
1052 M Brereton & J Burthem 
1203DM Hairy Cell Leukaemia 1261 K Patterson & J Burthem 
1204DM ATLL with G6PD 
deficiency (oxidative 
haemolysis) 
789 M Brereton & J Burthem 
1205DM T-ALL 935 K Patterson & J Burthem 
 
United Kingdom National External Quality Assessment Scheme  
for General Haematology 
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1206DM Pelger-Huet anomaly 1108 M Brereton & J Burthem 
1301DM AML with multi-lineage 
myelodysplasia 
1025 J Burthem & M Brereton 
1302DM CLL with AIHA 774 M Brereton & J Burthem 
1303DM Myelofibrosis, progression 
of primary polycythaemia 
956 J Burthem & M Brereton 
1304DM APML microgranular 
variant  
975 J Burthem & M Brereton 
1305DM May Hegglin anomaly 923 K Patterson & D Pelling 
1306DM Liver disease with 
hyposplensim 
995 J Burthem and M 
Brereton 
1401DM RAEB-II  798 K Patterson & D Pelling 
1402DM Glandular Fever 854 K Patterson & J Burthem 
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Appendix D: Codes for morphology feature selections available to participants 
 
